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 Overview  
 
This thesis is submitted in partial fulfilment of the requirements for the degree of Doctorate 
in Clinical Psychology (D.Clin.Psy.) at the school of Psychology, University of Birmingham.  
This thesis is presented in two volumes. Volume I is the research component consisting of a 
literature review and empirical paper each concerned with the effectiveness of psychosocial 
interventions on cancer treatment-related distress and symptoms.  Volume II is the written 
clinical component, comprising five Clinical Practice Reports.   
 
Volume I 
 
The literature review is a systematic evaluation and critique of empirical research published 
since 1990 to evaluate the effectiveness of psychosocial interventions on distress, symptoms 
and quality of life specifically in relation to cancer treatment.  Thirty-one relevant studies 
were identified evaluating 38 different interventions.  The review included an assessment of 
the quality of the interventions and study designs of included studies.  Interventions were 
grouped into relaxation, cognitive-behavioural, hypnosis and supportive interventions.  
Relaxation interventions demonstrated considerable effectiveness in reducing anxiety related 
to cancer treatment.  The impact of relaxation interventions on other psychological, 
symptom-related and quality of life outcomes were more variable.  No firm conclusions could 
be drawn for cognitive-behavioural interventions due to the vast heterogeneity in 
interventions and equivocal findings.  The evidence for hypnosis and supportive interventions 
was sparse.  Further good quality research is needed to add to the evidence base for cognitive, 
hypnosis and supportive interventions to discern with more confidence their impact on cancer 
treatment-related symptoms.   
 The empirical paper presents a pilot study designed to evaluate the effectiveness of a 
psychological preparation session on women’s distress prior to and following invasive 
internal radiotherapy treatment for gynaecological cancers.  This brief intervention was found 
to prevent further deterioration in anxiety and depression prior to treatment.  Significantly 
more patients in the control group were found to experience greater anxiety and depression 
prior to treatment compared to the intervention group.  The limitations of this empirical 
study, suggestions for future research and clinical implications are also discussed.  Both 
papers are prepared as if for submission to the Journal of Psycho-Oncology.  Some changes 
have been made to the formatting of these papers to comply with regulations for submitting a 
thesis.   
 
Volume II 
 
Volume II contains five Clinical Practice Reports (CPR’s). The first presents the assessment 
and formulation of a young female with needle phobia from a cognitive and psychodynamic 
perspective.  CPR two is a small-scale service related research report, evaluating a 
consultation service delivered by the Child and Adolescent Mental Health Service to Child 
and Family Support Workers based in schools.  The third CPR is a case study outlining the 
work carried out with the family of a 7 year old boy with autism whose behaviour presents 
challenges at home.  CPR four is a single case experimental design that evaluates the 
effectiveness of cognitive-behavioural therapy with a 54-year-old woman in cancer remission 
with health anxiety.  CPR five was presented orally and presented an individual and systems 
level formulation of an inpatient client from a cognitive-behavioural therapy perspective.  An 
abstract of this case provides a brief overview of this work.   
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Abstract 
 
Objective:  Cancer treatments are found to be associated with heightened distress and 
treatment-related symptoms.  The current review provides an up-to-date and detailed 
summary of the evidence regarding the effectiveness of a range of psychosocial 
interventions on treatment-related psychological distress and symptoms in patients 
receiving cancer treatment.  
Methods:  Relevant studies were identified via Medline and PsychINFO databases 
(1990 to April 2010) and from the reference lists of articles and reviews.  Randomised 
controlled trials in a cancer population evaluating at least one psychological or symptom 
related outcome were included.  Interventions had to be specifically targeting patients’ 
distress or physical symptoms as a result of treatment.  The quality of the interventions 
and studies was also assessed.     
Results:  29 studies covering 36 interventions were evaluated.  Relaxation 
interventions proved to have a significant effect on anxiety for cancer patients undergoing 
a variety of different medical treatments.  The findings for other psychological, symptom-
related and quality of life outcomes were more mixed.  The heterogeneity and equivocal 
findings for cognitive-behavioural interventions made it difficult to draw any conclusions.  
The evidence for hypnosis and supportive interventions was sparse. 
Conclusions:  Relaxation training should be incorporated in clinical practice for 
cancer patients receiving treatment.  Further good quality research is needed to ascertain 
the effectiveness of cognitive-behavioural, hypnosis and supportive interventions.   
 
Keywords: Review, psychosocial interventions, oncology, cancer, treatment 
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Introduction 
 
The treatment-related symptoms and heightened distress associated with cancer 
treatments are well documented (e.g. Roscoe, Morrow, Hickok & Stern, 2000; Jacobsen 
et al., 1999; Servaes, Verhagen & Bleijenberg, 2002).  The severity of treatment-related 
side-effects correlates negatively with appraisals of quality of life (Longman, Braden & 
Mishel, 1999) and greater emotional distress is associated with increased physical 
symptoms (Graydon, 1994).  A recent study found that preoperative anxiety had a 
detrimental effect on recovery (Kagan & Bar-Tal, 2008).  Thus, helping patients to cope 
with treatment-related symptoms and distress may influence quality of life and recovery 
post-treatment.  Reviews of psychosocial interventions for treatment-related distress and 
symptoms have reported that relaxation interventions have significant effects on 
symptoms, such as nausea and pain that result from non-surgical treatments of cancer 
(Leubbert, Dahme & Hasenbring, 2001).  Similarly a systematic review by Redd, 
Montgomery & DuHamel (2001) found that behavioural interventions could reduce 
anxiety and distress associated with invasive cancer treatment and assist in the 
management of anticipatory nausea and vomiting associated with chemotherapy (Redd et 
al., 2001).  This review, unlike the previous two reviews (Leubbert et al., 2001; Redd et 
al., 2001), which concentrated solely on behavioural interventions, evaluates a range of 
psychosocial interventions designed to target treatment related symptoms and distress.  
This will help to ascertain whether interventions, other than relaxation, also have an 
impact on treatment-related symptoms.  This review will also include more recent 
evaluations of relaxation interventions for treatment-related symptoms.   
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To the best of my knowledge, there have been no recent reviews that have 
evaluated the effectiveness of a broad range of psychosocial interventions on treatment-
related symptoms and/or distress in cancer patients receiving treatment.  This is the aim 
of this review.  Firstly, the methodology for this review will be described.  Secondly, the 
categories of interventions identified will be reviewed, followed by an evaluation of 
studies which compared different types of interventions.  The quality of the interventions 
and studies that are included will also be assessed.   
 
Methods 
 
Literature search strategy 
 
Electronic literature searches were performed on the Cochrane Central Register of 
Controlled Trials, MEDLINE and PsychINFO (see appendix 3).  A combination of MeSH 
(terms were exploded) and free text terms were utilised.  The search criteria were adapted 
for the individual databases because of the different search terms embedded within them.  
References in retrieved articles were further searched for relevant citations.  Keywords 
used in the searches included those related to cancer, different types of cancer treatment, 
psychological interventions and psychological and symptom outcomes.  
 
Study selection criteria 
 
Studies which described and evaluated a psychosocial intervention using a Randomised 
Controlled Trial (RCT) research design and published from 1990 onwards were eligible 
for inclusion in this review.  The participants were required to be adult (aged 18 years or 
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above) cancer patients receiving active treatment for cancer.  Patients who had completed 
their treatment were not eligible.  There were no restrictions according to number of 
participants or types of cancer.  The review focused exclusively on interventions which 
directly intended to assist patients in coping with their treatment related distress and / or 
symptoms while in active treatment.  Therefore, the review was limited to interventions 
which were delivered prior to, during or post-treatment.  Post-treatment interventions 
were only included if they were implemented within an hour following treatment and 
focused on distress and / or symptoms as a result of treatment.  A broad range of 
interventions was considered, including relaxation, cognitive-behavioural, psychotherapy, 
hypnosis and supportive interventions.  Individualised and group-based interventions 
were eligible, as were self-administered interventions which incorporated predominantly 
psychological components.  Purely educational and physical activity interventions and 
multifaceted interventions which used minimal psychological techniques were excluded.  
Multifaceted interventions were only included if psychological approaches were equal to 
or more than half (50% or greater) of the intervention.  At least one of the outcomes had 
to be psychological or symptom related.  There were no restrictions on the method of 
assessment, frequency, intensity or duration of interventions.   
 
Methods of the review 
 
The titles and abstracts of identified studies were first reviewed and those clearly not 
meeting the inclusion criteria were eliminated.  The full inclusion and exclusion criteria 
included: 
‐ Randomised controlled trials –random assignment had to be mentioned 
‐ Population had to have confirmed diagnoses of cancer 
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‐ Interventions needed to include a significant psychological component (50% or 
greater), such as relaxation, cognitive-behavioural techniques, and hypnosis.  
Interventions labelled as ‘psychological support’ and not described in further 
detail were excluded.   
‐ English only references included 
‐ Interventions had to be delivered prior to and/or during active treatment or within 
an hour following treatment.   
‐ Outcomes assessed had to be directly as a result of the treatment (symptom-related 
and psychological).   
‐ Studies which included all the main inclusion criteria but scored in the poor range 
on quality of study design and intervention (see quality assessment below) were 
excluded.   
 
When it could not be discerned from the title and abstract that the full inclusion 
criteria had been fulfilled, then full paper copies were retrieved and reviewed.  A data 
extraction form (see appendix 5) was used to organise data from the research papers.  
 
Quality assessment 
 
The Yates Scale (Yates, Morley, Eccleston & Williams, 2005; see appendix 6) designed 
specifically to assess the quality of studies evaluating psychological interventions was 
utilised in this review.  The quality of interventions was assessed on factors related to 
manualisation of intervention, fidelity checks, the level of therapist training, and 
engagement of patients.  The quality of study designs was measured by considering 
patient selection, attrition, methods of randomisation, allocation and measurement bias, 
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outcomes, follow-up, power and quality of control groups.  The scale provides a score for 
the quality of the intervention (range 0 – 9) and for the quality of the study design and 
methods (range 0 – 26).  There is no criterion included in the Yates Scale to categorise 
studies according to levels of quality therefore the following cut-offs were formed by the 
researcher to more clearly distinguish between poor and good quality research.  The 
quality of the study design was categorised as poor for a score of nought to eight, 
moderate nine to 17, and good 18 to 26.  The quality of the intervention was categorised 
as poor for a score of nought to three, moderate four to six and good seven to nine.   
Studies which scored in the poor range for study design and intervention were excluded.   
Cognitive-behavioural interventions were broadly defined and included any 
intervention which specified using cognitive and behavioural techniques.  The use of the 
term cognitive-behavioural has been applied to a wide range of interventions.  Therefore, 
it was felt important to consider how many key elements of the cognitive-behavioural 
therapy approach the interventions met.  A classification criterion developed by Jones, 
Cormac, Silveira da Mota Neto, and Campbell (2010) was utilised.  To adapt its use for 
psychosocial interventions in physical health it was slightly modified (see Table 1).  
Interventions were categorised as well-defined or less well defined (Jones et al. 2010).  
Well-defined interventions satisfied criteria one and two, and one element of the third 
criterion.  Less well-defined interventions did not meet this criterion (or did not provide 
enough information) but were described as using cognitive methods or cognitive-
behavioural strategies.  Less well-defined interventions could either satisfy criterion one 
or two, and one or more elements of the third criterion.  Or fail to satisfy criterion one and 
two, but fulfil one or more elements of the third criterion.   
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Table 1. Criterion to classify cognitive-behavioural interventions as well-defined or less 
well-defined 
Fulfil both of the following: 
1. Links between thoughts, feeling and actions 
2. Correction of an individual’s misinterpretations, irrational 
beliefs/thoughts, and reasoning biases, *illness perceptions 
Fulfil one of the following: 
3a. Monitoring of thoughts, feelings and behaviours 
3b. Promoting alternative coping methods 
3c. *Attempted modification of behavioural responses to symptoms and 
illness (e.g. rest, sleep, self management, activity pacing) 
* Amendments made to the criterion established by Jones et al. (2010) 
 
Results 
 
Literature search results  
 
Twenty-nine studies met the inclusion criteria and were included in the review (see 
Figure 1 for more details).  Across the 29 studies, 36 interventions were evaluated (see 
Table 2).  There were 14 studies which evaluated relaxation training interventions, 
covering 15 different interventions between them.  Four studies evaluated interventions 
including a substantial hypnosis/hypnotherapy component.  Eleven studies evaluated 
cognitive-behavioural interventions.  One study contributed two interventions to this 
section of the review (Jacobsen et al., 2002).  Six interventions were categorised as 
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supportive interventions and were evaluated in four studies.  One study contributed three 
supportive interventions (Burton & Parker, 1995).   
The designs of the majority of the studies (24; 77%) involved comparing an 
intervention group with a control group.  The sample size of the studies varied from 28 to 
411.  Seventy-four percent of the studies focused on patients receiving chemotherapy or 
radiotherapy.  Sixteen studies had one type of malignancy within their sample, mainly 
patients with breast cancer.  (See appendix 7 for further information about the 
characteristics of the studies).  A number of self-report measures were used in the studies 
to assess psychological, symptom-related and quality of life outcomes (see appendix 4 for 
a table of measures and reference list).  The most commonly used measure for 
psychological outcomes was the State-Trait Anxiety Inventory (STAI) which was used in 
eight studies and the Multiple Affect Adjective Checklist (MAACL) which was used in 
six studies.  For the investigation of quality of life outcomes the Medical Outcomes Study 
36-item Short Form (SF-36) was utilised in six studies.  Apart from the previous 
examples, there was little consistency in the measures employed across the 31 reviewed 
studies and some authors developed measures specifically for use in their studies.   
In terms of the quality of study designs, the majority (71%, 22) scored in the 
moderate range according to the quality criteria described above (see appendix 9).  In 
relation to the quality of the intervention, 55% (17) of the studies were rated as having 
interventions of moderate quality (see appendix 8).  The interventions have been grouped 
as relaxation, hypnosis, cognitive-behavioural and supportive, and each will be discussed 
separately below.   
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Figure 1. Process of selection for suitable studies 
5499 references 
retrieved 
94 identified for 
further 
consideration 
19 excluded- non-
intervention studies or 
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75 reviewed further 
according to 
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2- not RCT’s 
2- did not meet 
quality criteria 
3 – not available in 
English 
8 – not a cancer 
population 
8 – not related to 
cancer treatment 
11 – delivered post-
treatment (> 1 hour 
after treatment) or 
psychological/physi
cal outcomes not 
measured 
12- interventions 
not psychological 
29 studies
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Relaxation studies 
 
Fifteen relaxation interventions were reviewed.  Four interventions (Syrjala, Donaldson, 
Davis, Kippes & Carr, 1995; Burish, Snyder & Jenkins, 1991; Walker et al., 1999; Yoo, 
Ahn, Kim, Kim & Han, 2005) scored poorly on quality and were thus weighted less in the 
review.   
 The majority of studies compared an intervention and control group.  One study 
separately evaluated the delivery of the same intervention by clinical psychologists or 
clinical oncologists and oncology nurses, and compared these to a control group (Morrow 
et al., 1992).  Burish and Jenkins (1992) evaluated five different types of interventions in 
a six-group design.  These interventions involved various combinations of 
Electromyographic (EMG) biofeedback, skin-temperature (ST) biofeedback, no 
biofeedback and the provision and non-provision of relaxation training.   
The interventions incorporated a number of different relaxation components (see 
appendix 10).  Progressive muscle relaxation and guided imagery were the most 
commonly utilised relaxation techniques.  The time points at which the interventions were 
delivered were diverse: including (1) from a few weeks to or a few hours prior to 
treatment (2) at the same time as treatment (3) mid-way through treatment and (4) 
immediately following treatment (to view further details of the studies refer to Table 2 
and the measures used by studies are listed in appendix 4).   
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Psychological outcomes 
 
Eleven of the 14 relaxation studies evaluated psychological outcomes, either by assessing 
emotional reactions to treatment or coping strategies.  Relaxation interventions seemed to 
be effective in promoting changes in psychological outcomes in the desirable direction.  
Of these 11 studies, all but one found significant changes in psychological outcomes as a 
result of the intervention.    
 Morrow and colleagues (1992) found that a systematic desensitisation and 
progressive muscle relaxation intervention did not significantly reduce anxiety in 
chemotherapy patients compared to the control group.  It is worth noting that this study’s 
primary objective was to reduce anticipatory nausea and vomiting (ANV), and thus 
patients with these symptoms were selected.  Therefore, an improvement in anxiety may 
not have been a prime objective of this intervention.  In contrast, Burish and Jenkins 
(1992) whose intervention also aimed to reduce ANV and which also selected participants 
suffering with these symptoms did report a significant reduction in anxiety in the 
intervention group compared to the control group.  A comparison of the components of 
these interventions shows that Burish and Jenkins (1992) offered guided imagery, while 
this was not utilised by Morrow and colleagues (1992).   
 Seven studies reported a significant reduction in anxiety as a result of the 
relaxation interventions (Leon-Pizarro et al., 2007; Nunes et al., 2007; Yoo et al., 2005; 
Arawaka, 1997; Burish & Jenkins, 1992; Burish et al., 1991; Lerman et al., 1990).  
However, reductions in anxiety were not always found at all time points. For example, 
Burish and Jenkins (1992) found that relaxation patients had significantly less anxiety 
than non-relaxation intervention patients for the fifth session of chemotherapy only.  
Lerman et al. (1990) investigated the influence of personality style, and found that 
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individuals with a blunting coping style who received the intervention had a significant 
reduction in anxiety before chemotherapy when compared to the control group.  The 
findings for depression were more mixed.  Two studies reported that their interventions 
significantly lowered depression compared to the control group (Leon-Pizarro et al., 
2007; Nunes et al., 2007), while three studies failed to find any significant results 
(Lerman et al., 1990; Molassiotis, Kangas, David, Hallquist & Green., 2002; Yoo et al., 
2005).   
Relaxation interventions were also found to significantly reduce self-reported 
stress (Nunes et al., 2007), overall mood disturbance (Molassiotis et al., 2001), anger and 
tension (Decker, Cline-Elsen & Gallagher, 1992).  There were other psychological 
outcomes in which no significant change was demonstrated, such as tension and anger 
(Molassitotis et al., 2001) and hostility (Yoo et al., 2005).   
 
Treatment-related symptoms  
 
Eight of the studies measured symptom severity as an outcome.  In all but one study the 
main symptoms of interest were nausea and/or vomiting as a result of chemotherapy 
treatment.  All studies reported a reduction in some aspect of nausea and/or vomiting 
outcomes, although significant outcomes were not found in all measures of nausea used in 
the studies or at all time points assessed.   
Three studies found no differences in vomiting frequency (Vasterling, Jenkins, 
Tope, Burish, 1993; Arakawa, 1997; Burish & Jenkins, 1992) and one study reported no 
differences in the intensity of vomiting (Molassiotis et al., 2002).  However, two studies 
reported significantly lower levels of vomiting in the intervention group (Molassiotis et 
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al., 2002; Burish et al., 1991) and two reported that the duration of vomiting was 
significantly less in the intervention group (Molassiotis et al., 2002; Morrow et al., 1992).  
 Four studies significantly reduced the duration of nausea (Molassiotis et al., 2002; 
Morrow et al., 1992; Lerman et al., 1990; Vasterling et al., 1993) and the severity or mean 
scores of nausea were found to be significantly lower in five studies as a result of the 
intervention (Yoo et al., 2005; Arakawa, 1997; Burish et al., 1991, Morrow et al., 1992; 
Burish & Jenkins, 1992).  However, for some studies these significant differences were 
only found at particular time points (Burish et al., 1992; Lerman et al., 1990; Yoo et al., 
2005; Vasterling et al., 1993).  For example, Burish and Jenkins (1992) found these 
significant differences for the last three chemotherapy sessions only. 
 Burish and Jenkins. (1992) evaluated five different combinations of interventions 
which comprised of electromyographic biofeedback (EMG) or skin temperature (ST) 
feedback combined with or without relaxation.  This study found significantly lower 
nausea in those interventions consisting of relaxation alone or relaxation combined with 
biofeedback, compared to the control and biofeedback only groups.  Syrjala and 
colleagues (1995) measured pain associated with bone marrow transplant treatment and 
found that those in the intervention group who received training in progressive muscle 
relaxation, guided imagery and deep breathing reported significantly less pain than 
patients in the control group, but not compared to the supportive attention group.   
 
Quality of life. 
 
Quality of life outcomes were assessed by three studies (Leon-Pizarro et al., 2007; 
Walker et al, 1999; Yoo et al., 2005).  In the study by Leon-Pizarro and colleagues (2007) 
the body discomfort component of the quality of life measure was found to be 
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significantly less at post-treatment in the intervention group compared to the control 
group.  Two poorer quality interventions found that the intervention group had 
significantly better overall quality of life compared to the control group (Walker et al., 
1999) and intervention participants were found to have a more positive quality of life in 
relation to the physical and emotional concerns for breast cancer (Yoo et al., 2005) 
compared to the control group.  In the latter study these differences in quality of life were 
maintained at six months follow-up.   
 
Hypnosis interventions 
 
The components of the hypnosis interventions are shown in Table 2.  In this section four 
interventions are reviewed.  Two are solely hypnosis/hypnotherapy (Stalpers et al., 2005; 
Syrjala, Cunnings & Donaldson, 1992) and two are hypnosis combined with cognitive-
behavioural techniques (Schnur et al., 2009; Montgomery et al., 2009).  None of the 
studies or interventions was rated as poor.  All interventions comprised one-to-one 
individual sessions and offered two pre-treatment intervention contacts.  Of these four 
interventions, two assessed treatment-related symptom outcomes (Montgomery et al., 
2009, Syrjala et al., 1992), two psychological outcomes (Schnur et al., 2009; Stalpers et 
al., 2005) and one quality of life outcomes (Stalpers et al., 2005).   
 
Psychological outcomes 
 
Schnur and colleagues (2009) used the Mood Report Form to measure positive (happy, 
pleased) and negative (unhappy, depressed, frustrated) affect.  This study found that the 
hypnosis and cognitive-behavioural intervention significantly reduced negative affect and 
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increased positive affect in patients receiving radiotherapy.  Additionally, compared to 
the control group, the intervention group had significantly more intense positive affect 
and significantly less intense negative affect, and a greater number of days when they 
experienced more positive affect than negative affect (Schnur et al., 2009).  In contrast, 
Stalpers et al. (2005) reported no change in the levels of anxiety between the intervention 
and control group for radiotherapy treatment. 
 
Treatment-related symptoms  
 
Side effects targeted by interventions included fatigue and muscle weakness as a result of 
radiotherapy (Montgomery et al., 2009), and oral pain and nausea as a consequence of 
bone marrow transplant treatment (Syrjala et al., 1992).  Montgomery and colleagues 
(2009) reported a significant effect on rate of change in fatigue during treatment.  
Participants in the hypnosis and cognitive-behavioural group were not found to have 
increases in fatigue over time whereas there were linear increases of fatigue in the control 
group (Montgomery et al., 2009).  Similarly, increases in muscle weakness were lower in 
the intervention group compared to the control group.   An earlier study, found that 
participants in the hypnosis group had significantly lower pain compared to the cognitive-
behavioural intervention and attention support control group (Syrjala et al., 1992).  
However, no differences were reported for nausea (Syrjala et al., 1992). 
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Quality of life outcomes 
 
Stalpers and colleagues (2005) investigated the impact of their hypnosis intervention on 
quality of life outcomes.  The study found no differences between the intervention and 
control group on the SF-36.  It was suggested by the authors that perhaps the measure 
utilised was too insensitive to measure change in wellbeing over time.  The authors also 
noted that at baseline the scores on the mental health component of the SF-36 were high, 
leaving little room for further improvement.   
 
Cognitive-behavioural interventions 
 
Four studies described their interventions as cognitive behavioural (Given et al., 
2004; Syrjala et al., 1995; Phillips et al., 1998; Syrjala et al., 1992), four explicitly used 
the term cognitive-behavioural or cognitive in relation to the key strategies utilised in the 
intervention (Parker et al., 2009; Armes, Chalder, Addington-Hall, Richardson & Hotopf, 
2007; Brown et al., 2006; Vasterling et al., 1993).  There were five studies (Ream, 
Richardson & Alexander-Dann, 2006; Krischer, Xu, Meade & Jacobsen, 2007; Jacobsen 
et al., 2002; Larson, Duberstein, Talbot, Caldwell & Moynihan, 2000; Burton & Parker, 
1995) which did not identify their interventions as cognitive.  However, upon 
examination of the components of these interventions (see appendix 11 & 13) four 
interventions (Jacobsen et al., 2002 (professionally-administered stress management 
training (PSMT) and self-administered stress management training (SSMT)); Larson et 
al., 2000; Krischer et al., 2007), were not dissimilar in content to the cognitive-
behavioural interventions.  In fact, two of these studies had interventions which could be 
categorised as well-defined cognitive-behavioural interventions.  Therefore, it was 
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decided that these three interventions would also be included in this section of the review.  
In total, 12 interventions were evaluated in this section (appendices 12, 13 and 14 show 
the various components of the interventions).  Three studies did not incorporate relaxation 
strategies in their cognitive-behavioural interventions (Armes et al., 2007; Given et al., 
2004; Vasterling et al., 1993).  Two interventions were group-based and two interventions 
were self-administered.  The time-points at which interventions were introduced were 
diverse, including before treatment, just prior to and during treatment (see Table 2 for 
characteristics of the studies and appendix 4 for the measures utilised).   
 Using the criteria described in the methods section for cognitive-behavioural 
interventions (see appendix 11), three studies fulfilled the criteria to be classified as well-
defined (Jacobsen et al., 2002 (PMST); Larson et al., 2000; Armes et al., 2007).  Four 
interventions were found to only fulfil one criterion for cognitive-behavioural 
interventions (Brown et al., 2006; Given et al., 2004; Parker et al., 2009; Vasterling et al., 
1993) and these were weighted less. 
 
Psychological outcomes  
 
The evidence regarding the impact of cognitive-behavioural interventions on 
psychological outcomes was mixed.  Anxiety and depression were measured by six 
studies.  Three studies reported significant improvements in the intervention group on 
psychological outcomes compared to the control groups.  Intervention groups were found 
to report less anxiety and depression during chemotherapy (Jacobsen et al., 2002 (SSMT)) 
and had lower disgust scores (Larson et al., 2000).  A poorly defined cognitive-
behavioural intervention was found to significantly reduce mood disturbance before 
surgery (Parker et al., 2009) compared to the control group.  Significant differences in 
   - 19 -
  
outcomes were sometimes not found for the whole sample but for sub-groups.  Krischer 
and colleagues (2007) found that significantly less depression in the intervention group 
was only evident when comparing highly distressed participants in the intervention and 
control groups.  For some studies significant differences were not found for all 
psychological outcomes, including traumatic stress (Larson et al., 2000; Parker et al., 
2009) and depression (Larson et al., 2000).  Three interventions failed to detect any 
changes in psychological outcomes (Armes et al., 2007; Jacobsen et al., 2002 (PSMT); 
Syrjala et al., 1995).   
 
Treatment-related symptoms  
 
The symptoms considered included fatigue (Armes et al., 2007; Brown et al., 2006), pain 
(Syrjala et al., 1992; Syrjala et al., 1995), nausea (Syrjala et al., 1995; Syrjala et al., 1992; 
Vasterling et al., 1993), symptom severity (Given et al., 2004) and vomiting (Vasterling 
et al., 1993, Syrjala et al., 1992).  Armes and colleagues (2007) reported a trend towards 
improved cancer-related fatigue in the intervention group and reported significant results 
in favour of the intervention group at four week follow-up compared to the control group.  
At week eight, Brown et al. (2006) found that the intervention group (poorly defined 
cognitive-behavioural intervention) reported significantly less fatigue than the control 
group.  Differences in fatigue were not found for all measures of fatigue or at all time 
points.   
Participants in a distraction intervention (poorly defined cognitive-behavioural 
intervention) reported less nausea prior to and during the first four cycles of 
chemotherapy (Vasterling et al., 1993).  In contrast a few studies reported no differences 
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in nausea (Jacobsen et al., 2002; Syrjala et al., 1992; Syrjala et al., 1995) or frequency of 
vomiting (Syrjala et al., 1992; Vasterling et al., 1993).   
Significantly less pain was reported in patients having bone marrow transplant 
treatment in the intervention group than the treatment as usual group, but not when 
compared to the “supportive attention” control group in a study by Syrjala and colleagues 
(1995).  An earlier study reported no significant differences in pain (Syjala et al., 1992).  
Finally, a poorly defined cognitive-behavioural intervention was found to significantly 
lower symptom severity in participants who entered the trial with high levels of severity 
compared to the control group (Given et al., 2004).   
 
Quality of life  
 
The most common measure used to assess quality of life was the SF-36 (Ware & 
Sherbourne, 1992).  This was utilised by four studies for five interventions (Krischer et 
al., 2007; Larson et al., 2000; Parker et al., 2009; Jacobsen et al., 2002).  The SF-36 
contains eight multi-item scales including general health perceptions, physical 
functioning, role limitations due to physical problems, bodily pain, general mental health, 
vitality, role limitations due to emotional problems, and social functioning.  It is worth 
noting that studies which reported significant findings only found these for some of the 
subscales.  Jacobsen et al. (2002) reported that the SSMT intervention group reported 
significantly better physical functioning, greater vitality and fewer role limitations 
because of emotional problems associated with chemotherapy treatment compared to the 
control group.  However, no significant findings were found for the PSMT intervention.  
Krischer and colleagues (2007) found that participants with higher levels of distress at the 
initiation of radiotherapy and who received the intervention, reported significant 
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improvements in the mental health subscale.  Parker et al. (2009) reported that their 
intervention group (poorly defined cognitive-behavioural intervention) had significantly 
better physical functioning at one year follow-up compared to the control group following 
radical prostatectomy treatment.  However, no significant differences were found on the 
Prostate Cancer Index.  Finally, Larson and colleagues reported no significant changes in 
quality of life using the SF-36.  Using other measures, Armes and colleagues (2007) 
found improvements in the EORTC physical functioning at four weeks and nine months 
follow-up in chemotherapy patients.   
 
Supportive interventions 
 
The remaining six interventions were supportive in nature (Ream et al., 2006; Gaston-
Johansson et al., 2000; Burton & Parker, 1995; and Burish et al., 1991).  Ream and 
colleagues (2006) provided a “support intervention” and Gaston-Johansson and 
colleagues (2000) a “comprehensive coping strategy program” (see Table 2 for further 
details of the interventions).  Burish et al. (1991) offered a “PREP” intervention which 
aimed to provide information and to elicit and address patients concerns about treatment.  
Burton and Parker (1995) contributed three interventions, all of which comprised a pre-
operative session but with varying additional components.  One group received the pre-
operative session only, while another group received an additional non-therapeutic chat, 
and another group received an addition psychotherapeutic session.   
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Psychological and quality of life outcomes  
 
Ream and colleagues (2006) found that patients receiving chemotherapy in the supportive 
group reported significantly less depression and anxiety compared to the control group.  
Burish et al. (1991) found that patients in the PREP intervention, which was rated as poor 
in quality, were found to have significantly less depression prior to treatment 
chemotherapy sessions.  No differences in psychological outcomes were reported by 
Gaston-Johansson and associates (2000).  The analysis of interview data by Burton and 
Parker (1995) found that participants who received the pre-operative session for 
mastectomy treatment had lower body image distress, lower depression and anxiety, and 
at one year follow-up had less worry and more fighting spirit compared to the control 
group.  For participants identified as having stressful life events those who received the 
additional psychotherapeutic chat reported significantly lower distress.  Ream and 
colleagues (2006) found that the intervention group had significantly higher perceptions 
of coping, used significantly more humour and less behaviour engagement compared to 
the control group.  This study also found that intervention group had significantly greater 
vigour and better mental health compared to the control group.       
 
Treatment-related symptoms  
 
The side effects evaluated in these studies were fatigue (Gaston-Johansson et al., 2000; 
Ream et al., 2006), nausea (Burish et al., 1991; Gaston-Johansson et al., 2000), pain 
(Gaston-Johansson et al., 2000) and vomiting (Burish et al., 1991).  Ream et al. (2006) 
found that the intervention group reported significantly less chemotherapy-related fatigue, 
lower fatigue-related distress, and less impact of fatigue on valued past-times compared 
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to the control group.  In contrast, once Gaston-Johansson and associates (2000) controlled 
demographic variables there were no significant differences between the groups on 
fatigue outcomes for patients having autotologous bone marrow transplantation.   
Burish and colleagues (1991) found that the PREP group had significantly lower 
levels of anticipatory nausea at all sessions of chemotherapy and vomited significantly 
less following chemotherapy.  Gaston-Johansson et al. (2000) found that seven days after 
autotologous bone marrow transplantation the intervention group had significantly lower 
nausea than the control group.  In relation to pain, no significant differences were 
reported by this study.  
 
Comparisons of different interventions 
 
Six studies made comparisons between different types of interventions (Burish et al., 
1991; Burish & Jenkins, 1992; Jacobsen et al., 2002; Vasterling et al., 1992; Syrjala et al., 
1992; Syrjala et al., 1995).  
Burish et al. (1992) compared five interventions.  These involved different 
combinations of EMG biofeedback, ST biofeedback, no biofeedback and the provision 
and non-provision of relaxation training.  This study found participants who received 
relaxation training reported significantly less nausea in the last three chemotherapy 
sessions and less anxiety compared to non-relaxation groups.  The authors concluded that 
relaxation training and not biofeedback were the active ingredients of the intervention 
which produced change.   
Jacobsen and colleagues (2002) compared self-administered stress management 
training and professionally-administered stress management training.  It was found that 
the self-administered intervention reported significantly better quality of life outcomes 
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when compared to the control group in patients receiving chemotherapy.  The 
professionally-administered group was not found to significantly differ compared to the 
control group.  The authors suggested that self-administered intervention may have 
promoted greater mastery in the participants and the patient testimonies, which were 
absent from the professional-administered intervention, may have through a process of 
modelling provided participants with a greater perception of the effectiveness and 
usefulness of relaxation techniques in improving quality of life.   
Syrjala et al. (1995) compared a relaxation training intervention with a cognitive-
behavioural intervention on patients receiving bone marrow transplant.  The cognitive 
behavioural intervention also encompassed the complete relaxation training element of 
the other intervention.  It was found that both interventions significantly reduced pain but 
had no effect on nausea compared to the control group.  In this study the cognitive-
behavioural components did not provide an additive affect beyond that of relaxation 
training alone.  Syrjala et al. (1992) compared a hypnosis and CBT intervention.  
Analyses indicated that the hypnosis intervention group reported significantly less pain 
than the cognitive-behavioural group.  However, no differences were found in nausea, 
emesis or opoid use for bone marrow transplant patients.   
Vasterling and colleagues (1993) reported that both a relaxation training and 
distraction intervention resulted in significantly less nausea as they awaited their 
chemotherapy before the first and follow-up session compared to the control group.  
Burish et al. (1991) compared a coping intervention ‘PREP’ with a relaxation 
intervention, and a group who received both interventions.  It was found that patients who 
received the PREP intervention were significantly more knowledgeable about the 
treatment, reported significantly less anticipatory nausea, were less depressed before 
treatment sessions and had significantly less interruption in their daily lives.  Patients who 
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received the relaxation training reported significantly lower levels of anticipatory nausea 
across all sessions, had significantly less anxiety at session one and two of chemotherapy.  
Patients who received the PREP combined with relaxation training intervention had 
significantly less vomiting after chemotherapy compared to the control group.   
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Table 2. Characteristics and main findings of included studies 
 
Intervention 
format 
Intervention 
components 
Control 
group 
Outcomes Main findings Quality Score Authors/year
/ country/ 
treatment/ 
arms of trial 
Description 
of sample 
   Psych Side 
effects
QoL  Int Study 
Montgomery 
/ 2009 / 
America / 
radiotherapy 
/ IG and CG 
Hypnothera
py  
Breast 
cancer 
42 (22 in 
IG & 20 
CG) 
2 pre-
treatment 
sessions (15-
30 minutes) 
and twice 
weekly 
booster 
sessions (5-
15 minutes) 
 
  
Individual format 
Hypnosis: 
Hypnotic induction 
Guided imagery 
Suggestions  
Cue word to induce 
individual hypnosis 
Audio of session 
CBT: 
Recognising negative 
beliefs 
Alternative more 
helpful belief 
Activity scheduling 
CBT workbook 
Weekly thought 
records 
 
TAU  ?  IG had significant effect 
on fatigue over the 
course of the treatment.  
CG had significant 
increases in fatigue, 
while IG remained 
unchanged.   
Rate of increase in 
muscle weakness was 
significantly lower in IG 
compared to CG. 
4 20 
Parker / 
2009 / 
America / 
radical 
prostatectom
y / IG, SA, 
CG 
CB 
Prostate 
cancer 
159 
participants
, 53 in IG, 
54 in SA, 
52 in SC 
 
2 pre-
treatment 
sessions (60-
90 minutes), 
2 booster 
(10-12 
minutes),  
including one 
Individual format 
Deep breathing 
Guided imagery 
Imaginal exposure 
Audio  
Daily practice  
Coping skills 
Social support 
SA 
& TAU 
 
?  ? IG group had 
significantly less mood 
disturbance prior to 
surgery compared to 
CG.   
IG group had 
significantly higher 
scores on the physical 
4 19 
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after 
treatment. 
Concerns and fears  component of the SF-36 
compared to the CG.  
Significant findings 
only found between IG 
and CG, but not in 
relation to SA.   
 
Schnur / 
2009 / 
America / 
radiotherapy 
/ IG and CG 
Hypnothera
py  
Breast 
cancer 
40 
participants 
(20 in IG 
and 20 in 
CG) 
 2 pre-
treatment 
sessions (15-
30 minutes) 
and twice 
weekly 
booster 
sessions (5-
15 minutes) 
 
Hypnosis & CBT 
Hypnotic induction 
Guided imager 
Suggestions 
Cue word to induce 
hypnosis 
Audio of session 
Negative beliefs 
Alternative beliefs 
Behavioural strategies 
CBT workbook 
Thought records 
 
TAU ?   IG significantly reduced 
levels of negative affect 
(every week) and 
increased levels of 
positive affect (week 1, 
2, 3 &5).   
 
7 18 
Phillips / 
2008 / 
America / 
mastectomy, 
lumpectomy, 
chemotherap
y, 
radiotherapy 
/ IG & CG 
CB 
Breast 
cancer 
128 
participants 
(63 IG and 
65 CG) 
Unreported 
when started.  
10 weekly 2-
hour sessions 
Delivered by 
trained 
female 
facilitators  
Group format 
Deep breathing 
Guided imagery 
Meditation  
Progressive muscle 
relaxation 
Daily practice 
Coping skills 
Cognitive restructuring 
Assertion training  
Social support 
 
condens
ed 
seminar 
of 
interven
tion.  
?   IG had significantly 
greater reductions in 
cortisol levels across 12 
months compared to 
CG- cautious 
interpretation.  
IG reported greater 
increases in ability to 
relax than controls- non 
significant 
5 8 
   - 28 -  
Armes /2007 
/ UK / 
chemotherap
y / IG and 
CG 
CB 
Various 
cancers. 60 
(30 in CG 
and 30 in 
IG). 
Only 55 
completed 
baseline 
assessments 
Started just 
prior to 
treatment.  3 
individual 
face-to-face, 
60 minute 
sessions at 3 
to 4 weekly 
intervals  
Individual format 
Coping skills 
Alternative illness 
perceptions 
Identifying thoughts 
and feelings 
Self-monitoring 
Distraction  
Activity scheduling 
Written information 
 
TAU ? ?  Significant 
improvement in 
physical functioning in 
IG at 4 weeks and 9 
months.  Significant 
differences in fatigue 
inventory at 4 weeks 
and 9 months.  IG 
increased activity levels.  
No differences on other 
fatigue outcomes 
  
8 18 
Krischer / 
2007 / 
America / 
radiotherapy 
/ 
IG & CG 
CB 
Various 
cancers. 
 310 
participants 
(154 in IG 
and 156 in 
CG) 
Self-
administered 
Nurse gave 
materials 
Self administered 
Paced breathing 
Guided imagery 
Progressive muscle 
relaxation 
Audio 
Self statements 
Thought monitoring 
Written  
Videotape 
 
TAU ?  ? Participants with high 
levels of psychological 
distress reported 
significant 
improvements in their 
SF-36 mental health 
subscale and depression 
compared to the CG. 
5 15 
Leon-Pizarro 
/ 2007 / 
Spain / 
brachytherap
y / IG & CG 
Psycho-
oncology 
Relaxation  
Breast 
cancer and 
gynaecolog
ical cancers  
66 (32 in 
IG and 34 
in CG) 
Pre-
treatment. 
Single 
session 2 
weeks prior 
to treatment 
Individual format 
Guided imagery 
Deep breathing 
Audio, Daily practice 
Information provision 
and elicitation of 
concerns- the same as 
control group 
 
Informa
tion 
provisio
n & 
elicitat 
of 
concern
s.   
 
?  ? Compared with the 
control group the IG 
demonstrated a 
statistically significant 
reduction in anxiety, 
depression and body 
discomfort 
3 15 
   - 29 -  
 
Nunes / 2007 
/ Brazil / 
radiotherapy/
IG & CG/ 
Relaxation  
Breast 
cancer 
34 (20 in 
EG & 14 in 
CG) 
24 daily 30 
min 
structured 
groups (4 
participants) 
delivered 
immediately 
following 
treatment 
Provider: 
Psychologist 
  
Group format 
Progressive muscle 
relaxation 
Guided imagery 
Deep breathing  
Meditation  
Tumour visualisation 
Audio 
Daily practice 
TAU ?   IG showed significantly 
reduced levels of stress, 
anxiety and depression 
scores following the 
intervention. 
Cortisol levels as well 
as proliferation and 
sensitivity to 
glucocorticoid remained 
unchanged. 
5 11 
Brown / 
2006 / 
America / 
Radiation 
therapy / IG 
& CG 
CB 
Various 
cancers-
Intermediat
e to 
advanced 
cancer. 
115 
participants 
(49 in IG 
and 54 in 
CG) 
Unclear 
when started. 
8x90 minute 
sessions over 
4 weeks. 
Provider: 
Psychiatrist / 
psychologist 
Co-facilitated 
by nurse, 
chaplain, or 
social worker 
 
 TAU  ?  Intervention participants 
reported significantly 
less fatigue  
No other significant 
differences were found 
between the groups on 
outcomes.  
8 15 
Ream / 2006 
/ Uk / 
chemotherap
y / IG and 
CG  
Supportive 
Various 
cancers- 
103 
participants 
(IG 48, CG 
55).  
Provided 
over first 3 
treatment 
cycles.  W 
Weekly visits 
by support 
Fatigue diary- monitor 
fatigue 
Education- exercising, 
relaxation, sleep 
enhancement 
Information pack 
TAU ? ? ? IG reported significantly 
less fatigue, lower 
distress and less impact 
of fatigue on pastimes 
compared to CG. 
IG reported significantly 
5 17 
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nurse Coaching self-care less anxiety and 
depression and used 
more adaptive coping 
compared to CG. 
 
Stalpers / 
2005 / 
Netherlands 
/ 
radiotherapy 
/ IG and CG 
Hypnothera
py  
Various 
cancers-  
69 
participants 
(IG 33, CG 
36) 
Pre-treatment 
and during 
treatment. 
Sessions at 
intake before 
1st treatment 
and mid-way 
through 
Provider: 
Hypnotherapi
st  
Describing a safe and 
secure place 
Symptoms discussed 
Progressive muscle 
relaxation 
Passive imagination 
Audio of session 
TAU ?  ? No statistically 
significant differences 
found in anxiety and 
QOL between the 
groups.  Analysis of 
interview data found 
that the IG group 
reported significantly 
greater improvements in 
mental and overall well-
being.  
 
6 14 
Yoo / 2005 / 
South Korea/ 
chemotherap
y / IG & CG 
Relaxation  
Breast 
cancer 60 
participants 
(30 in each 
group) 
6 sessions – 1 
hour duration 
prior to 
treatment 
 
Provider: 
Therapist 
Individual format 
Progressive muscle 
relaxation 
Guided imagery 
Daily practice  
TAU ? ? ? IG reported significantly 
less anxiety, depression 
and hostility than 
control group.  IG 
experienced 
significantly less 
anticipatory and post-
chemotherapy vomiting 
and nausea.  At 6 
months, quality of life 
in the IG was 
significantly higher on 
physical, emotional, 
concerns for breast 
cancer and overall. 
3 14 
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Given / 2004 
/ America / 
chemotherap
y / IG and 
CG 
CB 
Various- 
breast, 
colon, lung, 
other (IG 
97, CG, 94) 
10 contact 20 
week 
programme 
started prior 
to treatment. 
Provider: 
Nurse  
 
Individual format 
Problem solving 
Self-management 
information 
Counselling  
TAU  ?  Patients in IG who at 
baseline had higher 
reports of symptom 
severity reported 
significantly lower 
severity compared to the 
CG at 10 and 20 weeks 
8 10 
Jacobsen / 
2002 / 
America / 
chemotherap
y / 
Professionall
y 
administered 
stress 
management 
training 
(PSMT), 
self-
administered 
stress 
management 
training 
(SSMT), CG 
CB 
Various 
cancers-. 
 411 – CG 
137, PSMT 
134, SSMT 
140.  
PSMT- 60 
minute 
session prior 
to treatment 
and 5 mins 
before 1st 
cycle  
 
SSMT- 10 
minutes to 
give 
materials and 
5 mins before 
1st cycle 
PSMT 
Individual format 
Deep breathing 
Guided imagery 
Progressive muscle 
relaxation 
Audio 
Self statements 
Identifying thoughts 
and feelings 
SSMT 
Self-administered 
Guided imagery 
Progressive muscle 
relaxation 
Audio 
Self statements 
Written  
Videotape 
 
TAU ? ? ? SSMT compared to CG 
had significantly larger 
improvements on the 
mental component, 
physical functioning, 
vitality, role-emotional 
and mental health 
components of the SF-
36.  The SSMT also 
produced significantly 
greater reduction in 
anxiety and Depression. 
9 18 
Molassiotis / 
2001 / Hong 
Kong / 
Breast 
cancer  
71 
PMR session 
1 hour before 
chemotherap
Individual format 
Progressive muscle 
relaxation 
Therapi
st talked 
to 
? ?  IG decreased duration 
of nausea and vomiting 
compared with control 
5 15 
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chemotherap
y / IG & CG 
Relaxation  
participants 
(38 in IG & 
33 in CG) 
y and then 
every 
afternoon for 
6 post-
treatment 
days.  
Duration of 
sessions 25 
mins. In total 
36 sessions 
Provider: 
oncology 
nurse 
 
Guided imagery 
Deep breathing 
Audio 
Video 
Daily practice  
control 
particip
ants 
prior to 
chemot
herapy 
group- these effects 
significant for first 4 
days post 
chemotherapy. 
Significantly less severe 
overall mood 
disturbance over time in 
the IG. 
Gaston-
Johansson / 
2000 / 
America / 
Bone 
marrow 
transplantati
on / IG & 
CG 
Supportive 
Breast 
cancer 
110 
participants 
(52 in IG 
and 58 in 
CG) 
Session 2 
weeks before 
hospital 
admission.  
Reinforced 
by brief 
contact. 
Main 
provider: 
clinical social 
worker. 
Reinforced 
by ABMT 
oncology 
nurse or 
project 
investigators. 
 
Preparation 
information 
Education about pain 
and techniques to 
decrease pain and 
emotional distress 
Cognitive restructuring 
Positive self-
statements 
Brief muscle relaxation 
Imagery 
Audiotape  
TAU ? ?  No significant 
differences between the 
groups on pain or 
psychological outcomes.
The IG reported 
significantly less nausea 
than the CG 7 days after 
treatment even when 
controlling for 
demographic variables.   
4 13 
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Larson / 
2000 / 
America / 
Surgery 
including 
radiotherapy 
and 
chemotherap
y 
/ IG & CG 
CB 
Breast 
cancer 
41 
participants
- 18 control 
& 23 
intervention  
Unclear 
when started. 
2 90 minute 
sessions  
Most 
individually 
and a few in 
small groups 
(2-3) 
Provider: 
Clinical 
psychologists 
Individual format and 
group format 
(participants only 
attended one) 
Progressive muscle 
relaxation 
Audio 
Daily practice 
Coping skills 
Cognitive restructuring 
Alternative illness 
perceptions 
Goal setting  
Identifying thoughts 
and feelings 
Self-monitoring 
Distraction 
Psychoeducation about 
stress 
Activity scheduling  
 
 
 
TAU ?  ? Missing data meant that 
there were small sample 
sizes in the analysis. 
Evidence of suppression 
of interferon (IFN~y) in 
CG but not in the IG- 
however did not remain 
significant when 
baseline differences 
taken into account. 
Patients in the 
intervention group had 
significant decreases 
over time in measure of 
disgust. 
4 11 
Kolcaba / 
1999 / 
America / 
radiotherapy 
/ IG & CG 
Relaxation  
Breast 
cancer 
53 
participants 
(26 in IG & 
27 in CG) 
Given tape 
(unsure 
when) and 
instructions 
 
Self administered 
Guided imagery 
Audio 
Written 
Daily practice 
 
TAU ?   Significantly higher 
comfort scores for the 
IG across all time 
points.  
Qualitative feedback 
from diaries and 
telephone contact found 
that women often 
developed a routine for 
5 9 
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relaxation practice.   
 
Walker / 
1999 / UK / 
chemotherap
y / IG & CG 
Relaxation  
Breast 
cancer 
96 
participants 
(48 in each 
group) 
First 40 
women in IG 
had five live 
training 
sessions 
during 
treatment.  
Intervention 
started before 
treatment-not 
specified 
when. 
 
Individual format 
Progressive muscle 
relaxation 
Guided imagery 
Cue-controlled 
Tumour visualisation 
Audio 
Daily practice 
Diary  
TAU ?  ? IG significantly more 
relaxed during study 
and had significantly 
better QoL.  IG had 
significantly reduced 
emotional suppression. 
No differences on 
clinical or pathological 
outcomes but imagery 
ratings correlated with 
clinical response. 
3 18 
Arakawa / 
1997 / Japan 
/ 
chemotherap
y / IG & CG 
Relaxation  
Various 
cancers. 
60 
participants 
(30 in each 
group) 
First session 
45-60mins 
Daily (25 
min) 
observation 
of 
participants 
PMR 
techniques. 
Not specified 
when 
intervention 
begins or 
ends  
 
Individual format 
Progressive muscle 
relaxation 
Audio 
Daily practice 
10-15 
minutes 
daily to 
discuss 
concern
s 
? ?  IG had significantly 
lower nausea & 
vomiting scores 36 
hours after initiation of 
chemotherapy. Similarly 
48 hours after onset of 
chemotherapy the IG 
had statistically lower 
mean score of nausea. 
No differences reported 
in the rates of vomiting.  
IG significantly lower 
mean scores of post-
treatment state anxiety.   
6 11 
Burton / 
1995 / UK / 
Breast 
Cancer  
45 minute 
preoperative 
Preoperative interview: 
Discussed diagnosis, 
TAU & 
SA 
?   Preoperative interview- 
lasting effect on body 
4 10 
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mastectomy 
/ 4 groups- 
1) 
preoperative 
interview, 
preoperative 
interview 2) 
preoperative 
interview 
and chat 3) 
preoperative 
interview 
and 
psychotherap
eutic session, 
4) CG 
Supportive 
244 
participants 
(group 1, 
64; group 
2, 62; 
group 3, 
61; group 
4, 57).   
interview 
afternoon 
before 
surgery.  
Psychotherap
eutic session 
or chat for 30 
minutes on 
evening 
before 
surgery 
worries, social support, 
stressful life events, 
past regrets and 
concerns. 
Psychotherapeutic 
chat: placed illness and 
surgery in patients life 
situation and explored 
feelings.   
(chat 
evening 
prior to 
surgery) 
 
image and distress.  At 3 
months and 1 year 
follow-up CG greater 
body distress compared 
to other groups.   
CG higher overall 
distress at 3 months 
1 year follow-up in, CG 
higher scores on loss of 
breast and partner 
response and total 
number of worries.  
CG significantly less 
fighting spirit in 1 
month follow-up. 
3 months follow-up 
psychotherapeutic 
session superior to the 
chat for those 
participants who had 
experiences stressful life 
events.   
 
Syrjala / 
1995 / 
America / 
bone marrow 
transplant / 
CG, therapist 
support, RT, 
CBT&RT 
Relaxation  
Leukaemia, 
myelodyspl
asia, 
lymphoma 
94 
participants 
(CG 23, 
therapist 
support 24, 
Both 
interventions  
2 pre-hospital 
training 
sessions 
(unclear 
when)  and 
then twice a 
week 20-40 
Relaxation: 
Progressive muscle 
relaxation  
Guided imagery 
Deep breathing 
Audio 
Written 
Daily practice 
Cognitive-
TAU & 
SA 
(therapi
st 
equivale
nt time 
as 
interven
tion 
 ?  CB&RT and RT groups 
reported significantly 
less pain than CG. 
CBT&RT group did not 
have additive effects 
beyond the RT group. 
9 15 
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CB RT 23, 
CBT&RT 
24). 
mins booster 
sessions for 
first 5 weeks 
of treatment 
behavioural: 
Same as relaxation 
above and cognitive 
restructuring, self 
statements, distraction, 
activity scheduling, 
written information.  
Also included pain and 
theory and 
mechanisms of nausea.  
 
 
giving 
support) 
Vasterling / 
1993 / 
America / 
chemotherap
y / high 
anxiety CG, 
high anxiety 
RT, high 
anxiety 
distraction, 
low anxiety 
CG, low 
anxiety RT 
and low 
anxiety 
distraction  
Relaxation  
CB 
Various 
cancers: 60 
participants 
(10 in each 
group) 
Sessions 
provided 
after 
chemotherap
y started for 
sessions 2,3 
and 4.  
RT :3 
sessions 
provided 
before 
chemotherap
y- 45 minutes 
Distraction: 3 
sessions 
provided 
before 
chemotherap
y - 20 
minutes 
Individual format 
Relaxation: 
Progressive muscle 
relaxation 
Guided imagery 
Cognitive 
distraction 
Control 
group 
given 
time to 
rest 
quietly 
before 
treatme
nt 
started 
? ?  Distraction group and 
RT group reported 
significantly less nausea 
prior to first and follow-
up chemotherapy 
sessions.  Both groups 
also had and 
significantly lower 
systolic blood pressure 
after the first and second 
sessions and for the RT 
group also for the third 
session.   
RT group had 
significantly lower 
diastolic blood pressure 
compared to the control 
group during the second 
session.   
No significant 
4 9 
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differences between RT 
and distraction. 
 
Burish / 
1992 / USA / 
chemotherap
y / 1) RT, 2) 
EMG, 3) ST, 
4) 
RT+EMG, 
5) RT+ST, 
6) CG 
Relaxation  
 
Various 
cancers- 
81 
participants 
(RT-13, 
EMG-17, 
ST-12, 
RT+EMG- 
17, RT+ST-
12, CG-15) 
Biofeedback 
& RT 
delivered 
during 
treatment in 4 
chemotherap
y sessions 
and practice 
recommende
d at home. 
Intervention 
started mid-
way through 
treatment. 
 
 
Relaxation 
Individual format 
Progressive muscle 
relaxation 
Guided imagery 
Audio 
Daily practice 
Biofeedback 
Biofeedback. 
TAU ? ?  RT group reported less 
nausea, reaching signif-
icance in the 5th session 
compared to the other 
groups.  RT and EMG 
had significantly lower 
blood pressure across all 
sessions. 
ST significantly lower 
pulse rate than RT.  ST 
& RT significantly 
lower pulse rate.  
5th session RT patients 
significantly less 
anxiety than none-RT 
groups.  
RT, EMG, RT+EMG & 
RT+ST significantly 
lower EMG scores than 
control group.  
RT patients during last 
3 sessions significantly 
lower levels of nausea 
compared to non-RT 
patients. 
 
3 9 
Decker / 
1992 / 
America / 
Various 
cancers- 
82 
6 – 1 hour 
sessions 
Unclear 
Individual format 
Progressive muscle 
relaxation 
TAU ?   Significant decrease in 
tension & anger for the 
IG. 
4 10 
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radiotherapy 
/ IG & CG 
Patients 
needed to 
have 
anticipatory 
nausea & 
vomiting to 
be eligible 
for inclusion 
Relaxation 
  
participants 
– 34 in IG 
& 29 in CG  
 
when started 
(more 
details) 
 
Provider: 3 
graduate 
students 
supervised by 
first author 
Deep breathing 
Cue-controlled 
Audio 
Written information 
Daily practice  
There was also a trend 
towards less depression 
in the IG.  
CG had statistically 
significant increase in 
fatigue. 
Morrow / 
1992 / 
America / 
chemotherap
y / clinical 
psychologist 
intervention 
(CPI), 
Medical 
personnel 
intervention 
(MPI) & 
CG. 
Relaxation  
Not 
specified - 
Cancer 
patients 
with ANV 
reported- 2 
successive 
experiences
. 
72 
participants 
(29 in CPI, 
29 in MPI, 
& CG 14). 
Two 1 hour 
sessions 
between 3rd 
and 4th 
chemotherap
y treatments 
Providers: 
clinical 
psychologists 
compared to 
clinical 
oncologist or 
oncology 
nurses. 
 
Individual format 
Progressive muscle 
relaxation 
Systematic 
desensitisation 
Audio 
Daily practice  
TAU ? ?  Both interventions were 
effective in significantly 
reducing Anticipatory 
and post-treatment 
nausea & vomiting 
severity and duration 
compared with control 
group.   
No differences found 
between the health 
personnel used to 
deliver the interventions 
5 11 
Syrjala / 
1992 
/America / 
bone marrow 
transplant / 
Hematologi
c 
malignancy
, lymphoma  
 
2 Pre-
hospital 
training 
sessions 
(unsure 
Hypnosis 
Hypnotic induction 
Induction targeting 
treatment-related pain, 
nausea and emotional 
TAU & 
SA 
(therapi
st 
support) 
 ?  Hypnosis group 
reported significantly 
less pain when 
compared to the other 
groups. 
6 11 
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CG, therapist 
support, CB, 
hypnosis) 
Hypnothera
py  
CB 
45 
participants 
(CG 10, 
therapist 
support 12, 
CB 11, 
Hypnosis 
12) 
 
when) and 
then twice a 
week 20-40 
mins booster 
sessions for 
first 5 weeks 
of treatment 
 
reactions 
Inductions taped and 
daily practice. 
Cognitive-behavioural 
 
Nausea, emesis and 
opioid use did not differ 
significantly between 
the groups 
Burish / 
1991 / 
America / 
chemotherap
y / 
intervention 
1 (PREP), 
intervention 
2 (RT), 
combined 
(PREP+RT) 
and control 
 Relaxation  
Supportive 
Various 
cancers: 
60 (4 arms- 
15 
participants 
in each) 
Intervention 
1: 90 minutes 
before first 
chemotherap
y session 
Intervention 
2: 45 mins 
before 
chemotherap
y session 1-3.  
4-5 self-
instruction 
Combined: 
both of the 
above 
PREP 
Tour of clinic 
Concrete and sensory 
information 
Video about 
chemotherapy 
Procedural information 
Discuss concerns and 
feelings 
Booklet  
Relaxation 
Individual format 
Progressive muscle 
relaxation 
Guided imagery 
Written  
Daily practice  
TAU ? ?  Participants in the PREP 
intervention had 
significantly better 
knowledge in all areas 
and significantly lower 
levels of anticipatory 
nausea across all 
sessions. 
By final session patients 
in PREP and PREP+RT 
reported significantly 
less vomiting after 
chemotherapy.   
RT reported less anxiety 
for most sessions and 
this was significant for 
session 1 & 2. 
PREP group cancer 
interfered significantly 
less with their daily 
lives. 
PREP and RT groups 
reported significantly 
3 9 
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less vomiting at home in 
first 24 hours after 
chemotherapy 
 
Lerman / 
1990 / 
America / 
chemotherap
y / IG & CG 
Relaxation  
Various- 
breast, 
lung, colon, 
ovary, 
Hodgkin 
and other 
48 
participants 
– 25 IG & 
23 CG 
30 minute 
session for 
relaxation 
training prior 
to (unclear 
when) 
treatment. 
Providers: 
Nurses and 
health 
educators 
Individual format 
Progressive muscle 
relaxation 
Deep breathing 
Audio 
Written  
Daily practice 
 
TAU ? ?  No significant 
differences between 
monitors and blunters in 
the use of relaxation. 
Intervention was 
effective in reducing the 
number of hours of 
nausea subsequent to 
chemotherapy.  
An effect of relaxation 
on anxiety before 
chemotherapy (data 
only for 3rd cycle) for 
participants classified as 
blunters in the 
intervention group. 
4 12 
 
Key to abbreviations:         
CB     Cognitive-behavioural 
CG       Control group 
EMG Electromyographic biofeedback 
IG Intervention group 
INT Intervention  
Psych Psychological 
QoL Quality of Life 
RT Relaxation Training 
SA        Supportive Attention Group 
ST Skin temperature 
TAU     Treatment as usual 
   - 41 -
  
Discussion 
 
The aim of this review was to provide an overview of the psychosocial interventions 
designed to improve psychological and treatment-related symptoms in cancer patients 
undergoing treatment, and to evaluate the effectiveness of these interventions.  Thirty-six 
interventions were found which were tested in RCTs.  The quality of these studies and 
interventions was generally moderate and two studies were excluded because of poor 
quality ratings.  The interventions were classified in this review as relaxation, hypnosis, 
cognitive-behavioural and supportive.  The most common interventions were either 
relaxation or cognitive-behavioural.   
In general, relaxation interventions provided the most convincing evidence for 
alleviating anxiety before and during treatment.  Seven of the eight studies reported a 
significant reduction in anxiety as a result of the relaxation intervention.  This supports 
the findings of two previous reviews by Leubbert and colleagues (2001) and Redd et al. 
(2000) which reported that behavioural interventions had significant effects on 
psychological adjustment for cancer treatment including anxiety.  Therefore, according to 
the frequently utilised components of the interventions in this review, it can be deduced 
that relaxation interventions which incorporate at least progressive muscle relaxation, 
guided imagery, audio recordings and recommend daily practice have a greater chance of 
being effective.  However, a number of factors need to be considered in relation to the 
findings in this review.  Firstly, the effects of relaxation interventions on anxiety were not 
found at all time points prior to and during treatment and for one study the effects on 
anxiety were only found for a sub-group of participants (Lerman et al., 1990).  Secondly, 
of the fourteen relaxation studies reviewed, only four conducted a power calculation, and 
two of these were unable to recruit a sufficient sample size.  Thus, it is unclear whether 
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the majority of studies were adequately powered and therefore caution should be applied 
to the conclusions drawn.  Despite these shortcomings the literature on relaxation 
interventions appears somewhat convincing and provides some evidence for its potential 
to influence anxiety.  The effect of relaxation interventions on quality of life outcomes 
also seems promising; however, only three studies incorporated quality of life outcomes 
and therefore there were too few studies to draw any firm conclusions.   In relation to 
treatment-related side effects and other psychological outcomes the findings were 
inconclusive.   
The findings for the hypnosis and supportive interventions were mixed.  The 
evidence base for these interventions is sparse and future research is needed to discern the 
effectiveness of these interventions more accurately.  It was unclear whether supportive 
interventions which adopted a general approach were less effective than those 
interventions which were based on a theoretical approach because of the paucity of 
studies and mixed findings.  
For the cognitive-behavioural interventions the findings were mixed for the 
psychological, side effects and quality of life outcomes.  In terms of the interventions 
fulfilling the key elements of cognitive-behavioural therapy only three interventions could 
be classified as well-defined.  These three studies, did not, however, seem to be more 
effective in influencing outcomes.  Due to the considerable variability in the quality and 
the findings of the various studies it is not possible to draw any conclusions for the 
cognitive-behavioural interventions.  The heterogeneity of the content of supportive and 
cognitive-behavioural interventions would make it difficult to establish if certain elements 
in the intervention could be essential in improving treatment-related outcomes and 
distress.  In addition, all studies in this review varied considerably in the number of 
intervention contacts, the timing of contacts and the duration of the intervention.   
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For some studies the impact of the intervention was only found for later 
chemotherapy sessions (Burish et al., 1992; Lerman et al., 1990; Yoo et al., 2005).  This, 
perhaps, points to a practice effect, with participants becoming more skilled in the coping 
skills offered.  If this is the case, then perhaps interventions should incorporate pre-
treatment sessions, to enable patients to develop coping techniques and prepare them so 
that they can gain benefits from the beginning of treatment.  Follow-ups of at least six 
months were found in 6 studies (Yoo et al., 2005; Brown et al., 2006; Parker et al., 2009; 
Phillips et al., 2008; Armes et al., 2007; Burton & Parker, 1995).  Of these five reported 
some differences at follow-up of six months, with some effects being observed at nine 
months to 12 months follow-up (Parker et al., 2009; Armes et al., 2007).  This points to 
the possibility that interventions delivered prior to and during treatment might have 
lasting effects.  There were only a handful of studies which directly compared different 
types of interventions, and it was not possible to draw any inferences from these. 
 
Limitations of studies 
 
There are several methodological aspects of these studies that had shortcomings.  Very 
few studies (9; 29%) had a manual to accompany the intervention.  In addition, the 
majority did not measure participants’ adherence with coping skills, did not give 
providers specific intervention training, or check the fidelity of the intervention.     
In terms of assessing participants’ adherence, if an intervention is not effective 
then it could be due to the fact that people have not used the strategies learnt outside of 
the intervention.  Furthermore, the increases in psychological mindedness and the rise in 
the popularity of yoga, relaxation and meditation make it quite feasible that greater 
numbers of the population may already practice effective coping strategies or use 
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techniques which are similar to those offered in interventions.  This is partly 
demonstrated by Gaston-Johansson and colleagues (2000), who assessed the existing 
coping strategies of intervention participants and found that 40% of participants used 
some type of coping strategy and 30% used relaxation.  Therefore, the ineffectiveness of 
an intervention may be due to the existing coping skills already utilised by the population 
of interest or patients not using skills/techniques learnt or practiced during intervention 
sessions.   
Only nine studies gave information about the method of randomisation used, and 
very few studies considered allocation, or measurement bias, or reported power 
calculations.  As it is very difficult in psychosocial trials to blind the participants and 
therapists, and in most studies data collection was not conducted by an independent 
person, it is possible that treatment effects could be attributed partly to the outcome 
expectations of both researcher and patient.  Of the 10 studies which reported a power 
calculation, six studies achieved an adequate sample size.   Thus, insufficient power 
carries a considerable risk that studies may have been unable to demonstrate differences 
between the groups which are present (Type II error; Pocock, 1983). 
In this review only 19% (6) of studies incorporated a follow-up of six months or 
greater, and this provided very little insight into the expected duration of effects following 
the delivery of the intervention.  Finally, only nine studies had a control group which 
could be described as an active alternative to the intervention group.  In these studies 
there were instances where differences were not found between the intervention and 
supportive control groups (e.g Parker et al., 2009), indicating that intervention effects 
may be attributable to the non-specifics aspects of interventions, and not the specific 
therapy or coping skills delivered.   
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Limitations of the review 
 
RCTs were excluded if it was not clearly specified that cancer patients were receiving 
treatment at the time of the intervention or if the intervention did not aim to address 
treatment-related symptoms and distress.  It cannot be absolutely ruled out that relevant 
studies have not been missed out.  This review is based on published studies only, and 
hence may be subject to publication bias.  The possibility remains that studies which 
found no effects or negative results might not have been published, and therefore were 
not included in this review.   
 
Recommendations and future research  
 
There are several methodological aspects of studies evaluating psychosocial interventions 
for symptoms of cancer treatment that could be improved.  Recommendations include 
having a treatment manual for interventions so that they can be replicated in future 
studies.  Additionally, studies should aim to measure participants’ adherence with the 
techniques of the intervention, train providers and check fidelity of the interventions.  
These factors would help to improve the quality of interventions.  In relation to study 
design, more attention needs to be paid to reporting the method of randomisation, to 
limiting allocation and measurement bias, conducting intention-to-treat analyses and 
reporting power calculations.  Every effort should be made to minimise the effect of 
biases in psychosocial trials, and where possible individuals independent to the research 
project should be used to randomise participants and / or researchers blind to participants’ 
group allocations should be used to collect data.  There is also a need for better reporting 
of studies, including more detailed descriptions of the interventions and detailing attrition 
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details in accordance with CONSORT guidelines (Moher, Schulz & Altman, 2001).  
More comparisons of interventions to attention control groups is needed, so that it can be 
more clearly determined whether the effects observed are due to the intervention or the 
non-specifics of contact with a provider/therapists.   
At present there are substantial gaps within the literature.  The non-existent or 
short-term follow-up of interventions has resulted in very little understanding of when, 
whether and how an improvement in treatment-related symptoms or distress deteriorates 
over time.  Thus, for nearly all the studies it is difficult to determine whether 
improvements observed are sustained for short or long periods of time.  A systematic 
review of psychosocial intervention studies in cancer patients reported that the strongest 
treatment effect often happens several months after the completion of the intervention 
(Newell, Sanson-Fisher & Savolainen, 2002).  Having a longer term of follow-up in 
studies would help to establish more clearly the long or short term effects of 
interventions.  The inconsistencies of intervention components within similar 
interventions, particularly within cognitive-behavioural interventions, hinder the 
accumulation of evidence that will enable identification of the elements within an 
intervention that are consistently effective or ineffective.  It is also recommended that 
cognitive-behavioural interventions are designed to match more specifically the elements 
fundamental to cognitive-behavioural approaches.  Researchers developing cognitive-
behavioural interventions can be guided by pre-existing criterions, such as those designed 
by Jones et al. (2010), which outline the key elements that underpin cognitive-behavioural 
interventions.  Such criterions are being used to classify whether interventions match 
cognitive-behavioural principles (see Jones et al, 2010).    
Larger RCTs are required to supplement the initial findings of this review, and to 
add further information about the effectiveness of different types of interventions.  Future 
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good quality studies are needed to test whether certain interventions have influences on 
psychological and treatment-related symptoms and to explore the potential mediators for 
the effects of interventions.  It would also be useful to this literature if future studies also 
investigate the length of intervention which is effective, and to identify the optimal 
duration and best method of delivery.  In particular, whether booster sessions are 
beneficial and result in greater improvements in desirable outcomes.   
It is important to understand why some psychosocial interventions are successful 
or unsuccessful, and therefore adopting a theoretical approach is recommended. Future 
research should aim to ascertain for whom interventions might be the most beneficial.  
Are interventions which prepare patients for treatments and its symptoms more effective 
if they target patients more susceptible to distress or particular symptoms during 
treatment.  Finally, as suggested by Armes et al. (2007) it needs to be more clearly 
specified whether interventions are designed to prevent distress or treatment-related 
symptoms or if they are to treat these.   
 
Clinical implications 
 
There are a variety of interventions available for patients who experience distress and 
symptoms prior to and during cancer treatment.  Relaxation interventions demonstrated 
the most promising results, achieving significance despite variation in the types of 
treatments targeted.  Relaxation is a skill that with some practice can be learnt and 
implemented very quickly, enabling individuals to feel greater control in stressful 
situations.  Progressive muscle relaxation, guided imagery, audio materials and 
recommending daily practice were the most common elements of relaxation 
interventions, and incorporating these into interventions would be recommended.  The 
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findings for cognitive-behavioural interventions were variable and no firm conclusions 
can be drawn.  The possibility of preparing patients in group formats or using self-
administered packages has not been adequately explored but may be of interest to 
clinicians in terms of cost effectiveness.  Interventions to prepare patients for treatments 
and their symptoms should be routinely incorporated into clinical practice.  
 
Conclusions 
 
Although further research is needed, the present literature seems to suggest that relaxation 
interventions are generally effective in alleviating treatment-related anxiety.  Beyond this, 
there is little that can be used to guide the design or selection of appropriate interventions. 
The overall indication is that hypnosis, cognitive-behavioural and supportive 
interventions have variable success in reducing treatment-related symptoms and distress.  
The incorporation of a theoretical basis to intervention development and evaluation, and 
larger good quality RCTs might provide answers to the many unanswered questions in 
this research area.  Such an approach might help to unpack the reasons why an 
intervention has proven effective or otherwise in reducing treatment-related symptoms.  
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Abstract 
 
Objective:  The primary objective of this study was to evaluate the effectiveness of a 
psychological preparation session, consisting of eliciting concerns, procedural 
information, cognitive-behavioural and mindfulness techniques, on distress in 
gynaecological cancer patients undergoing internal radiotherapy treatment.  A secondary 
objective was to determine its impact on illness beliefs and coping strategies, and its 
feasibility and acceptability as an intervention.   
Methods:  A controlled before and after study design was used to evaluate this 
intervention.  19 participants scheduled to receive internal radiotherapy treatment 
participated in the study.  Participants in the control group had treatment as usual.  All 
participants were given questionnaires assessing anxiety and depression (HADS), general 
mood (SV-POMS), illness beliefs (BIPQ) and coping styles (COPE), which were 
administered four weeks prior to treatment, five days prior to and the day after treatment.   
Results:  The intervention group demonstrated a statistically significant reduction 
in anxiety from baseline to pre-and post-treatment.  Analyses of reliable change and 
clinical significance showed that significantly more patients in the control group 
experienced deterioration in anxiety and depression compared to the intervention group.  
Qualitative feedback indicated that patients found the intervention acceptable and helpful, 
and used coping strategies taught to alleviate distress.   
Conclusions:  The findings are encouraging and provide evidence of the 
preparation session’s benefits on anxiety and depression among women undergoing an 
invasive and emotionally challenging treatment.   
Keywords: relaxation; cognitive-behavioural; radiotherapy; cancer; oncology 
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Introduction  
 
The distress and symptoms associated with cancer treatment are well documented (e.g. 
Roscoe, Morrow, Hickok & Stern, 2000; Stiegelis, Ranchor & Sanderman, 2004; Servaes, 
Verhagen & Bleijenberg, 2002).  Internal radiotherapy treatment (IRT; also called 
brachytherapy, intracavity radiation) is available for women with gynaecological 
malignancies.  This treatment enables delivery of radiation directly to the site of the 
cancerous tumour.  Applicators designed to hold radioactive sources are inserted into the 
vagina, and placed into and near the uterus.  Patients are hospitalised and radiation 
protection requires a private room with restricted contact by health professionals only 
during at least a 24 hour period.  Notwithstanding the potential of IRT in treating 
gynaecological cancers, the procedure is invasive and intimate, and can thus lead to a 
disturbance in psychosocial functioning.   
The distress that women experience during IRT has long been established.  
Andersen, Karlsson, Anderson and Tewfik (1984) reported that women experienced 
significant increases in anxiety from a few days to the night before the procedure, and this 
did not significantly reduce the day after the end of treatment.  More recently, Kramer et 
al. (2007) found that 68% of women scored within the borderline and abnormal ranges of 
anxiety prior to IRT.  This is significantly more than the 10-20% of patients found to 
experience anxiety prior to external radiotherapy for a range of cancers (see review by 
Stiegelis et al. 2004).  Indeed, research has found that more intrusive medical procedures 
result in significantly greater anxiety (Aksoy, Ozdemir & Yavuz, 2000).  A retrospective 
study by Warnock (2005) found that 87% of women associated negative states such as 
anxiety, worry and fear with IRT.  Qualitative studies have found that women feel 
isolated, vulnerable and helpless during IRT treatment (So & Chui, 2007), have a poor 
   - 57 -
  
understanding of the procedure and report a discrepancy between their doctor’s 
explanations and their subsequent experiences of treatment (Wray, Markovic & 
Manderson, 2007).   
The literature strongly indicates that women need support to cope with this 
treatment and this has been reflected by researchers working in this field (see So & Chui, 
2007; Velji & Fitch).  However, there is very little in the literature about management of 
pre- and post- psychological distress caused by IRT.  Psychosocial interventions have 
been found to be effective in managing treatment-related symptoms and distress for 
cancer.  Interventions designed to prepare patients for treatment and treatment-related 
symptoms have included: hypnosis, procedural information, psychoeducation, cognitive-
behavioural approaches, relaxation, supportive therapy and counselling (Armes, Chalder, 
Addington-Hall, Richardson & Hotopf, 2007; Burish, Snyder & Jenkins, 1991; 
Montgomery et al., 2009; Parker et al., 2009; Phillips et al., 2008; Ream, Richardson & 
Alexander-Dann, 2006; Stalpers et al., 2005).  A meta-analysis reported that relaxation 
interventions were effective in the management of anxiety, hostility and depression in 
patients undergoing non-surgical treatments for cancer (Luebbert, Dahme & Hasenebring, 
2001).  Similarly, a systematic review published the same year also found that 
behavioural interventions could relieve anxiety and distress in non-surgical and invasive 
cancer medical treatments (Redd, Montgomery & DuHamel, 2001).  Procedural 
information, behavioural instruction, cognitive and relaxation interventions are more 
likely to reduce negative affect in patients preparing for surgery (Johnson & Vogele, 
1993).   
Specifically in relation to IRT, Leon-Pizarro and colleagues (2007) found that 
women with breast and gynaecological cancer taught relaxation and guided imagery 
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techniques prior to internal radiotherapy1 scored significantly lower on anxiety, 
depression and body discomfort compared to a control group.  The authors of this study 
noted that combining breast and gynaecological cancer patients may have reduced the 
analytical power of their study, as the experiences of these two groups are different 
during treatment.  For example, greater pain was experienced by gynaecological patients, 
and during treatment breast cancer patients are able to move around while gynaecological 
patients must stay in a fixed lying down position.  This perhaps indicates there are 
differences within the treatment experiences of IRT for breast and gynaecological 
patients.  To date, there do not appear to be any studies evaluating the effectiveness of a 
multifaceted preparation session solely with gynaecological patients having IRT.   
Overall, the literature appears to indicate that psychosocial interventions can be 
effective in reducing the burdens faced by patients prior to and during treatment.  Pre-
treatment preparation interventions are a means of preparing patients for the physical and 
psychological difficulties they are likely to face.  This type of intervention may reduce 
psychological distress and improve recovery (Moline, 2000; Contrada, Leventhal & 
Anderson, 1994).  The aim of this pilot study was to evaluate the effects of a 
psychological pre-treatment preparation session including procedural information, 
relaxation, mindfulness and cognitive strategies on patient distress.  This pilot study 
would also enable the methodology employed to be tested and along with the findings 
from this study, could be used to inform the design of a larger definitive trial, should this 
be appropriate.   
                                                 
1  Internal radiotherapy for breast cancer involves inserting a radioactive source in the breast  
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Theory-base of the intervention 
 
The primary aim of the intervention in this study was to reduce women’s pre-treatment 
and post-treatment anxiety.  The overall theoretical framework used to guide the selection 
of strategies used in the intervention was the self-regulation model (Leventhal et al., 
1980).  This model posits that in response to a health threat (i.e. diagnosis, symptoms, 
treatment) cognitive and emotional systems are activated in parallel.  The emotional 
system activates feelings such as anxiety, which influence coping strategies to manage the 
resultant distress.  The cognitive system involves the development of illness 
representations related to the health threat, which are organised around five themes 
including symptom identity, time-line, cause, consequences and cure / control.  These 
representations influence the coping strategies adopted by an individual to cope with the 
health threat (Leventhal et al., 1980).  If inaccurate illness beliefs are held then an 
individual may adopt a method of coping that is not helpful for the stressful illness 
experience (see Horowitz, Rein & Leventhal, 2004).   
The strategies adopted for the cognitive system of the self-regulation model were 
based on Beck’s cognitive model of anxiety (Beck, Emery & Greenberg, 1985).  This 
model proposes that individuals suffering from anxiety hold maladaptive distorted 
cognitions that tend to overestimate the likelihood of threat and underestimated the ability 
to cope with the threat.   In the case of physical health, unlike mental health, beliefs held 
by individuals may be maladaptive but not involve a distortion because they are well 
grounded in the reality of ill health experiences (Sage, Sowden, Chorlton & Edeleanu, 
2008, Taylor, 2006).   Therefore, the focus of the intervention was on unhelpful thoughts 
and illness beliefs that interfered with patient’s ability to cope, and to develop more 
helpful alternatives.   The intervention in this study focused on normalising patient’s 
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experiences of anxiety and influencing illness beliefs by providing women with 
information about the treatment and psychoeducation about anxiety based on cognitive-
behavioural principles.  Unhelpful illness beliefs and threat-orientated thoughts were 
identified and more helpful alternative beliefs developed to help patients to cope more 
effectively with the treatment process.  To facilitate changes action plans were created 
where individuals set goals for areas of difficulty as part of the distress thermometer 
(Roth et al, 1998, see p68 for more information on the distress thermometer) and made 
plans for practicing new techniques. 
Different relaxation strategies, such as deep breathing, guided imagery and 
progressive muscle relaxation, were offered in the intervention to help women to manage 
the treatment-related distress.  Progressive muscle relaxation has been found to promote 
muscle relaxation (Bernstein & Borkovec, 1973) and guided imagery can reduce 
psychological distress (Dossey, 1988).  Information and practice of brief cognitive and 
relaxation anxiety management strategies (e.g. deep breathing, coping self-statements, 
upper body progressive muscle relaxation, brief tense and relax relaxation) was included 
as quick coping skills that could be used during active treatment when they experienced 
anxiety.    
Mindfulness based interventions are becoming increasingly common in 
healthcare.  Mindful meditations are paying attention to moment-by-moment experiences 
in a non-judgemental way and with acceptance (Kabat-Zinn, 2003).  Mindfulness 
meditation is a skill that patients can use to cope with the stresses of illness and treatment.  
A meta-analytic review found that mindfulness-based stress reduction interventions had a 
moderate effect on the clinical and non-clinical problems of people from patient and non-
patient populations (Grossman, Niemann, Schmidt & Walach, 2004).  A recent review of 
ten studies indicated that mindfulness-based stress reduction may be helpful for the 
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mental health of cancer patients (Ledesma & Kumano, 2009).  In the intervention the 
three minute breathing space, mindfulness of the breath and a more visual mountain 
meditation were offered.   
The self-regulation model also encompasses ongoing appraisals of strategies 
adopted for coping which can then feedback into the illness representations and emotional 
response.  Firstly to facilitate the process of behaviour change action plans were 
developed using implementation intentions (see page 69 for further information about 
implementation intentions).  To facilitate the appraisal process women were encouraged 
to reflect upon their experiences of using the techniques covered in the intervention via 
recording their practice and during the brief telephone booster session prior to treatment 
but following the hour long preparation session.  It was envisaged that this would 
facilitate the appraisal process which would then feedback into modifying their regulation 
efforts.  The strategies adopted in the intervention and how they are related to the self-
regulation model are depicted in Figure 1 and the six stages of the preparation session are 
detailed on page 68.   
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Health threat- 
internal 
radiotherapy 
treatment 
Representations of 
illness: identity, cause, 
consequences, time-line, 
cure / control 
Coping with 
illness / 
treatment
Appraisal of 
coping 
effectiveness 
Coping with 
emotional 
response
Appraisal of 
coping 
effectiveness 
Emotional 
response: fear, 
anxiety 
Information about treatment 
Psychoeducation about 
anxiety 
Distress thermometer 
Normalisation  
More helpful beliefs 
Coping self-statements 
Action plans  
Booster 
telephone 
session 
Imagery 
Progressive muscle relaxation 
(brief and extended) 
Deep breathing 
Mindfulness techniques  
Recording use of chosen 
coping technique 
Booster telephone 
session 
Plan of actions Figure1. Theoretical base of the intervention  
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Method 
 
This pilot study utilised a controlled, before-and-after design to assess the effectiveness of 
a psychosocial preparation session on anxiety, depression, mood, illness beliefs and 
coping.  As the primary objective, it was hypothesised that women in the intervention 
group would experience less anxiety prior to and post-treatment compared to the usual 
care group.   The aims of secondary exploratory objectives were to test the effects of the 
intervention on depression, mood, coping style and illness beliefs.   
 
Design and sample  
 
Participants were patients with gynaecological cancers scheduled to receive low-dose IRT 
from a specialist cancer centre within a teaching hospital in an urban area.  Eligible 
women were (1) aged 16 years or older (2) able to provide consent and therefore without 
signs of cognitive impairment, (3) without signs of severe psychopathology and (4) had 
working knowledge of English.   
A power calculation (see appendix 22) estimated that 40 participants in total (20 
per group) would be required for this study to achieve 80% power with a significance 
level of 0.05, on the basis of an effect size of 0.70 (based on a comparable study) for the 
primary outcome of anxiety as measured by the Hospital Anxiety and Depression Scale.   
Patients were identified and approached during outpatient clinics from May 2009 
to April 2010 and given a pack comprising an information sheet (see appendices 16 and 
17), introductory letter from their consultant (appendix 18), consent form (appendix 19) 
and first questionnaire (appendix 20).  An additional consent form (see appendix 21) 
completed upon introduction of the study noted a willingness to hear further about the 
   - 64 -
  
study in a telephone conversation with the researcher prior to entering the study.  A gentle 
reminder was sent a week later to non-responders.   Those women consenting to take part 
in the study from May 2009 to September 2009 were assigned to the intervention group 
and from October 2009 to April 2010 to the control group.  Participants were aware of 
which group they would be assigned to prior to providing consent.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Flow of participants throughout the study 
 
Details for the flow of participants in the study are shown in Figure 2.  34.5% (20) 
of the patients agreed to participate in the study.  Of these 20 patients, 19 patients 
completed the study, 10 in the intervention group and 9 in the control group.  In view of 
not obtaining the desired sample size, the analytical strategy was adapted as described in 
the statistical analysis section.  The complete procedures for the study are outlined in 
64 women allocated to 
receive treatment 
5- Did not speak English 
1- Died 
58 women met 
eligibility criteria 
23- no response 
9- refused 
1- baseline questionnaire 
received post-treatment 
5- did not have treatment 20 women consented 
9 control group 11 intervention group 
1 withdrew 
10 completed 
9 completed 
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appendix 23.  Due to the design of the study, participants were aware of the group to 
which they were allocated prior to giving consent.  To reduce investigator bias the 
questionnaires were scored by an independent researcher.   
 
Measures 
 
A social demographic questionnaire contained items related to participants’ age, marital 
status, ethnicity, educational level, time of cancer diagnosis and treatment.   
The Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) is 
the primary outcome measure for this study.  It contains two 7-item scales, one for 
anxiety (HADS-A) and one for depression (HADS-D), with response options ranging 
from 0 to 3 and a score range of 0 to 21.  The measure has been used to screen for 
emotional disorders using a criterion of 8 to 10 to indicate borderline caseness, and 11 or 
greater for caseness (abnormal levels of anxiety).  The HADS has demonstrated reliability 
and validity for assessing anxiety and depression (Herrman, 1997).  It has been shown to 
assess for symptom severity and caseness of anxiety and depressive disorders in somatic, 
psychiatric and primary care patients (Bjelland, Dahl, Haug & Neckelmann, 2002).   
Secondary outcome measures included the Shortened version of the POMS (SV-
POMS), Brief Illness Perceptions Questionnaire (BIPQ) and brief Coping Orientations to 
Problems Experienced (COPE).  The SV-POMS (Shacham, 1983) includes 36 adjectives 
which measure the 6 domains of tension-anxiety, depression-dejection, anger-hostility, 
vigour-activity, fatigue-inertia, and confusion-bewilderment.   Mean subscale scores were 
calculated by totalling responses and dividing by the number of adjectives in the subscale.  
A total score for mood disturbance was calculated by totalling the scores of tension-
anxiety, depression-dejection, anger-hostility, fatigue-inertia and confusion-bewilderment 
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and subtracting the vigour-activity subscales.  McNair, Corr and Droppleman (1992) 
suggest that the total mood disturbance score is useful and can be presumed to be highly 
reliable because of the intercorrelations among the SV-POMS subscales.   
The BIPQ-brief provides a concise measurement of key illness perceptions central 
to Leventhal’s self-regulation theory (Broadbent, Petrie, Main & Weinman, 2006). It 
consists of nine items which assess cognitive and emotional representations of illness.  
Eight items are scored on a 10-point Likert scale and the ninth item is an open-response 
item.  This brief questionnaire has been shown to compare well with the more 
comprehensive Illness Perceptions Questionnaire - Revised (Moss-Morris et al., 2002).  It 
has good test-retest reliability and good concurrent, predictive and discriminant validity 
(Broadbent et al., 2006).   An overall score was computed which reflected the degree of 
threat associated with the illness, a higher score reflected a more threatening view of the 
illness. 
The coping strategies used to cope with IRT were assessed using the brief COPE 
(Carver, 1997).  This measure has a similar factor structure to the original COPE (Carver, 
Scheier & Weintraub, 1989) and has good internal reliability (Carver, 1997).  It contains 
14 distinct subscales of cognitive and behavioural coping strategies, with two items per 
scale, scored on a four-Likert scale.  Coping strategies include acceptance, active coping, 
planning, behavioural disengagement, denial, substance use, humour, positive reframing, 
religious coping, self-distraction, use of emotional support, use of instrumental support, 
self-blame and venting.   These subscales have acceptable alpha reliabilities (>.50) 
(Carver, 1997).   
Assessments were performed at three time points.  The first assessment was at 
least a month prior to IRT and involved completion of the HADS, SV-POMS, BIPQ and 
COPE.  The second assessment comprised the HADS and SV-POMS and was completed 
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five days prior to IRT; this was following the preparation session for intervention 
participants.  The third assessment was the day after IRT and comprised the same 
measures as time one.  Qualitative feedback (see appendix 24) was obtained from 
intervention participants three to four weeks following the treatment via telephone 
interviews by a clinical psychologist who was not responsible for the study procedures or 
delivering the intervention.  The interviews were semi-structured allowing the interviewer 
some flexibility to ask for clarification or to pursue ideas raised in the interview.  They 
lasted approximately 10 minutes and detailed notes, as much as possible being verbatim, 
were taken by the interviewer.  The interview schedule was designed with open-ended 
questions in order to elicit feedback about the session, helpfulness of the session, coping 
strategies discussed in the session, coping strategies used and recommendations for future 
improvements.   
 
Intervention 
 
Four women who had already received the treatment were consulted prior to the 
development of the intervention.  These women shared their experiences, their coping 
strategies and feelings about the treatment.  Feelings of isolation, anxiety and distress 
were reported by these women during treatment and all felt they could have benefited 
from being prepared for their treatment experiences, in terms of coping strategies, 
information and practical planning for the day of treatment.  The intervention was 
informed by these findings, previous literature, feedback from professionals in cancer 
care and feedback from patients who had received pilot preparation sessions.   
The preparation session lasted 50 to 60 minutes and was delivered five to seven 
days before IRT.  A telephone booster session lasting 10 to 20 minutes was offered mid-
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way between the delivery of the intervention and treatment; this was approximately three 
days prior to treatment.  All intervention participants received this telephone booster 
session.  The researcher delivered all the face-to-face intervention sessions and telephone 
booster sessions.  The intervention was manualised and three sessions were recorded.  
Clinical supervision in relation to the delivery of the intervention was provided by a 
Counselling Psychologist independent to the study and fidelity checks were made in 
supervision by reviewing audio recordings of the interventions.   
The session comprised six stages: (1) building rapport (2) identifying patients’ 
concerns and illness beliefs and establishing an action plan to address these where 
necessary (3) information about procedure and practical planning (4) understanding and 
managing anxiety (5) abdominal deep breathing (6) option of guided imagery, progressive 
muscle relaxation or brief mindfulness exercise practice.   
Patients’ bio-psycho-social concerns were elicited using the Distress Thermometer 
(DT; Roth et al., 1998; see appendix 25).  Regular screening of bio-psycho-social 
concerns is recommended by the NICE guidance on supportive and palliative care (NICE, 
2004).  In regard to gynaecological cancers, Maguire (1999) found that only 40% of 
concerns held by women with cervical cancer had been disclosed in the year after 
diagnosis.  It has been shown that simply acknowledging concerns with a patient has 
proven to have a positive impact on their quality of life (Velikova et al., 2004). The DT 
enables identification of women’s distress and brings forth their concerns in relation to 
their cancer and forthcoming treatment.  The DT has a one-item visual analogue scale for 
screening distress, followed by a comprehensive problem list on which patients identify 
those which cause them distress (Jacobsen et al., 2005).  Added to this is an element 
where patients rank their four main concerns and develop a plan of action to address 
these.   Strategies utilised in the plan of action included information sharing with health 
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professionals, signposting, exploring practical options, and / or using cognitive-
behavioural strategies.  The Self Regulation Model (Leventhal, Meyer & Nerenz, 1980) 
posits that to understand an individual’s reaction to a significant health event (e.g. cancer, 
treatment) it is important to understand their cognitive and emotional representations of 
the treatment and illness.  Thus, one part of this intervention was to be aware of an 
individual’s illness beliefs, (the researcher had an awareness of these from the BIPQ 
completed at baseline) and to explore those that might be having a negative effect on their 
coping, and to discuss cognitive and behavioural strategies which could help to manage 
these beliefs.  
The third part of the session provided patients with information about the 
treatment and its procedure.  Patients were given an option of seeing pictures of the 
treatment room.  This was followed by discussions about practical planning for the 
treatment day, such as what they would like to take with them into hospital (e.g. 
distracting activities, objects of reference), and things they might have to consider to 
make the whole process less stressful (e.g. planning travel arrangements).   
The next part, included psychoeducation about anxiety and helping patients to 
identify their cognitive, somatic, emotional and physiological responses associated with 
anxiety.  Brief anxiety management techniques were taught, including deep abdominal 
breathing, developing more balanced beliefs, developing coping self-statements and quick 
methods of muscle relaxation.   
In the final step patients could practice a coping strategy of their choice from a 
range of relaxation and mindfulness techniques.  It was recommended that the relaxation 
strategies were practiced prior to treatment and a plan of practice was developed 
incorporating implementation intentions.  Implementation intentions comprise a basic 
plan of action: An individual specifies when, where and how (‘if situation Y is 
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encountered, then I will perform behaviour X’) an intention to perform a behaviour will 
be enacted (Gollwitzer, 1999; Gollwitzer, 1993).  The literature indicates that 
implementation intentions can be effective in facilitating behaviour (e.g. Sheeran & 
Orbell, 2000; Orbell, Hodgkins, & Sheeran, 1997; Orbell & Sheeran, 2002).  Therefore, it 
was anticipated that the formulation of a plan based on implementation intentions might 
promote the use of relaxation after the session.  
Patients were provided with written materials comprising their DT and plans of 
action, personalised practical planning for the day, written information of treatment 
procedure, guidance on the strategies in the session and audio recordings of all the 
relaxation and mindfulness exercises.  Patients were encouraged to try the strategies they 
had not practiced in the session.  A booster telephone session was completed mid-way 
between the preparation session and treatment.  This was to ensure that women had 
understood the techniques discussed in the session, and plans for practice were revisited.  
Any barriers to meeting the plans established in the session and any further concerns or 
questions were addressed.  The control group only received information about the 
treatment from their consultants as part of routine clinical practice.   
 
 Data Treatment  
 
The range, minimum and maximum scores were checked on all variables.  When two 
answers were given for the same question, they were treated as missing.  Substitutions for 
missing data were made for the HADS, SV-POMS, and COPE with a participant’s 
personal average for the subscale if more than half of the items for the subscale had been 
completed.  No substitutions were made for single item scale data.  The normality of 
distributions was statistically tested using the Kolmogorov-Smirnov test.  The scores for 
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the BIPQ at baseline and several of the COPE subscales (denial, substance use, emotional 
support, behavioural engagement, venting, humour, acceptance, religion and self-blame) 
were not normally distributed and therefore non-parametric tests were used to analyse 
these data.   
 
Statistical Analysis 
 
All statistical analyses were performed using the Statistical Package for Social Sciences 
(SPSS) (Version 14).  The following statistical analyses were conducted to test whether 
the preparation session group was more effective at improving outcomes compared to the 
control group.  To test the primary hypothesis, participants’ anxiety scores on the HADS-
A were transformed into change scores between assessment points.  The change scores 
were calculated by subtracting a participant’s score at baseline from their score at pre-
treatment, and subtracting the baseline score from the post-treatment score.  Independent 
t-tests were conducted to determine whether there were significant differences in the 
change scores between the two groups.  The same statistical analysis was conducted to 
test secondary outcomes, and to compare differences between the groups on HADS-D, 
SV-POMS, BIPQ and COPE.  As noted above the BIPQ scores at baseline indicated a 
deviation from normality, and thus differences between the groups were tested using a 
non-parametric Mann-Whitney test.  Finally, to explore coping strategies used, the 
descriptive and frequency data on the COPE was considered.    
The analytical strategy was adapted to take the small sample size into account, and 
thus it was decided that conducting analyses to ascertain changes in outcomes at the 
individual level would help to assess more closely the effects of the intervention.  Much 
of the existing work on the evaluation of interventions focuses on changes in outcomes 
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that occur at the group level.  Achieving a significant change between two assessment 
points is considered adequate evidence that the intervention is effective.  However, the 
variation in outcomes at the individual level is not considered and a statistically 
significant change does not provide information about the clinical meaningfulness of this 
finding.  Jacobsen and Truax (1991) have suggested a supplementary means of analysis 
which considers significant change at the level of individual participants, thus giving an 
insight into the impact an intervention has on clients and the benefits or otherwise derived 
from it.   Jacobsen and Truax recommend examining data according to two criteria: (a) 
the reliable change index (RCI) and (b) an established cut-off point of clinical 
significance (e.g. a score that distinguishes between caseness and non-caseness).   
The RCI was used to assess for changes in scores from baseline to pre-treatment 
and baseline to post-treatment for the anxiety and depression subscales of the HADS 
because this was the primary outcome measure and the one that is most likely to be used 
in routine clinical practice to assess change.  The RCI has a precise cut-off criterion for 
improvement which is psychometrically based.  If the value of RCI is greater than 1.96 
then the score is a reflection of a ‘real’ change (p=0.05) and not one due to the random 
error of an imprecise measuring instrument.  Hence, in this study participants were 
classified as showing a change in anxiety and depression which was statistically 
meaningful if the value of RC exceeded 1.96 (95% confidence).    
The cut-off of 8 for both the HADS-A and HADS-D has been established as 
providing the most optimal balance between sensitivity and specificity (Bjelland et al., 
2001).  This was the criterion used in this study, scores above 8 on the HADS-A and 
HADS-D were classified as caseness and scores below this as non-caseness.  Scores 
which passed this threshold either as an improvement or deterioration between baseline 
and pre or post-treatment were considered clinically important.  However, in terms of 
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mental health, cancer patients are a non-clinical population.  Thus, it is possible that an 
individual could have a baseline score firmly in the normal range and demonstrate 
improvement or deterioration that does not cross the cut-off threshold but may still be 
clinically important (Jacobsen & Traux, 1991).  Therefore, based on these two criteria, 
individuals were classified in the following ways (based partly on Jacobsen & Traux, 
1991):  
(1) Considerable improvement- individuals passed RCI criteria and passed cut-off on 
HADS from caseness to non-caseness 
(2) Improved- passed RCI criteria but not cut-off for caseness to non-caseness 
(3) Unchanged- passed neither criterion 
(4) Decline – passed RCI criteria but not enough to go from non-caseness to caseness 
(5) Deterioration- passed RCI criteria and passed cut-off from non-caseness to 
caseness. 
Finally, a post-hoc sample size calculation was conducted to assess if the study had 
adequate power.   
 
Results 
 
20 patients consented to participate in the study, although one participant later withdrew 
from the intervention group.  For a closer examination of the characteristics of the 
participants who completed the study please refer to Table 1.   
 No significant differences were found on the HADS-A, HADS-D, SV-POMS, 
BIPQ (see appendix 26) or demographic characteristics between the groups at baseline 
(see Table 1).  In terms of the relaxation and mindfulness options selected by participants 
in the intervention, 7 opted for guided imagery and 3 for progressive muscle relaxation.  
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None opted for mindfulness in the intervention; however, two participants tried this 
outside the session.  8 participants reported that they had tried the techniques following 
the session.   
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Table 1. Characteristics of the sample 
 Intervention 
group 
Control group All group 
 Mean (SD) Mean (SD) Mean (SD) 
Age (n=19) 57.00 (4.28) 54.33 (3.98) 55.74 (12.52) 
 N (%) N (%) N (%) 
Diagnosis (n=19)    
Cervical cancer 7 (70) 7 (77.8) 14 (73.7) 
Endometrial cancer 3 (30) 2 (22.2) 5 (26.3) 
Ethnicity (n=19)    
White British 9 (90) 8 (88.9%) 17 (98.5) 
Mixed Heritage  1 (10) 1 (11.1%) 2 (10.5) 
Marital status 
(n=19) 
   
Married / co-
habiting 
5 (50) 5 (55.5) 10 (52.6) 
Single 1 (10) 1 (11.1) 2 (10.5) 
Separated  4 (40) 2 (22.2) 6 (31.6) 
Widower  1 (11.1) 1 (5.3) 
Higher / further 
education (n=16) 
   
Yes  6 (75) 3 (37.5) 9 (56.3) 
No  2 (25) 5 (62.5) 7 (43.7) 
Treatment other 
than IRT 
   
Chemotherapy only 2 (20) 0 2 (10.5) 
Radiotherapy only 1 (10) 2 (22.2) 3 (15.8) 
Chemotherapy and 
radiotherapy 
7 (70) 6 (66.7) 13 (68.4) 
No other treatment 0 1 (11.1) 1 (5.3) 
 
.  
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Table 2. Descriptive statistics for main outcome measures at baseline, pre-treatment and 
post-treatment time-points  
Scale Group Baseline 
 
Mean (SD) 
Pre-
treatment 
 
Mean (SD) 
Post-
treatment 
Mean (SD) 
Change 
scores 
Baseline to 
pre-
treatment 
Change 
scores 
baseline to 
post-
treatment 
HADS-
A 
I 9.30 (4.06) 7.6 (3.47) 7.7 (3.34) -1.7 (2.63) -1.6 (3.20) 
 C  7.67  (4.61) 11.00 (4.58) 10.75 (4.50) 3.33 (6.20) 3.0 (3.74) 
HADS-
D 
I  6.8 (3.55) 7.7 (4.00) 6.8 (3.08) 0.90 (3.14) 0.00 (2.05) 
 C  6.11 (4.04) 9.0 (2.78) 8.75 (2.71) 2.89 (4.17) 2.33 (3.74) 
SV-
POMS 
I  35.00 (22.81) 36.10 (23.39) 31.05  (29.01) 1.1 (23.11) -3.95 
(26.28) 
 C 30.00 (31.14) 37.33 (25.12) 44.25 (20.29) 7.3 (25.85) 14.25 
(21.46) 
       
  Baseline 
Median 
Post-
treatment 
Median 
Change scores from baseline 
to post-treatment 
median 
 
BIPQ I 43.5 39.5 -4  
 C 34 30.5 -4  
 
Anxiety and depression outcomes 
 
The primary aim in this study was to test the effects of the preparation session on anxiety 
compared with the control condition.  Secondary analyses included testing differences 
between the groups on depression, mood, coping and illness representations.   
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As shown in the descriptive statistics in Table 2 and Figure 2, the anxiety scores in 
the control group increased from baseline to pre-treatment, and then remained relatively 
unchanged to post-treatment.  Anxiety in the intervention group lessened from baseline to 
pre-treatment, and then remained unchanged.  In the intervention group anxiety on the 
HADS-A was scored as borderline and abnormal in 60% of patients at baseline, 50% at 
pre-treatment and 60% at post-treatment.  In the control group anxiety was categorised as 
borderline and abnormal at baseline in 44% of participants, 66.7% at pre-treatment and 
66.7% at post-treatment.  The results of an independent samples t-test revealed that there 
were significant differences between the intervention group and control group for anxiety 
between baseline and pre-treatment (t=-2.348, df=17, p=0.03) and from baseline to post-
treatment (t=-2.887, df=17, p=0.01).    
The depression scores increased slightly in the intervention group at pre-treatment 
and then decreased slightly at post-treatment (see Table 2 and Figure 3).  In the control 
group, depression increased from baseline to pre-treatment and remained unchanged at 
post-treatment.  At baseline, 50% of participants in the intervention group scored in the 
borderline and abnormal range of depression, 50% at pre-treatment and 50% at post-
treatment, compared to 22% of the control group at baseline, 67% at pre-treatment and 
44% at post-treatment.  T-tests showed that there were no significant differences between 
the groups (see Table 3). 
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Figure 3. Mean scores for intervention and control participants at baseline, pre-treatment 
and post-treatment for anxiety and depression 
 
                        HADS-A control group        
                         
                        HADS-D control group  
                         
                        HADS caseness cut-off 
                        HADS-A intervention group          
                         
                        HADS-D intervention group 
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Table 3: T-tests to assess group differences on main outcome measures 
 
Measure Time points assessed t-value Degrees of 
freedom 
Significance 
level 
HADS-A Baseline to pre-treatment -2.348 17 0.031* 
HADS-A Baseline to post-treatment  -2.887 17 0.010* 
HADS-D Baseline to pre-treatment -1.183 17 0.253 
¹HADS-D Baseline to post-treatment  -1.659 12.14 0.123 
SV-POMS Baseline to pre-treatment -0.555 17 0.586 
SV-POMS Baseline to post-treatment  -1.829 16 0.086 
COPE     
¹Self-
distraction 
Baseline to post-treatment -0.459 14.955 0.653 
Active 
coping 
Baseline to post-treatment 0.857 15 0.405 
Instrumental 
support 
Baseline to post-treatment 0.788 16 0.442 
Positive 
reframing 
Baseline to post-treatment 0.780 15 0.447 
Planning Baseline to post-treatment 0.573 16 0.575 
Mann 
Whitney 
Test 
Time points U value N1, N2 Significance
BIPQ  Baseline to post-treatment 43.000 9, 10 0.905 
COPE     
Denial Baseline to post-treatment 29.500 8, 10 0.360 
Substance 
use 
Baseline to post-treatment 35.500 8, 9 0.963 
Emotional 
support 
Baseline to post-treatment 21.000 8, 9 0.167 
Behavioural 
engagement 
Baseline to post-treatment 33.000 8, 9 0.815 
Venting Baseline to post-treatment 26.000 8, 9 0.370 
Humour Baseline to post-treatment 33.000 8, 9 0.815 
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Table 3 Continued  
Mann 
Whitney 
Test 
Time points U value N1, N2 Significance
Acceptance Baseline to post-treatment 25.000 8, 9 0.321 
Religion Baseline to post-treatment 26.000 8, 9 0.370 
Self-blame Baseline to post-treatment 29.500 8, 9 0.541 
* Significant at p<0.05 
¹ Levene’s test significant and statistics for equal variances not assumed as assumption of 
homogeneity of variance violated.   
 
Mood disturbance and illness beliefs 
 
At baseline the control and intervention group had similar total mood disturbance scores 
on the SV-POMS.  At post-treatment the total mood disturbance scores decreased very 
slightly in the intervention group, while increasing somewhat in the control group.  This 
seems to indicate that at post-treatment the distress experienced by the control group 
patients increased.  However, analyses (see Table 3) indicated that there were no 
significant differences between the groups.   
Although not significant, the median scores for the BIPQ at baseline were higher 
for the intervention group than the control group.  This indicates that the intervention 
group perceived a somewhat greater threat from their illness compared to the control 
group.  While the median scores for the BIPQ decreased a little from baseline to post-
treatment in both groups, the median for the intervention group still remained higher than 
the control group, again, suggesting that after treatment patients in the intervention group 
perceived a greater threat from their cancer.  A Mann Whitney test indicated that there 
were no significant differences between the groups (U=43.000, N1=9, N2=10, p=0.905). 
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Coping 
 
T-tests on the coping styles at baseline and post-treatment found no significant 
differences between the groups (Table 3).  Descriptive and frequency data for the coping 
styles commonly used by participants are shown in Table 4.  The most common coping 
strategies utilised by participants included self-distraction, emotional support, 
instrumental support, positive re-framing, planning and acceptance.  While the 
differences between the groups were not significant, it is worth noting that according to 
the frequency data, a larger proportion of participants in the intervention group used 
acceptance and planning compared to the control group post-treatment.   
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Table 4. Descriptive and frequency data for commonly used coping styles 
  Percentages for proportion of participants who 
rated using the coping strategy as quite a bit or 
extremely  
Coping style Mean and std 
deviation / 
median if 
non-
parametric at 
baseline 
Baseline Post-
treatment 
intervention 
 Post-
treatment 
control  
Self-distraction 5.17 (1.72) 50% 22.2% 50% 
Emotional 
support 
6.50* 61.1% 88.9% 62.5% 
Instrumental 
support 
5.17 (1.69) 38.9% 50% 37.5% 
Positive 
reframing 
5.00 (1.97) 39% 44.4% 25% 
Planning  5.11 (1.20) 38.9% 60% 25% 
Acceptance  6.00* 55.5% 88.9% 25% 
* items not normally distributed and median reported 
 
Reliable Change Index and clinical significance 
 
The proportion of participants classified as showing considerable improvement, 
improvement, no change, decline and deterioration are shown in Tables 5, 6, 7 and 8 for 
anxiety and depression outcomes (to see individual scores at each assessment point for 
anxiety and depression see appendix 27).   
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Anxiety 
Table 5. Clinical significance and reliable change index analyses on anxiety between 
baseline to pre-treatment   
Groups Considerable 
Improvement 
Improvement Unchanged Decline Deterioration 
Anxiety baseline to pre-treatment 
Intervention  1/10 0/10 9/10 0/10 0/10 
Control  1/9 0/9 4/9 0/9 4/9 
Difference 
between 
groups 
0.94 0.99 <0.05* 0.99 P=0.03* 
* Significant at p<0.05 
 
As seen in Table 5, five participants in the control group and one participant in the 
intervention group had a score above 1.96 (scores of 1.96 or greater indicated significant 
deterioration and scores of -1.96 or greater indicated significant improvement) indicating 
change on HADS-A between baseline and pre-treatment beyond that of random error.  
Nine participants’ anxiety (90%) in the intervention group remained unchanged between 
baseline and pre-treatment compared to four (44%) in the control group.  This difference 
was significant, indicating that significantly more patients in the intervention group had 
stable levels of anxiety from baseline to pre-treatment (i.e. not resulting in significant 
deterioration or improvement) (see Table 5).  Four control participants (44%) showed 
deterioration in anxiety between baseline and pre-treatment, i.e. the RCI criterion was met 
and scores moved from non-caseness to caseness levels, compared to no participants in 
the intervention group meeting these criterion.  This difference was significant, indicating 
that the intervention may have been effective in preventing further deterioration in 
anxiety from baseline to pre-treatment.   
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Table 6. Clinical significance and reliable change index analyses on anxiety between 
baseline to post-treatment   
Groups Considerable 
Improvement 
Improvement Unchanged Decline Deterioration 
Anxiety baseline to post-treatment 
Intervention  0/10 2/10 7/10 0/10 1/10 
Control  1/9 0/9 5/9 1/9 2/9 
Difference 
between the 
groups 
0.29 0.17 0.52 0.3 0.48 
* Significant at p<0.05 
 
Three participants in the intervention group and four participants in the control 
group had an RCI score above 1.96 on the HADS-A (see Table 6) between baseline and 
post-treatment.  One participant in the intervention group was found to show deterioration 
and three participants in the control group had a decline or deterioration between baseline 
and post-treatment.  There were no significant findings between the intervention and 
control group in anxiety from baseline to post-treatment.   
 
Depression  
Table 7. Clinical significance and reliable change index analyses on depression between 
baseline and pre-treatment.  
Groups Considerable 
Improvement 
Improvement Unchanged Decline Deterioration 
Depression baseline to pre-treatment 
Intervention 0/10 1/10 6/10 2/10 1/10 
Control  1/9 0/9 3/9 0/9 5/9 
Difference 
between the 
groups 
0.29 0.34 0.26 0.17 <0.05* 
* Significant at p<0.05 
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Between baseline and pre-treatment four participants in the intervention group and six 
participants in the control group had an RCI score above 1.96 (see Table 7).  Analyses for 
depression found that five of the participants in the control group showed deterioration 
between baseline and pre-treatment compared to one participant in the intervention group.  
This difference indicated that significantly more patients in the control group showed 
deterioration in depression from baseline to pre-treatment.   
 
Table 8. Clinical significance and reliable change index analyses depression between 
baseline and post-treatment 
Groups Considerable 
Improvement 
Improvement Unchanged Decline Deterioration 
Depression baseline to post-treatment 
Intervention 1/10 0/10 8/10 0/10 1/10 
Control  1/9 0/9 3/9 1/9 4/9 
Difference 
between the 
groups 
0.94 0.99 0.05* 0.29 0.11 
* Significant at p<0.05 
 
At baseline to post-treatment, two participants in the intervention group and six 
participants in the control group had a RCI score above 1.96 (see Table 8).  Eight 
participants in the intervention remained unchanged between baseline and post-treatment, 
compared to three participants in the control group.  This was significant indicating that 
more patients in the intervention group had stable levels of depression from baseline to 
pre-treatment.  Finally, four participants showed deterioration and one participant showed 
decline in the control group compared to one participant in the intervention group who 
showed deterioration.  Combining the scores for deterioration and decline, shows that 
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significantly more patients in the control group showed a decline or deterioration 
compared to the intervention group (<0.05).   
 
Post-hoc sample calculation 
 
Using a statistical method for determining trial size (Pocock, 1983) based on this pilot 
study it was found that 66 participants in total (33 per group) would be required for this 
study to achieve 80% power with a significance level of 0.05, two tailed for the primary 
outcome measure of anxiety for a more definitive trial.   
 
Discussion 
 
The present study was designed to evaluate the potential psychological benefits of a 
preparation session for women undergoing IRT compared to treatment as usual.  To our 
knowledge, this is the first time that a pre-treatment preparation session comprising 
cognitive-behavioural techniques, eliciting and addressing concerns, and procedural 
information has been attempted exclusively with gynaecological patients undergoing IRT.  
The results indicate that participants in the intervention group had significantly lower 
anxiety at pre- and post-treatment compared to the control group.  Clinical significance 
and RCI analyses found that significantly more patients in the control group showed 
significant levels of deterioration from baseline to pre-treatment compared to the 
intervention group for anxiety and depression.  The majority of participants in the 
intervention group were found to have unchanged levels of anxiety and depression prior 
to IRT treatment.  The findings seem to suggest that the preparation session had a 
prophylactic effect, in that patients’ anxiety and depression did not significantly increase 
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as treatment approached.  Significantly more patients in the intervention group had 
unchanged levels of depression at post-treatment compared to baseline, than was the case 
for the control group.  Significantly more patients in the control group either had a decline 
or deterioration in depression post-treatment compared to baseline.  This again indicates 
that perhaps the intervention may have prevented further deterioration in depression at 
post-treatment.  This study adds to the growing literature which demonstrates that brief 
psychologically-informed interventions can influence psychological outcomes in cancer 
patients undergoing treatment.   
The preparation session did not have an effect on overall mood disturbance, 
coping skills or perceived threat of illness.  This study conducted a preliminary 
assessment of coping strategies to explore the mechanisms by which the intervention may 
have had an impact on psychological outcomes.  While exploratory data analysis of 
frequency data seemed to suggest that intervention participants used more acceptance and 
planning coping skills compared to the control group, these findings were not significant.   
A number of possible factors may explain the effects of the intervention on 
anxiety.  Firstly, relaxation techniques have been shown to be effective in reducing 
psychological distress associated with a wide range of different cancer treatments and the 
management of treatment-related symptoms (Leon-Pizarro et al. 2007; Nunes et al, 2007; 
Burish & Jenkins, 1992; Burish et al, 1991; reviews: Luebbert et al., 2001, Redd et al, 
2001).  Procedural information, cognitive, and behavioural interventions have been found 
to reduce negative affect in preparing patients for surgery (Johnson & Vogele, 1993).  
The booster session and provision of written and audio materials may also have 
contributed to the effectiveness of the intervention.  This study replicates the findings of 
Leon-Pizarro and colleagues (2007) who reported that patients with breast and 
gynaecological cancer undergoing IRT who received information provision about 
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treatment and training in guided imagery, had significantly less anxiety, depression and 
body discomfort.   
Patients did not generally tend to view the mindfulness strategies as coping 
techniques that would be helpful for them.  Of the two participants who attempted the 
mindfulness strategies, neither found them useful.  Patients may need more direction in 
using these techniques.   Mindfulness interventions usually tend to consist of at least 8 
weeks of training (Speca, Goodey & Angen, 2000; Carlson, Speca, Patel & Goodey, 
2003; Tacon, Caldera & Ronaghan, 2004).  Further research is required to ascertain 
whether mindfulness techniques could be helpful in helping clients to manage distress and 
/ or symptoms related to cancer treatment.   
Patients in this study were self-selecting.  Sixty-five per cent of patients opted not 
to participate, and this raises questions about whether there were differences between the 
patients who participated and those who did not wish to participate.  As participants were 
aware of whether they were in the control or intervention group, it is feasible that they 
had different reasons for wishing to take part depending on the group that was on offer 
during their treatment.  It is, therefore, possible that those in the intervention group were 
more motivated to seek further information about the treatment and /or considered the 
learning of new coping skills as being important for helping them to manage their 
distress, possibly because they were experiencing more or less distress compared to other 
patients.  There were no means of identifying whether the patients who entered the study 
differed from the general population of gynaecological patients.  However, Kramer’s 
study (2007) which evaluated patient anxiety just prior to IRT treatment found that 32% 
of participants had anxiety within the normal range and 68% in the borderline and 
abnormal ranges of anxiety.  The findings of anxiety for this study in the control group at 
pre-treatment (five days prior) were very similar with 33% with anxiety in the normal 
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range and 67% in the borderline and abnormal range.  This suggests that the 
characteristics of anxiety in this group were comparable to findings in previous studies 
with this patient population.   
The feasibility of the study design was established through the successful 
recruitment of patients into the intervention arm of the study.  There was only one 
participant who decided to withdraw their participation from the study because they did 
not want to obtain any further information or talk about IRT.  The remaining participants 
attended the preparation session, and 100% completed assessments pre- and post- 
treatment, and eight also provided feedback on the intervention two to four weeks post-
treatment.  The retention of participants in this study indicates that future research in this 
area will be feasible.   
 
Limitations of the study and directions for future research 
 
Despite every effort to try to increase recruitment, it was impossible to attain the sample 
required for adequately statistical power for this study.  A strategy adopted by other 
researchers in response to low recruitment has been to extend the recruitment period 
(Chang, Hendricks, Slawsky, & Locastro, 2004).  However, this was not a feasible option 
due to the limited time period available for this research programme.     
A sample size calculation for a more definitive trial based on this pilot study 
indicated that the study was inadequately powered to fully determine differences between 
the groups.  Therefore, this study carries a considerable risk of being unable to 
demonstrate differences between the groups (Type II error; Pocock, 1983) and precise 
estimate of treatment effect was not possible.  The results of this study should be 
interpreted taking this into consideration and this limits the weight that can be placed on 
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the findings. It is also possible that the small sample size hindered the identification of 
mechanisms (e.g. coping strategies, illness beliefs) that enabled the intervention to 
influence outcomes.  It is possible that changes in general mood disturbance were not 
achieved because the intervention failed to influence illness beliefs and coping skills, 
however, testing this definitively was not possible.  Future studies should strive to adopt 
appropriate theoretical models to inform the evaluations and development of 
interventions, particularly as a meta-analysis by Graves (2003) found that treatment 
packages for adult cancer patients which consisted of a larger number of social cognitive 
components had larger effect sizes.   
The utility of psychological and social cognitive theories in the development of 
interventions to improve outcomes in cancer patients should be explored further.  To 
facilitate the development of theoretically informed interventions the causal modelling 
approach (Hardeman et al., 2005) can be used.   This process enables researchers to 
identify and link all elements of their interventions and its evaluation by theoretical 
pathways, thus, ensuring that theoretical components, alongside end-points such as 
psychological distress and symptoms, are incorporated into the evaluation and the 
mechanisms via which the intervention will influence outcomes is defined.   
It was not possible to minimise the effect of observer bias by blinding the 
researcher regarding the group to which patients were allocated, because the researcher 
was also responsible for recruitment and delivering the intervention.    Due to resource 
limitations, it was only possible for the scoring and entry of study data and the qualitative 
interviews to be conducted by an independent researcher.  Patients were also aware of 
group allocation prior to recruitment.  It is therefore possible that the outcome 
expectations of both researcher and patient may have contributed to the treatment effect 
and patients may have overestimated the benefits they obtained.    
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Not adopting the gold standard of a randomised controlled trial was also a 
limitation of this study.  This methodology is preferred because it more effectively 
distributes extraneous external factors between trial groups, and therefore, differences 
found between the groups can be more confidently assigned to the intervention (Eccles, 
Grimshaw, Campbell & Ramsay, 2002).   Although significant baseline differences were 
not found in this study, the existence of differences cannot be ruled out because of the 
small sample size.  Indeed, it is worth highlighting that at baseline 60% of participants in 
the intervention group had anxiety levels in the borderline to abnormal range compared to 
44% in the control group.  In addition, 50% of patients in the intervention group had 
depression levels in the borderline to abnormal ranges compared to 22% in the control 
group.  This does raise questions about whether patients who chose to participate in the 
intervention group had higher levels of distress.   
A further limitation in this study was the lack of measurement for practice of 
coping skills covered in the session and in the additional materials provided.  It is 
uncertain whether patients practiced the coping skills regularly.  It has been found in the 
literature that the extent to which patients practiced relaxation skills was related to the 
extent of emotional suppression and levels of unhappiness (Walker et al., 1999).   The 
absence of a follow-up assessment resulted in no information being gathered on the 
duration of effects observed from the intervention or possible longer term effects.  It has 
been documented in the literature that effects from psychosocial interventions for 
treatment-related symptoms have at times resulted in significant benefits six months or 
longer following the intervention (Armes et al. 2007; Parker et al., 2009).  Future studies 
should include an attention equivalent control group, to ascertain whether the impact of 
an intervention is beyond that which is due to the non-specific aspects (e.g. rapport, 
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attention).  The limitations of this study should be adequately addressed in future more 
definitive trials of this preparation intervention.   
 
Clinical implications 
 
The analyses using the reliable change index and clinical significance criterion provided 
information useful for making clinical decisions.  These preliminary findings do indicate 
that the preparation session may be effective in preventing further significant anxiety in 
four in every nine patients prior to IRT and preventing further significant depression prior 
to IRT in about half of patients.  Furthermore, the intervention seemed to prevent further 
deterioration in depression at post-treatment.  Patient feedback indicates that the 
intervention was acceptable to this patient population, and techniques practiced and 
discussed in the preparation session were used to manage distress they experienced.  This 
gives adequate justification for advocating the use of preparation sessions routinely in 
clinical practice for gynaecological patients undergoing invasive IRT.  It might also be 
worth considering whether the preparation session could be adapted for use with patients 
undergoing other medical procedures.  In this study a trainee clinical psychologist 
administered the preparation session, it is quite feasible for other members of the primary 
oncology team to deliver this intervention after training, thus further reducing the costs of 
the session’s delivery.   
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Conclusions  
 
This research programme was developed to provide a preliminary evaluation of a brief 
psychologically-informed preparation session, in a control before-and-after study design, 
on psychological outcomes.  It appears that the preparation session functions by 
preventing significant exacerbation of anxiety or depression prior to or as an immediate 
result of the invasive internal radiotherapy treatment.  These preliminary findings are 
encouraging, although they are limited and it is difficult to interpret them in the absence 
of an adequate sample size.  The study does suggest that this topic is worthy of further 
research and provides a justification for evaluating the effects of this preparation session 
in a larger more definitive trial.   Future research should seek to incorporate a longer 
follow-up period, in order, to establish whether the preparation session can also influence 
outcomes over a longer duration.   
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Cancer treatment-related distress:  
Evaluating the effectiveness of psychosocial interventions 
 
This study was conducted by Narinder Shergill in partial fulfilment of the requirements 
for the Doctorate in Clinical Psychology, at the University of Birmingham. This study 
was supervised by Dr Jan Oyebode, Dr Ruth Howard and Dr Inigo Tolosa. 
 
Background 
Internal radiotherapy treatment (IRT) is available for women with gynaecological 
cancers.  This treatment enables radiation to be directed specifically at the site of the 
tumour.  Notwithstanding the effectiveness of IRT for treating gynaecological cancers, 
the procedure is invasive and intimate.  It has long been established that women find IRT 
distressing.  It was found that 68% of women scored within the borderline and abnormal 
ranges of anxiety prior to IRT (Kramer et al., 2007) and negative states such as anxiety, 
worry and fear were associated with the treatment (Warnock et al., 2005).  It is clear from 
the previous research that women need support to cope with this treatment.   
 
This research carried out consists of a literature review and a clinical study.  The review 
summarises evidence regarding the effectiveness of psychosocial interventions on the 
distress and symptoms related to cancer treatment.  The report of the clinical study 
evaluates the impact of a psychological preparation session on psychological distress in 
women undergoing IRT.   
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Literature Review 
Published research looking at different psychosocial interventions, such as relaxation, 
cognitive-behavioural interventions, hypnosis and supportive interventions, was 
summarised and critically evaluated.  Relaxation techniques were found to be the most 
effective for patients undergoing various cancer treatments, particularly for symptoms of 
anxiety.  The evidence of impact of relaxation interventions on other psychological 
outcomes, symptoms and quality of life was more mixed.  The differences in the 
components of cognitive-behavioural interventions and the mixed findings about their 
impact on psychological, symptom and quality of life made it difficult for definite 
conclusions to be drawn.  There were too few studies looking at hypnosis and supportive 
interventions to draw firm conclusions about their effectiveness.   
 
Empirical study 
Aims  
The first aim of this study was to evaluate the impact on patients’ anxiety of a brief 
psychological preparation session for women before they have IRT.  The project also 
aimed to understand the impact of the session on women’s levels of depression, mood 
disturbance, perceived threat of cancer and coping strategies.  
 
Study design and participants 
A controlled, before-and-after design was used.  Nineteen women participated in the 
study – 10 received the preparation session (intervention group) and 9 acted as a control 
group.  All were due to receive IRT for gynaecological cancer at a large cancer centre.  
The participants had a mean age of 55.74 years, 74% had cervical cancer and 26% had 
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endometrial cancer.  Ethical approval was obtained from North Staffordshire Research 
Ethics Committee.   
 
Intervention  
The psychological intervention session being tested lasted one hour and was given five to 
seven days prior to IRT.  The intervention had several parts: (1) building a rapport (2) 
identifying patients concerns using the distress thermometer (3) providing information 
about the procedure (4) understanding and managing anxiety (5) abdominal deep 
breathing (6) one of the following: guided imagery, progressive muscle relaxation and 
brief mindfulness techniques.  Written information and audio tapes of the relaxation and 
mindfulness exercises were provided.  A booster telephone session was offered mid-way 
between the preparation session and their IRT.  Women in the control group received 
routine care.   
 
Measures and procedures 
Packs were provided to eligible women at outpatient clinics, including an information 
sheet, consent form, and questionnaires.  The questionnaires included: (1) Hospital 
Anxiety and Depression Scale (Zigmond & Snaith, 1983) (2) Shortened version of the 
POMS (Shacham, 1983) (3) Brief illness perception questionnaire (Broadbent et al., 
2006) and (4) Brief Coping Orientations to Problems Experienced (Carver, 1997). 
 
The questionnaires were completed at three time-points.   
1. At least a month before IRT, including all the measures.   
2. Five days before IRT (following the preparation session) including the HADS 
and SV-POMS  
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3. The day after IRT and including all the measures.   
Qualitative feedback about the session was obtained from intervention participants via a 
telephone call to the women after the IRT was complete.   
 
Results  
The women receiving the intervention experienced significantly less anxiety from 
baseline to pre and post-treatment compared to those in the control group.  Statistical 
analysis showed that significantly more women in the control group experienced a 
deterioration in anxiety and depression compared to the intervention group.  The findings 
suggested that the preparation session was effective in preventing increases in the 
womens’ distress.  There were no differences found on the outcomes of mood 
disturbance, perceived threat of cancer or coping strategies.  Qualitative feedback 
indicated that patients found the preparation session acceptable and helpful, and used 
some of the coping strategies they learned in the session to alleviate distress.   
 
Shortcomings and recommendations 
The study needed a larger sample size in order to provide firm conclusions.  The study 
did not use a randomised controlled trial design.  Patients and researchers were aware of 
the group they were participating in.  Therefore, the expectations of both researcher and 
the patients may have influenced the findings.  Future studies should include a longer 
follow-up period.  Nevertheless the findings are clinical very useful and it is 
recommended that similar preparation sessions are used routinely in clinical practice for 
patients undergoing invasive and difficult treatments.  It is also feasible for members of 
the cancer team to be trained to deliver brief preparation sessions such as the one 
described here.  
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Appendix 3: Search strategies for Medline and PsychINFO 
 
MEDLINE SEARCH 
 
Database: Ovid MEDLINE(R) <1950 to November Week 1 2009> 
 
Search for: limit 34 to yr="1990 - 2009" 
 
-------------------------------------------------------------------------------- 
1   CANCER KEYWORDS- Neoplasms or Carcinoma or Cancer 
 
2   TREATMENT TYPES- Radiotherapy or Drug Therapy or Chemotherapy or Surgical ( 
General Surgery, Surgical Procedures, Minor, Operative, Elective, Minimally Invasive) or 
Therapeutics or Treatment or Preoperative Care or invasive 
 
3   PSYCHOLOGICAL THERAPIES- Cognitive Therapy or  Gestalt Therapy or 
Behavior Therapy or Psychoanalytic Therapy or Marital Therapy or Relaxation Therapy 
or Couples Therapy or Mind-Body Therapies or Psychology, applied or Counseling 
 
4   OUTCOMES- Stress, Psychological or Stress, Physiological or Pain or Anxiety or 
Anxiety Disorders or Depression or Quality of Life or Emotions or Nausea or 
Postoperative nausea and vomiting or Fatigue or Self Care 
 
Step 1: Combine keywords for cancer and treatment types 
Step 2: Combine step 1 with keywords for psychological therapies and outcomes. 
 
PsychINFO SEARCH 
 
Database: PsycINFO <1987 to November Week 3 2009> 
 
Search for: limit 34 to yr="1990 - 2009" 
 
-------------------------------------------------------------------------------- 
1   CANCER KEYWORDS- Neoplasms or Carcinoma or Cancer 
 
2   TREATMENT TYPES- Radiation Therapy or Drugs or Chemotherapy or Surgery or 
Surgical patients or Invasive or Medical treatment or Medical Patients or Treatment 
 
3   PSYCHOLOGICAL THERAPIES- Behavior modification or Cognitive techniques or 
Pain management or Psychotherapeutic techniques or Psychotherapy or Relaxation 
therapy or Cognitive Behavior Therapy or Cognitive Therapy or Progressive Relaxation 
Therapy or Muscle Relaxation or Stress management  
 
4   OUTCOMES- Physiological Stress or Psychological Stress or Stress (Chronic, Acute, 
Reactions) Pain or Anxiety Disorders or Depression or Quality of Life or Emotions or 
Nausea or Fatigue or Self Care Skills or exp Self Management 
 
Step 1: Combine keywords for cancer and treatment types 
Step 2: Combine step 1 with keywords for psychological therapies and outcomes. 
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Appendix 4: Table, glossary and reference list of outcome measures 
 
Table. Chosen outcome measures of included studies  
 
Measures Type of 
intervention 
Studies 
Psychological  
STAI Relaxation  
 
CB 
Hypnosis 
Supportive  
Nunes et al. 2007; Molassiotis et al. 2001; 
Arawaka, 1997; Morrow et al. 1992 
Jacobsen et al. 2002; Krischer et al. 2007 
Stalpers et al.  2005 
Gaston-Johansson, 2000 
MAACL Relaxation  
 
CB 
Yoo et al. 2005; Burish et al. 1992; Lerman et al. 1990; 
Burish et al. 1991 
Vasterling et al. 1993 
POMS Relaxation 
CB 
Molassiotis et al. 2001; Decker et al. 1992 
Parker et al. 2009  
HADS Relaxation  
CB 
Supportive 
Leon-Pizarro et al.  2007 
Armes et al. 2007 
Ream et al. 2006 
BAI Relaxation  Nunes et al. 2007 
BDI Relaxation  
Supportive  
Nunes et al. 2007 
Gaston-Johansson, 2000 
CECS Relaxation  Walker et al. 1999 
MRS* Relaxation  
Hypnosis  
Walker et al. 1999 
Schnur et al. 2009 
ISSL Relaxation  Nunes et al. 2007 
7-point  
Anxiety scale* 
Relaxation  
CB 
Burish et al. 1991 
Vasterling et al. 1993 
CES-D CB Larson et al. 2000;  Krischer et al. 2007; Jacobsen et al. 
2002 
DES IV 
 
CB Larson et al. 2000 
IES CB Larson et al. 2000, Parker et al. 2009 
LOT CB Larson et al. 2000 
COPE Supportive Ream et al. 2006 
VAS for 
coping* 
Supportive  Ream et al. 2006 
Interview data* Supportive  Burton et al. 1995 
Physical side effects 
Nausea and vomiting 
7- point scales* Relaxation  
 
Supportive 
Yoo et al. 2005; Burish et al. 1991; Lerman et al. 1990 
Burish et al. 1991 
MANV Relaxation  Molassiotis et al. 2002; Morrow et al. 1992 
INV-2 Relaxation  Arakawa, 1997, Troesch et al. 1993 
VAS for 
nausea* 
CB 
Hypnosis  
Supportive  
Syrjala et al, 1992; Syrjala et al. 1995 
Syrjala et al. 1992 
Gaston-Johansson, 2000 
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Nausea 
questions* 
CB Jacobsen et al. 2002 
Patient and 
Nurse Rating* 
CB Vasterling et al. 1993 
 
Physical symptoms 
SSI* CB Given et al. 2004; Sikorskii et al. 2006 
Fatigue  
Fatigue   
EORTC-
QLQc30c 
CB Armes et al. 2007- physical functioning subscale only 
VAS fatigue* CB 
Hypnosis  
Supportive  
Armes et al. 2007 
Montgomery et al. 2009 
Gaston-Johansson, 2000; Ream et al. 2006 
VAS muscle 
weakness* 
Hypnosis  Montgomery et al. 2009 
Fatigue-vigor-
POMS 
CB Brown et al. 2006 
MFI CB Armes et al. 2007 
FOM* CB Armes et al. 2007 
LASA* CB Brown et al. 2006 
Pain 
VAS* Relaxation  
CB 
Hypnosis  
Syrjala et al.  1995 
Syrjala et al. 1992; Syrjala et al. 1995 
Syrjala et al. 1992 
POM Supportive  Gaston-Johansson, 2000 
Quality of life 
QL-CA-A-A-
Fex 
Relaxation  Leon-Pizarro et al. 2007 
FACT-B Relaxation  
Hypnosis  
Yoo et al. 2005 
Montgomery et al. 2009- fatigue subscale only 
GQOL* Relaxation  Walker et al. 1999 
SF-36 CB 
 
Hypnosis  
Supportive  
Larson et al. 2000; Parker et al. 2009; Krischer et al. 
2007; Jacobsen et al. 2002 (short form) 
Stalpers et al. 2005 
Ream et al. 2006 
PCI CB Parker et al. 2009 
* Measure designed specifically for study  
Key to abbreviations: 
CB Cognitive-behavioural 
VAS Visual Analogue Scale  
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Glossary and reference list of outcome measures 
 
BAI Beck Anxiety Inventory:  Beck, A.T., Epstein, N., Brown, G., & Steer, 
R.A. (1988).  An inventory measuring clinical anxiety: 
Psychometric properties.  Journal of Consulting and Clinical Psychology, 
56, 893–897. 
 
BDI Beck Depression Inventory: Beck: A.T., & Steer, R.A. (1987). Manual for 
the Beck Depression Inventory. San Antonio, TX: Psychological 
Corporation. 
 
CECS Courtauld Emotional Control Scale:  Watson , M & Greer, S. (1983).  
Development of a questionnaire measure of emotional control.  Journal of 
Psychosomatic Research, 27 (4), 299-305 
 
CES-D Centre for Epidemiologic Studies Depression Scale:  Radloff, L.S. (1977).  
The CES-D scale: A self-report depression scale for research in the general 
population.  Applied Psychological Measurement, 1, 385-401 
 
COPE Coping Orientations to Problems Experienced:  Carver, C. S., Scheier, M. 
F., & Weintraub, J. K.  (1989).  Assessing coping strategies: a theoretically 
based approach.  Journal of Personality & Social Psychology, 56(2), 267-
83. 
DES-IV Differential Emotions Scale-IV:  Izard, C.E., Libero, D.Z., Putnam, P. & 
Haynes, O.M. (1993).  Stability of emotional experiences and their 
relations to traits of personality.  Journal of Personality and Social 
Psychology, 64, 847-60.   
 
EORTC European Organization for Research and Treatment of Cancer Quality 
QLQc30c  of-Life Questionnaire Core 30, version 3:  Aaronson N.K. (1993).  The 
EORTC-QLQ-30: a quality of life instrument for use in international 
clinical trials in oncology.  Quality Life Research, 2, 51. 
 
FACT Functional Assessment of Chronic Illness Therapy:  Yellen, S.B., Cella, 
D.F., Webster, K., Blendowski, C. & Kaplan, E. (1997).  Measuring 
fatigue and other anemia-related symptoms with the Functional 
Assessment of Cancer Therapy (FACT) measurement system.  Journal of 
Pain and Symptom Management, 13, 63-74.   
Cella, D. (1997).  Manual of the Functional Assessment of Chronic Illness 
Therapy (FACIT) scales.  Centre on outcomes research and education 
(CORE) (1997).  Evanston Northwestern Healthcare and Northwestern 
University.   
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FOM Fatigue Outcome Measure:  Designed specifically for study by Armes, J., 
Chalder, T., Addington-Hall, J., Richardson, A., & Hotopf, M.  (2007).  A 
randomized controlled trial to evaluate the effectiveness of a brief, 
behaviorally oriented intervention for cancer-related fatigue.  Cancer, 
110(6), 1385-1395. 
GQOL Global Self-rated Quality of Life:  Assessed by a five-point Likert Scale 
specifically for the study by Walker, L. G., Walker, M. B., Ogston, K., 
Heys, S. D., Ah-See, A. K., Miller, I. D. et al.  (1999).  Psychological, 
clinical and pathological effects of relaxation training and guided imagery 
during primary chemotherapy.  British Journal of Cancer, 80(1-2), 262-8. 
HADS Hospital Anxiety and Depression Scale:  Zigmond, A. S. & Snaith, R. P.  
(1983).  The hospital anxiety and depression scale.  Acta Psychiatrica 
Scandinavica, 67(6), 361-70. 
IES Impact of Events Scale:  Horowitz, M., Wilner, N. & William, A.  (1979).  
Impact of Events Scale: a measure of subjective stress.  Psychosomatic 
Medicine, 41, 209-18.   
 
INV-2 Rhodes Index of Nausea and Vomiting Form 2:  Rhodes, V.A., Watson, 
P.M. & Johnson, M.H. (1986).  Association of chemotherapy related 
nausea and vomiting with pretreatment and posttreatment anxiety.  
Oncology Nursing Forum, 13, 41-7.   
 
ISSL Lipp’s Inventory of Stress Symptoms:  Lipp M.N. (2000).  Lipp’s 
Inventory of Stress Symptoms for Adults [in portuguese], 1st edn. Sa˜o 
Paulo: Casa do Psico´ logo, 
 
LASA Single-item Linear Analogue Self-Assessment:  Single item visual 
analogue scale designed for study by Brown, P., Clark, M. M., Atherton, 
P., Huschka, M., Sloan, J. A., Gamble, G. et al.  (2006).  Will 
improvement in quality of life (QOL) impact fatigue in patients receiving 
radiation therapy for advanced cancer?  American Journal of Clinical 
Oncology, 29(1), 52-58. 
LOT Life Orientation Test:  Carver, C.S. et al.  (1994).  Optimisim versus 
pessimism predicts the quality of women’s adjustment to early stage breast 
cancer.  Cancer, 73, 1213-20.   
 
MAACL Multiple Affect Adjective Checklist:  Zuckerman, M, Lubin, B, Vogel, L. 
& Valerius, E. (1964).  Measurement of experimentally induced affects.  
Journal of Consulting Psychology, 28, 418-425. 
 
MANV Morrow Assessment of Nausea and Vomiting:  Morrow, G.R. (1984).  The 
assessment of nausea and vomiting: past problems, current issues, and 
suggestions for future research.  Cancer, 23, 2267-2278. 
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MFI Multidimensional Fatigue Inventory:  Fitzpatrick R, Davey C, Buxton M.J. 
& Jones D.R. (1998).  Evaluating patient-based outcome measures for use 
in clinical trials.  Health Technology Assessment, 2(14), 1–74. 
 
MRS Mood Rating Scale:  Mood Rating Scale MRS (six visual analogue scales 
(relaxation, happiness, energy, confusion, easy-goingness and 
confidence) each of which has five defined anchor points).  Used in 
Walker, L. G., Walker, M. B., Ogston, K., Heys, S. D., Ah-See, A. K., 
Miller, I. D. et al.  (1999).  Psychological, clinical and pathological effects 
of relaxation training and guided imagery during primary chemotherapy.  
British Journal of Cancer, 80(1-2), 262-8. 
CCV Cuestionario de Calidad de Vida QL-CA-Afex:  Font A & Baye´s 
R.(1993).  Desarrollo de un instrumento para la medida de la calidad de 
vida en enfermedades cro´ nicas. En Aportaciones recientes a la 
evaluacio´n psicolo´gica, Foros Santacana M, Anguera Argilaga MT (eds).  
Universitas-53: Barcelona.  
 
PCI Prostate Cancer Index:  Litwin, M.S. et al.  (1998).  The UCLA Prostate 
Cancer Index:  Development, reliability and validity of a health-related 
quality of life measure.  Medical Care, 36, 1002-1012.   
 
POM Painometer:  Gaston-Johansson, F. (1996).  Measurement of pain: the 
psychometric properties of the pain-o-meter, a simple, inexpensive pain 
assessment tool that could change health care practices.  Journal of Pain 
and symptom management, 12, 172-81.   
 
POMS Profile of Moods State:  McNair, D. M., Lorr, M., & Droppelman, L. F. 
(1971). Manual for the Profile of Mood States. San Diego: Educational 
and Industrial Testing Services. 
 
SF-36 Short Form-36 Health Survey:  Ware, J.E. (1993).  SF-36 Health Survey: 
Manual and Interpretation Guide.  Boston, MA, The Health Institute.  
New England Medical Centre.   
 
SSI Symptom Severity Index.  Designed for study by Given, C., Given, B., 
Rahbar, M., Jeon, S., McCorkle, R., Cimprich, B. et al.  (2004).  Effect of 
a cognitive behavioral intervention on reducing symptom severity during 
chemotherapy.  Journal of Clinical Oncology, 22(3), 507-516. 
STAI  State-Trait Anxiety Inventory:  Spielberger, C.D. (1983).  Manual for the 
State-Trait Anxiety Inventory.  Palo Alto, CA, Consulting Psychologists 
Press.   
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Appendix 5: Data Extraction Form 
 
Title and author of study: 
Year: 
Country: 
Setting: 
Study design 
 
Number of participants 
Attrition  
Allocation to group 
Sample characteristics (cancer type, treatment status) 
 
Eligibility criteria 
 
Treatment 
Intervention  
 
 
 
Provider 
Sessions/how long/when given 
Comparison group 
 
Outcomes 
 
 
 
Results  
 
 
 
 
Conclusions 
 
 
 
 
Strengths and limitations 
 
 
 
Important notes  
 
 
 
 
   - 123 -
  
Appendix 6: The Yates Scale (Yates, Morley, Eccleston & Williams, 2005) 
 
Quality Rating Scale – Coding Notes 
 
Treatment Quality 
The aim of this section is to ensure that in the report a clear account of the treatment is 
given and that there is evidence that the investigators took steps to ensure that the 
treatment was delivered as intended by trained and competent personnel. Each item is 
therefore a judgement about whether this has been achieved. 
 
Item 
# 
Question and Items Score & Coding Notes 
Has a clear rationale for the treatment been given and an adequate 
description of its content? 
 
1 
 
1 part Treatment Content / Setting 
The aim of this item is to make a 
judgment of the quality of the treatment 
in the trial by ascertaining whether a 
coherent rationale is given e.g. reference 
to the relevant evidence base for the 
treatment. Another consideration is 
whether an adequate description of the 
treatment content is given such that 
there may be sufficient information to 
stratify studies for example. 
2 - Adequate: A clear rationale 
for the treatment has been reported 
along with an adequate description 
of its content. 
1 - Partial: Either a clear rationale 
or a description of the content of 
the treatment is reported. 
0 - Inadequate: Neither the 
rationale for treatment or the 
treatment content are adequately 
reported. 
Has the total treatment duration been reported? 
 
2 
 
1 part 
Treatment duration 
Total treatment duration includes both 
number of treatment sessions and 
duration of each session. 
Issues relating to the actual number of 
sessions attended i.e. attrition is dealt 
with in a later section. 
Reviewer decides. 
1 - Reported 
 
0 - Unknown 
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Is there a treatment manual that describes the active components 
of treatment? 
Manualisation 
Treatment manuals should clearly 
prescribe the active components of the 
treatment and ideally proscribe activities 
that should not be included within the 
treatment. Trials with more than one 
treatment arm should demonstrate that 
manuals were utilised for each of the 
treatments where appropriate, e.g. for 
relaxation training and coping skills 
training but not for treatment as usual. 
 
2 - Adequate: there is reference to 
use of a manual that describes the 
active components of the 
treatment of study. If more than 
one treatment arm, manuals were 
used for all the appropriate 
treatments.  
1 - Partial: In trials with more 
than one treatment arm, the use of 
a manual is described but not for 
all the treatments that would be 
expected to be manualised.  
0 - Inadequate: no evidence that a 
manual has been used, but 
reference is made to various 
principles. 
 
3 
 
2 
parts 
Adherence to the manual 
Treatment manuals are also considered 
essential as they provide a benchmark 
for various checks of validity e.g. 
whether therapists are adhering to the 
treatment under study and whether 
patients are doing what is required of 
them. 
 
1 - Adequate: there is evidence 
that the investigators have checked 
adherence to the manual during 
the period of study via direct 
observations, tape recording or 
supervisory processes that 
explicitly state adherence to the 
manual. 
0 - Inadequate: no evidence of 
adherence checks reported. 
Have the therapists been appropriately trained in the relevant 
procedures for this trial? 
 
4 
 
1 part Therapist training 
The important issue here is not just 
whether the therapists have the 
appropriate qualifications and 
experience per se, as a multidisciplinary 
team may implement the treatment. Of 
importance is whether the therapists 
involved have been trained appropriately 
to conduct the particular treatment of the 
trial. 
 
2 - Adequate: there is 
documentation of explicit training 
for the treatment of the trial. 
1 - Partial: the general level of 
therapist training is reported and is 
adequate (professionally qualified) 
but there is no mention of explicit 
training for the trial. 
0 - Inadequate: there is no 
convincing evidence that the 
therapists have an adequate level 
of training (e.g. graduate level) or 
explicit training for the trial. 
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Is there evidence that the patients have actively engaged in the 
treatment? 
 
5 
 
1 part Client Engagement 
This item assesses whether the 
investigators took steps to check that the 
patients actively engaged in the therapy 
and complied with the instructions of the 
treatment e.g. checks for evidence of 
skills practice, reviews of homework. 
1 - Adequate: documented that 
evidence of engagement was 
sought e.g. checks on homework 
were made, skills practice in 
sessions. 
0 - Inadequate: no evidence that 
checks were made on level of 
engagement. 
 
Quality of study design and methods 
The aim of this section is to ensure that investigators made attempts to ensure that the 
design of the study was appropriate for its aims and that rigorous methodological effort 
were made to reduce the potential for bias. Each item is a judgement about whether this 
has been achieved. 
 
Item 
# 
Question and Items Score & Coding Notes 
Are the inclusion and exclusion criteria clearly specified? 
Sample Criteria 
This item explores the context of the 
patient selection and allows the 
generalisability of the trial to be 
examined. Detailed information of the 
sample can also be used for stratifying in 
meta-analyses. 
1 - Adequate: the inclusion and 
exclusion criteria are clearly 
specified and there is evidence of 
adherence to the criteria. 
0 - Inadequate: criteria not 
clearly specified. 
 
1 
 
2 
parts 
Evidence that the criteria have 
been met 
It is equally important to check for 
evidence that the inclusion and 
exclusion criteria have been met. 
1 - Adequate: clear evidence is 
reported that the criteria have been 
met. 
0 - Inadequate: no evidence that 
any criteria have been met. 
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Is there evidence that CONSORT guidelines for reporting attrition 
have been followed? 
Attrition 
It is considered essential that good 
quality trials follow the CONSORT 
guidelines for reporting attrition i.e. “For 
each group report the numbers of 
participants randomly assigned, 
receiving intended treatment, completing 
the study protocol, and analyzed for the 
primary outcome. Describe protocol 
deviations from study as planned, 
together with reasons”. 
It should be noted that this criteria 
automatically biases against pre-
CONSORT trials i.e. prior to and during 
1996. 
2 - Adequate: documented 
evidence that the CONSORT 
guidelines have been followed. 
1 - Partial: a reasonable account 
of how attrition was dealt with is 
given, but without reference to 
CONSORT. 
0 - Inadequate: there is no 
documented evidence or 
insufficient evidence reported of 
how attrition was dealt with. 
 
2 
 
2 
parts 
Rates of attrition 
It is also important to ascertain whether 
final sample could be biased due to 
differential dropout rates between the 
treatment groups. 
1 - Adequate: there is evidence 
that any differential rates of 
attrition were not statistically 
significant. 
0 - Inadequate: there is 
insufficient evidence that 
differential rates of attrition have 
not resulted in significant bias. 
Is there a good description of the sample in the trial? 
Sample Characteristics 
This criterion is concerned with there 
being an adequate description of the 
actual sample obtained in terms of 
demographic information, concurrent 
treatments, treatment history, gender, 
diagnosis, site of pain and chronicity. 
1 - Adequate: there is a good 
description of the sample in the 
trial detailing areas such as 
demographic details, treatment 
history etc. 
0 - Inadequate: insufficient 
information is reported to allow 
adequate comparisons to be made. 
 
3 
 
2 
parts 
Group equivalence  
Good descriptions of the sample 
characteristics and testing are essential 
for ascertaining whether there is 
equivalence between the treatment 
groups. 
1 - Adequate: there is evidence 
that the groups are broadly 
equivalent shown by testing or 
examination of reported data. 
0 - Inadequate: either 
equivalence of groups is not 
reported or there is evidence of 
non-equivalence. 
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Have adequate steps been taken to minimise biases? 
Randomisation 
This item examines the steps taken to 
ensure that each participant of the trial 
has an equal chance of being allocated to 
the different treatment arms. In 
particular, it asks for evidence that an 
adequate method of randomisation has 
been used e.g. random number table or 
computerised random number generator 
(CONSORT, 1996). 
 
2 - Adequate: a convincing 
method for generating a random 
allocation sequence is reported 
that used an independent person 
not involved in enrolment or 
allocation of participants. 
1 - Partial: a convincing method 
of randomisation is reported but 
this did not involve an 
independent person. 
0 - Inadequate: randomisation is 
mentioned but there is not an 
adequate description of the 
methods used. 
Allocation bias 
Were steps taken to ensure that the 
allocation sequence of patients to the 
treatment arms was concealed so that 
investigators could not have biased it? 
Ideally, an independent person should 
make assignment; alternatively, 
assignment can be enclosed in 
sequentially numbered, opaque sealed 
envelopes (CONSORT, 1996). 
 
1 - Adequate: an adequate 
method is reported that removes 
the potential biases of 
investigators e.g. use of an 
independent person or sequentially 
numbered opaque sealed 
envelopes. 
0 - Inadequate: there is not an 
adequate description of attempts 
to deal with potential allocation 
bias. 
 
Measurement bias 
In order to reduce the risk of 
measurement bias a third party who is 
blind to the patient’s study group should 
be responsible for the collection of data. 
1 - Adequate: a convincing effort 
to reduce bias in outcome 
measurement is reported e.g. 3rd 
party blind data collection.  
0 - Inadequate: efforts to reduce 
measurement bias are not reported 
or are insufficient e.g. outcomes 
collected by therapist. 
 
 
4 
 
4 
parts 
Treatment expectations 
It is impossible for participants to be 
blind to the treatment they are receiving 
therefore it is imperative that steps are 
taken to check for equivalence in 
treatment expectations. 
 
1 - Adequate: credible checks for 
equivalence in treatment 
expectations are reported. 
0 - Inadequate: checks have not 
been reported or are insufficient. 
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Are the outcomes that have been chosen justified, valid and 
reliable? 
Justification of outcomes 
This item is concerned with whether the 
outcomes measures that have been 
chosen encompass the aims of the 
treatment and are therefore justified with 
regard to those aims. 
2 - Adequate: all of the outcome 
measures are justified. 
1 - Partial: most of the outcome 
measures are justified. 
0 - Inadequate: most or all of the 
measures used are not justified.  
Validity of outcomes for context 
A report stating that measures with 
known validity were used is not 
sufficient as measures cannot be said to 
be valid per se, only that they have 
validity in a particular context. This item 
therefore requires an informed 
judgement as to whether the measures 
chosen are valid given the context of the 
study population and the treatments 
implemented. 
2 - Adequate: all of the outcome 
measures are valid given the 
context of the study. 
1 - Partial: most of the measures 
are valid. 
0 - Inadequate: most or all of the 
measures are not valid given the 
context of the particular study. 
 
5 
 
3 
parts 
Reliability and sensitivity to 
change 
It is important that the outcome 
measures chosen have both good 
reliability (generally defined as r ≥ 0.8) 
and sensitivity to change. 
2 - Adequate: all the outcome 
measures chosen were shown to 
be reliable and sensitive to 
change. 
1 - Partial: most of the measures 
were reliable and sensitive to 
change. 
0 - Inadequate: most of the 
measures were not reliable or 
sensitive to change. 
 
Has there been a measure of any sustainable change between the 
treatment and control groups? 
 
6 
 
1 part Follow up 
This item examines whether attempts 
have been made to measure sustainable 
changes between the treatment and 
control groups e.g. over a period of at 
least 6 months. 
1 - Adequate: follow up 
measurements for at least 6 
months are reported. 
0 - Inadequate: the follow up 
period was inadequate to measure 
sustainable change e.g. less than 6 
months. 
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Are the statistical analyses adequate for the trial? 
Has a power calculation been used? 
The report must state that power 
calculations were calculated a priori. 
Reviewer decides. 
1 - Yes 
0 - No 
Has a sufficient sample size, based on 
the power calculation been obtained? 
Reviewer decides. 
1 - Yes 
0 - No 
Has the data analysis been adequately 
planned to assess the hypothesis and 
aims of the trial? 
Reviewer decides. 
1 - Yes 
0 - No 
Is there adequate reporting of 
summary statistics?  
The means, standard deviations and 
numbers should be reported for the 
variables.  
The proportions or frequencies should 
be reported for dichotomous variables. 
Reviewer decides. 
1 - Yes 
0 - No 
 
7 
 
5 
parts 
Did the analysis include an intention 
to treat analysis? 
It is important to account for any 
potential biases in rates of attrition by 
performing an intention to treat analysis 
as well as an analysis per protocol. 
Reviewer decides. 
1 - Yes 
0 - No 
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Has a good, well-matched alternative treatment group been used? 
 
8 
 
1 part 
Control group 
This item is concerned with the quality of 
the control condition in the trial and the 
efforts made to ensure that as many 
features as possible have been controlled 
for. 
2 - Adequate: an active alternative 
treatment group has been used that 
is well matched in terms of 
structural features of the treatment 
and its meaningfulness. 
1 - Partial: an active alternative 
treatment group has been used but it 
is not matched for structural features 
e.g. bibliotherapy. 
0 - Inadequate: a poor control 
group has been used that merely 
controls for the duration of time e.g. 
waiting list control. 
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Appendix 7: Characteristics of the studies included in the review 
 
Criteria RT Hypnosis CB Psychological 
support 
RT & 
PREP
RT 
& 
CB 
CB & 
hypnosis 
All 
studies
Treatment         
Chemotherapy 8  4 1 1 1  15 
Radiotherapy 3 3 2     8 
Brachytherapy 1       1 
Radical 
prostatectomy 
  1     1 
Mastectomy, 
lumpectomy, 
chemotherapy 
& radiotherapy 
  1     1 
Surgery and/or 
chemotherapy 
and/or 
radiotherapy 
  1     1 
Bone marrow 
transplant 
   1  1 1 3 
Mastectomy    1    1 
Cancer type         
Breast cancer 5 2 2 2  1  12 
Various 5 1 6 1 1   14 
Breast cancer 
and 
gynaecological 
1       1 
Prostate   1     1 
Leukemia      1  1 
Hematological       1 1 
Not specified 1       1 
Quality of 
studies 
        
0-8 1  3     4 
9-17 10 1 4 3 1 2 1 22 
18-26 1 2 2     5 
Quality of 
intervention 
        
0-3 6  1  1   8 
4-6 6 3 4 3  1  17 
7-9   4   1 1 6 
Key to abbreviations: 
RT Relaxation training  
CB Cognitive-behavioural  
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Appendix 8: Quality of the interventions in reviewed studies 
 
Quality 
criteria 
Arakawa 
1997 
Armes Brown 
2006 
Burish 
1992 
Burish 
1991 
Burton Decker 
1992 
Gaston-
Johansson 
2000 
Rationale & 
description  
?  ?  ?  
? ? ? ? ? ? ? ? 
Session 
details 
? ? 
? ? ? ? ? ? ? ? 
Treatment 
manual 
?  ?  ? 
? ? ? ? ? ? ? ? 
Adherence 
to manual 
? ? 
? ? ? ? ? ? ? ? 
Provider 
training 
?  ?  ? 
? ? ? ? ? ? ? ? 
Participant 
engagement 
? ? 
? ? ? ? ? ? ? ? 
Total score 
 
4 8 7 3 3 4 4 4 
 
Quality 
criteria 
Given 
2004 
Jacobsen 
2002 
Kolcaba 
1999 
Krischer 
2007 
Larson 
2000 
Leon-
Pizarro 
2007 
Lerman 
1990 
Rationale & 
description  
?  ?  ?  
? ? ? ? ? ? ? 
Session 
details 
? ? 
? ? ? ? ? ? ? 
Treatment 
manual 
?  ?  ? 
? ? ? ? ? ? ? 
Adherence to 
manual 
? ? 
? ? ? ? ? ? ? 
Provider 
training 
?  ?  ? 
? ? ? ?* ? ? ? 
Participant 
engagement 
? ? 
? ? ? ? ? ? ? 
Total score 
 
8 9 5 5 4 3 3 
* Was not applicable- self administered intervention  
 
Key to symbols 
? Fulfils criteria 
? Partly fulfils criteria (this option is only available for some criterion) 
? Does not fulfil criteria  
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Quality 
criteria 
Molassiotis 
2002 
Montgomery 
2009 
Morrow 
1992 
Nunes 
2007 
Parker 
2009 
Phillips 
2008 
Ream 
2006 
Rationale & 
description  
?  ?  ?  
? ? ? ? ? ? ? 
Session 
details 
? ? 
? ? ? ? ? ? ? 
Treatment 
manual 
?  ?  ? 
? ? ? ? ? ? ? 
Adherence 
to manual 
? ? 
? ? ? ? ? ? ? 
Provider 
training 
?  ?  ? 
? ? ? ? ? ? ? 
Participant 
engagement 
? ? 
? ? ? ? ? ? ? 
Total score 
 
5 4 5 5 4 5 5 
 
Quality 
criteria 
Schnur 
2009 
Staplers 
2005 
Syrjala 
1995 
Syrjala 
1992 
Vasterling 
1993 
Walker 
1999 
Yoo 
2005 
Rationale & 
description  
?  ?  ?  
? ? ? ? ? ? ? 
Session 
details 
? ? 
? ? ? ? ? ? ? 
Treatment 
manual 
?  ?  ? 
? ? ? ? ? ? ? 
Adherence 
to manual 
? ? 
? ? ? ? ? ? ? 
Provider 
training 
?  ?  ? 
? ? ? ? ? ? ? 
Participant 
engagement 
? ? 
? ? ? ? ? ? ? 
Total score 
 
5 6 9 5 4 3 3 
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Appendix 9: Quality of studies in review 
Quality 
criteria 
Arakawa 
1997 
Armes 
2007 
Brown 
2006 
Burish 
1992 
Burish 
1991 
Burton 
1995 
Decker 
1992 
Gaston-
Johansson 
2001 
Sample 
criteria 
? ? 
? ? ? ? ? ? ? ? 
Evidence met 
? ? 
? ? ? ? ? ? ? ? 
Attrition 
?  ?  ? 
?* ? ? ? ? ? ? ? 
Attrition rates 
? ? 
?* ? ?* ? ? ? ? ? 
Sample 
Characteristics 
? ?  
? ? ? ? ? ? ? ? 
Sample 
Equivalence 
? ? 
? ? ? ? ? ? ? ? 
Randomisation 
?  ?  ? 
? ? ? ? ? ? ? ? 
Allocation 
bias 
? ? 
? ? ? ? ? ? ? ? 
Measurement 
bias 
? ? 
? ? ? ? ? ? ? ? 
Treatment 
expectations 
? ? 
? ? ? ? ? ? ? ? 
Justification of 
outcomes 
?  ?  ? 
? ? ? ? ? ? ? ? 
Validity of 
outcomes 
?  ?  ? 
? ? ? ? ? ? ? ? 
Reliability of 
outcomes 
?  ?  ? 
? ? ? ? ? ? ? ? 
Follow-up 
? ? 
? ? ? ? ? ? ? ? 
Power  
? ? 
? ? ? ? ? ? ? ? 
Sample size 
? ? 
? ? ? ? ? ? ? ? 
Planned 
analysis 
? ? 
? ? ? ? ? ? ? ? 
Reporting 
? ? 
? ? ? ? ? ? ? ? 
Intention to 
treat analysis 
? ? 
? ? ? ? ? ? ? ? 
Control group 
?  ?  ?   
? ? ? ? ? ? ? ? 
Total  11 18 15 9 9 10 10 13 
* did not have to address 
Key to symbols   ? Fulfils criteria    ? Partly fulfils criteria (this option is only 
available for some criterion)   ? Does not fulfil criteria  
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Quality 
criteria 
Given 
2004 
Jacobsen 
2002 
Kolcaba 
1999 
Krischer 
2007 
Larson 
2000 
Leon-
Pizarro 
Lerman 
1990 
Molassiotis 
2001 
Sample 
criteria 
? ? 
? ? ? ? ? ? ? ? 
Evidence met 
? ? 
? ? ? ? ? ? ? ? 
Attrition 
?  ?  ? 
? ? ? ? ? ? ?* ? 
Attrition rates 
? ? 
? ? ? ? ? ? ?* ?* 
Sample 
Characteristics 
? ?  
? ? ? ? ? ? ? ? 
Sample 
Equivalence 
? ? 
? ? ? ? ? ? ? ? 
Randomisation 
?  ?  ? 
? ? ? ? ? ? ? ? 
Allocation 
bias 
? ? 
? ? ? ? ? ? ? ? 
Measurement 
bias 
? ? 
? ? ? ? ? ? ? ? 
Treatment 
expectations 
? ? 
? ? ? ? ? ? ? ? 
Justification of 
outcomes 
?  ?  ? 
? ? ? ? ? ? ? ? 
Validity of 
outcomes 
?  ?  ? 
? ? ? ? ? ? ? ? 
Reliability of 
outcomes 
?  ?  ? 
? ? ? ? ? ? ? ? 
Follow-up 
? ? 
? ? ? ? ? ? ? ? 
Power  
? ? 
? ? ? ? ? ? ? ? 
Sample size 
? ? 
? ? ? ? ? ? ? ? 
Planned 
analysis 
? ? 
? ? ? ? ? ? ? ? 
Reporting 
? ? 
? ? ? ? ? ? ? ? 
Intention to 
treat analysis 
? ? 
? ? ? ? ? ? ? ? 
Control group 
?  ?  ?   
? ? ? ? ? ? ? ? 
Total  10 18 9 15 11 15 12 15 
* did not have to address
   - 136 -
  
 
Quality 
criteria 
Montgomery 
2009 
Morrow 
1992 
Nunes 
2007 
Parker 
2009 
Phillips 
2008 
Ream 
2006 
Schnur 
2009 
Sample 
criteria 
? ? 
? ? ? ? ? ? ? 
Evidence met 
? ? 
? ? ? ? ? ? ? 
Attrition 
?  ?  ? 
? ?* ?* ? ? ? ? 
Attrition rates 
? ? 
? ?* ?* ? ? ? ? 
Sample 
Characteristics 
? ?  
? ? ? ? ? ? ? 
Sample 
Equivalence 
? ? 
? ? ? ? ? ? ? 
Randomisation 
?  ?  ? 
? ? ? ? ? ? ? 
Allocation 
bias 
? ? 
? ? ? ? ? ? ? 
Measurement 
bias 
? ? 
? ? ? ? ? ? ? 
Treatment 
expectations 
? ? 
? ? ? ? ? ? ? 
Justification of 
outcomes 
?  ?  ? 
? ? ? ? ? ? ? 
Validity of 
outcomes 
?  ?  ? 
? ? ? ? ? ? ? 
Reliability of 
outcomes 
?  ?  ? 
? ? ? ? ? ? ? 
Follow-up 
? ? 
? ? ? ? ? ? ? 
Power  
? ? 
? ? ? ? ? ? ? 
Sample size 
? ? 
? ? ? ? ? ? ? 
Planned 
analysis 
? ? 
? ? ? ? ? ? ? 
Reporting 
? ? 
? ? ? ? ? ? ? 
Intention to 
treat analysis 
? ? 
? ? ? ? ? ? ? 
Control group 
?  ?  ?   
? ? ? ? ? ? ? 
Total  20 11 11 19 8 17 18 
* did not have to address
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Quality 
criteria 
Staplers 
2005 
Syrjala 
1995 
Syrjala 
1992 
Vasterling 
1993 
Walker 
1999 
Yoo 
2005 
Sample 
criteria 
? ? 
? ? ? ? ? ? 
Evidence met 
? ? 
? ? ? ? ? ? 
Attrition 
?  ?  ? 
? ? ? ? ? ? 
Attrition rates 
? ? 
? ? ? ? ? ? 
Sample 
Characteristics 
? ?  
? ? ? ? ? ? 
Sample 
Equivalence 
? ? 
? ? ? ? ? ? 
Randomisation 
?  ?  ? 
? ? ? ? ? ? 
Allocation 
bias 
? ? 
? ? ? ? ? ? 
Measurement 
bias 
? ? 
? ? ? ? ? ? 
Treatment 
expectations 
? ? 
? ? ? ? ? ? 
Justification of 
outcomes 
?  ?  ? 
? ? ? ? ? ? 
Validity of 
outcomes 
?  ?  ? 
? ? ? ? ? ? 
Reliability of 
outcomes 
?  ?  ? 
? ? ? ? ? ? 
Follow-up 
? ? 
? ? ? ? ? ? 
Power  
? ? 
? ? ? ? ? ? 
Sample size 
? ? 
? ? ? ? ? ? 
Planned 
analysis 
? ? 
? ? ? ? ? ? 
Reporting 
? ? 
? ? ? ? ? ? 
Intention to 
treat analysis 
? ? 
? ? ? ? ? ? 
Control group 
?  ?  ?   
? ? ? ? ? ? 
Total  14 15 11 9 18 14 
*did not have to address 
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Appendix 10: Table of components of the relaxation interventions 
 
 IS G SA PMR GI DB Cue-
controlled 
SD Meditation Tumour 
visualization 
Audio Written Video 
 
Daily 
practice 
Adher 
ence 
Bio- 
feedback 
Arakawa, 1997 ?   ?       ?   ?   
Burish et al. 
1992– relaxation 
?   ? ?      ?   ?  ? 
Burish et al. 
1992- 
biofeedback 
             ?  ? 
Burish & Jenkins 
1992 
?   ? ?       ?  ?   
Decker et al. 1992 ?   ?  ? ?    ? ?  ?   
Kolcaba et al. 
1999 
  ?  ?      ? ?  ? ?  
Leon-Pizarro et 
al. 2007 
?    ? ?     ?   ?   
Lerman et al. 
1990 
?   ?  ?     ? ?  ? ?  
Molassiotis et al. 
2002 
?   ? ? ?     ?  ? ? ?  
Morrow et al. 
1992 
?   ?    ?   ?   ?   
Nunes et al. 2007  ?  ? ? ?   ? ? ?   ?   
Syrjala et al. 1995 ?   ? ? ?     ? ?  ?   
Vasterling et al. 
1993 
?   ? ?            
Walker et al. 
1999 
?   ? ?  ?   ? ?   ? ?  
Yoo et al. 2005 ?   ? ?         ?   
Key:to abbreviations  
 
 IS- individual sessions 
G- group 
SA- self-administered 
PMR- progressive muscle 
relaxation 
GI- guided imagery 
DB- deep breathing  
SD- systematic desentization  
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Appendix 11: The key elements of CBT satisfied by the interventions according to the criterion developed by Jones et al. 2010 
 
Both of these criterion One of these criterion Study 
Establishing links 
between thoughts, 
feelings and actions.  
Including 
psychoeducation.  
Correction of 
person’s 
misinterpretation, 
irrational beliefs and 
reassuring bias 
1.  Monitoring 
thoughts, feelings or 
behaviours 
2.  Promotion of 
alternative ways of 
coping 
3.  Attempted 
modification of 
behavioural responses 
to symptoms and 
illness 
Armes et al. 2007 ? ? ? ? ? 
Brown et al. 2006    ?  
Given et al. 2004     ? 
Jacobsen et al. 2002 
PMST 
? ?  ?  
Jacobsen et al. 2002 
PMST 
 ?  ?  
Krischer et al. 2007  ? ? ?  
Larson et al. 2000 ? ? ? ? ? 
Parker et al. 2009    ?  
Phillips et al. 2008  ?  ?  
Syrjala et al. 1995  ?  ? ? 
Syrjala et al. 1992  ? ? ? ? 
Vasterling et al. 1993    ?  
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Appendix 12: Table of general and relaxation components of cognitive-behavioural interventions 
 
Study  IS G SA Relaxation DB PB GI M PMR Cue 
Controlled
Audio Daily 
practice 
Imaginal 
exposure 
Autogenic 
relaxation 
Armes et al. 2007 ?              
Brown et al. 2006  ?  ? ?  ?  ?      
Given et al. 2004 ?              
Jacobsen et al. 
2002 PSMT 
?   ? ?  ?  ?  ?    
Jacobsen et al. 
2002 SSMT 
  ? ?   ?  ?  ?    
Krischer et al. 
2007 
  ? ?  ? ?  ?  ?    
Larson et al. 2000 ? ?  ?     ?  ? ?   
Parker et al. 2009 ?   ? ?  ?    ? ? ?  
Phillips et al. 2008  ?  ? ?  ? ? ?   ?   
Syrjala et al. 1995 ?   ? ?  ?  ?  ? ?   
Syrjala et al. 1992 ?   ?     ?  ? ?  ? 
Vasterling et al. 
1993 
?              
 
Key: 
IS- individual sessions 
G-group sessions 
SA- self administered 
DB- diaphragmatic breathing 
PB- paced breathing 
 
GI- guided imagery 
PMR- progressive muscle 
relaxation 
M- Meditation  
PSST- professional-
administered stress management 
training  
SSMT- self-administered stress 
management training  
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Appendix 13: Table of cognitive, coping and problem solving components of cognitive-behavioural interventions 
 
Study  S
M 
Coping 
skills 
CR Assertion 
training 
Problem 
solving 
Alternative 
illness 
percpetions
GS SS Thought 
monitoring 
Identifyin
g thoughts 
& feelings 
Self 
montoring 
Armes et al. 2007  ? ?   ? ?   ? ? 
Brown et al. 2006 ?   ? ?  ?     
Given et al. 2004     ?       
Jacobsen et al. 
2002 PSMT 
?       ?  ?  
Jacobsen et al. 
2002 SSMT 
?       ?    
Krischer et al. 
2007 
?       ? ?   
Larson et al. 2000  ?PF ?   ? ?   ? ? 
Parker et al. 2009 ? ?PF          
Phillips et al. 2008 ? ? ? ?        
Syrjala et al. 1995   ?     ?    
Syrjala et al. 1992   ?    ? ?   ? 
Vasterling et al. 
1993 
           
 
SM- stress management  
CR- cognitive restructuring  
GS- Goal setting 
SS- self statements 
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Study  Distraction Prioritising Self-
management 
information 
Psychoeducation 
about stress 
Activity 
scheduling 
Armes et al. 2007 ?    ? 
Brown et al. 2006  ?    
Given et al. 2004   ?   
Jacobsen et al. 
2002 PSMT 
     
Jacobsen et al. 
2002 SSMT 
     
Krischer et al. 
2007 
     
Larson et al. 2000 ?   ? ? 
Parker et al. 2009      
Phillips et al. 2008      
Syrjala et al. 1995 ?    ? 
Syrjala et al. 1992 ?  ?   
Vasterling et al. 
1993 
?     
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Appendix 14: Table of general components of cognitive-behavioural interventions 
 
Study  W V Spirituality Social 
support 
Concerns 
& fears 
Physical 
component 
Pain 
and 
theory 
Couns
elling 
Mechanisms 
of nausea 
Information 
about 
treatment 
Exploration 
of meaning 
Armes et al. 2007 ?           
Brown et al. 2006 ?  ? ?  ?      
Given et al. 2004        ?    
Jacobsen et al. 
2002 PSMT 
           
Jacobsen et al. 
2002 SSMT 
? ?          
Krischer et al. 
2007 
? ?          
Larson et al. 2000 ?    ?       
Parker et al. 2009    ? ?       
Phillips et al. 2008    ?        
Syrjala et al. 1995 ?      ?  ?   
Syrjala et al. 1992 ?         ? ? 
Vasterling et al. 
1993 
           
Key: 
W- written information 
V- videotape
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Appendix 15: Letter of Ethical Approval 
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Appendix 16: Information sheet for control group 
 
 
 
INFORMATION SHEET 
 
Evaluation of a preparation session for internal radiotherapy  
(selectron) treatment 
 
 
My name is Dr Nina Shergill and I am a trainee Clinical Psychologist (not 
medical doctor).  This information sheet tells you about a research study 
that I am doing jointly with the  
as part of my doctoral training in clinical psychology.  You are being invited 
to take part in this research study.   
 
Before you decide whether to take part it is important for you to understand 
why the research is being done and what it will involve.  Please take time 
to read the following information carefully and discuss it with others if you 
wish.  You will be given an opportunity to consent to the researcher 
contacting you in a few days time to answer any questions you may have 
and to go through the study information with you.  Please ask us if anything 
is not clear or if you would like more information.  
 
 
The information sheet consists of two parts: 
 
• Part 1 tells you the purpose of this study and what will happen to you 
if you take part. 
• Part 2 gives you more detailed information about the conduct of the 
study.  
 
If you have filled in the slip consenting to be contacted about this research 
then Dr Nina Shergill (chief investigator) will contact you in the next couple 
of days.  You can contact Nina Shergill at any time if you have any 
questions about the research study.  Thank you for taking the time to read 
this. 
 
 
PART 1 
Reasons for the study: 
In this research study we want to find out how people cope with internal 
radiotherapy treatment (selectron) and whether they can be helped with a 
simple preparation session before the treatment.  We know from previous 
research that some women having internal radiotherapy feel stressed, 
worried or nervous before and during the treatment.  We want to know 
more about how patients cope with internal radiotherapy and whether a 
preparation session will benefit patients and in what way. 
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The aim of this research is to find out: 
a) How patients are feeling before they have internal radiotherapy and 
afterwards 
b) Whether a simple preparation session will help patients to cope 
better with internal radiotherapy. 
 
 
 
Why have I been chosen? 
You have been invited to take part in this research because you are going 
to have internal radiotherapy as part of your treatment for gynaecological 
cancer and we are interested in how you may cope and feel about having 
this treatment.  We are hoping that at least 40 women will take part in this 
study. 
 
Do I have to take part? 
It is up to you to decide whether or not to take part.  This is your decision.  
If you do decide to take part you will be given this information sheet to keep 
and asked to sign a consent form.  You will still be free to withdraw from 
the study at any moment without any reason.  The decision to withdraw at 
any time will not affect your treatment in any way.   
 
What group can I be put in? 
To find out if providing people with additional brief support is useful we 
need to compare different ways of doing things.  We will do this by putting 
people into groups and compare them to see if one is better. In this study 
we have two groups. 
 
The first group (a control group) will receive usual care and fill in 
questionnaires 2 and 3 at two further time-points.  The second group will 
attend an hour long preparation session which is only available for a few 
months in 2009 and fill in questionnaires 2 and 3 at two time-points.  We 
have these two groups so that we can find out by comparing the groups if 
the preparation session helps patients to cope better with internal 
radiotherapy.   
 
If you take part in this study you will be in the control group.   
 
What do I have to do? 
You will be asked to fill in questionnaires on three separate occasions. 
Questionnaire 1 will be filled in shortly after you have been told that you will 
have internal radiotherapy.  Please note that questionnaire 1 is longer than 
questionnaires 2 and 3.  The second questionnaire will be filled in about 7-
10 days before you have your internal radiotherapy and the final 
questionnaire will be filled in the morning after you have had your internal 
radiotherapy.   
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What will happen to me if I take part? 
If you agree to take part in this study, you will be asked to do the following: 
 
1) Fill in consent form and questionnaire 
If you decide to take part, fill in the consent form and questionnaire 1 which 
is enclosed with this letter and return them in the pre-paid envelope 
provided.  You will then be contacted by us over the next few weeks to fill 
in another two questionnaires. 
 
2) Follow-up questionnaires  
Questionnaire 2:  We will send you a questionnaire 2 to fill in and return 
two weeks before you have your internal radiotherapy treatment.  If we do 
not receive this questionnaire within a week then you will be contacted by 
phone and have the opportunity to complete the questions over the phone.  
This is to make sure that we have all the information we need for this 
study. 
 
Questionnaire 3:  You will be visited by Nina Shergill, lead researcher for 
this study, on the morning following your internal radiotherapy, before you 
are discharged.  You will fill in questionnaire 3 on this morning. If, for any 
reason we are unable to meet with you that morning we will contact you 
within two days to complete the questions over the phone.   
 
What are the possible disadvantages and risks of taking part? 
There are no health risks involved in taking part in this study and your 
normal treatment will take place whichever group you are in.  The 
questionnaire may make you think about your treatment and we 
recommend that you talk to your consultant oncologist or nurse about this.  
If you feel that you are overly worried about the treatment then please talk 
to the health professionals involved in your care, and they can make a 
referral to psychology services if they feel this is appropriate.   
 
What are the possible benefits of taking part? 
Your participation in this study may help future patients like yourself 
because 
a) we will understand more fully how patients cope with internal 
radiotherapy and have screening methods in place to identify patients who 
are suffering from feelings of anxiety or sadness, and who may need 
further support. 
b) we will collect information about whether a preparation session is 
beneficial to patients and in what way. This will help us to support patients 
who are going to have internal radiotherapy in order to achieve better 
patient care.  
 
What happens when the research study stops? 
Your medical care is independent of this study and your consultant will 
continue to provide the care for your current illness. 
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What if there is a problem? 
If you are unhappy or unsure about anything that happens during the 
study, please feel free to contact the researchers at any time.  They will do 
their best to listen to and address any concerns you may have.  Their 
contact details are printed below.  If you feel unable to do this, or are not 
satisfied with the response that you receive in reaction to your concerns, 
the normal NHS complaint procedures apply. 
 
Will my taking part in the study be kept confidential? 
Yes.  All the information which is collected about you during the course of 
the research will be kept strictly confidential.  Personal information will be 
securely stored at the University of Birmingham and will not be released or 
viewed by anyone other than the researchers in this study.  The 
questionnaire data will not be linked to you as an individual, they will be 
anonymous.  If you consent to take part in the study, your GP and other 
doctors treating you will be notified of your participation in the study.  By 
signing the consent form you are agreeing for this to be done.  
 
 
 
 
PART 2 
 
What will happen to the results of this research study? 
The researchers plan to submit the findings to a peer reviewed scientific 
journal for publication.  We will also produce a summary sheet of the main 
findings for participants of the study.  You will be given the opportunity to 
express your interest in receiving this summary in questionnaire 1 and at 
the end of the study.  Results of the study will not include your name or any 
other identifiable characteristics and you will not be identified in any of the 
reports/publications.  
 
What will happen if I don’t want to carry on with the study? 
Nothing.  The only thing we ask you to do is let the researcher know that 
you no longer wish to participate.  You don’t have to give them a reason.  
This decision will not affect your treatment in any way. 
 
Who is organising and funding the research? 
This research is being conducted as part of Nina Shergill’s Doctoral 
research and is hence not funded.   
 
Who has reviewed the study? 
The scientific study review has been undertaken by the School of 
Psychology at the University of Birmingham. 
 
If you have any questions or require any further information then 
please do not hesitate to contact me. 
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Contact details 
 
Dr Nina Shergill,    
 
 
For concerns or complaints with regard to this study, please contact  
 
   
 
Thank you for taking the time to read this-  
please ask any questions if you need to. 
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Appendix 17: Information sheet for intervention group 
 
 
 
INFORMATION SHEET 
 
Evaluation of a preparation session for internal radiotherapy  
(selectron) treatment 
 
 
My name is Dr Nina Shergill and I am a trainee Clinical Psychologist (not 
medical doctor).  This information sheet tells you about a research study 
that I am doing jointly with  
as part of my doctoral training in clinical psychology.  You are being invited 
to take part in this research study.   
 
Before you decide whether to take part it is important for you to understand 
why the research is being done and what it will involve.  Please take time 
to read the following information carefully and discuss it with others if you 
wish.  You will be given an opportunity to consent to the researcher 
contacting you in a few days time to answer any questions you may have 
and to go through the study information with you.  Please ask us if anything 
is not clear or if you would like more information.  
 
The information sheet consists of two parts: 
 
• Part 1 tells you the purpose of this study and what will happen to you 
if you take part. 
• Part 2 gives you more detailed information about the conduct of the 
study.  
 
If you have filled in the slip consenting to be contacted about this research 
then Dr Nina Shergill (chief investigator) will contact you in the next couple 
of days.  You can contact Nina Shergill at any time if you have any 
questions about the research study.  Thank you for taking the time to read 
this. 
 
PART 1 
 
Reasons for the study: 
In this research study we want to find out how people cope with internal 
radiotherapy treatment (selectron) and whether they can be helped with a 
simple preparation session before the treatment.  We know from previous 
research that some women having internal radiotherapy feel stressed, 
worried or nervous before and during the treatment.  We want to know 
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more about how patients cope with internal radiotherapy and whether a 
preparation session will benefit patients and in what way. 
 
The aim of this research is to find out: 
c) How patients are feeling before they have internal radiotherapy and 
afterwards 
d) Whether a simple preparation session will help patients to cope 
better with internal radiotherapy. 
 
Why have I been chosen? 
You have been invited to take part in this research because you are going 
to have internal radiotherapy as part of your treatment for gynaecological 
cancer and we are interested in how you may cope and feel about having 
this treatment.  We are hoping that at least 40 women will take part in this 
study. 
 
Do I have to take part? 
It is up to you to decide whether or not to take part.  This is your decision.  
If you do decide to take part you will be given this information sheet to keep 
and asked to sign a consent form.  You will still be free to withdraw from 
the study at any moment without any reason.  The decision to withdraw at 
any time will not affect your treatment in any way.   
 
What group can I be put in? 
To find out if providing people with additional brief support is useful we 
need to compare different ways of doing things.  We will do this by putting 
people into groups and compare them to see if one is better. In this study 
we have two groups. 
 
The first group (a control group) will receive usual care and fill in 
questionnaires 2 and 3 at two further time-points.  The second group will 
attend an hour long preparation session which is only available for a few 
months in 2009 and fill in questionnaires 2 and 3 at two time-points.  We 
have these two groups so that we can find out by comparing the groups if 
the preparation session helps patients to cope better with internal 
radiotherapy.   
 
If you take part in this study you will be in group 2, the group that receives 
the preparation session.   
 
What do I have to do? 
You will be asked to fill in questionnaires on three separate occasions. 
Questionnaire 1 will be filled in shortly after you have been told that you will 
have internal radiotherapy.  Please note that questionnaire 1 is longer than 
questionnaires 2 and 3.  The second questionnaire will be filled in about 7-
10 days before you have your internal radiotherapy and the final 
questionnaire will be filled in the morning after you have had your internal 
radiotherapy.  Participants will attend an hour long preparation session and 
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have a short telephone session before the treatment.  They will also be 
contacted two weeks following their treatment to hear their views about the 
preparation session.   
 
What will happen to me if I take part? 
If you agree to take part in this study, you will be asked to do the following: 
 
2) Fill in consent form and questionnaire 
If you decide to take part, fill in the consent form and questionnaire 1 which 
is enclosed with this letter and return them in the pre-paid envelope 
provided.  You will then be contacted by us over the next few weeks to fill 
in another two questionnaires. 
 
 
2) Preparation session 
Preparation session:  We will contact you shortly after receiving your 
consent form to arrange a time to have the preparation session.  The 
preparation session is a hour long and you will be given the opportunity to 
talk about any concerns you have about the treatment and ways in which 
you can cope before and during the treatment.  This session will take place 
at a time that is convenient to you.   
 
Telephone session:  A week before you have your treatment we will 
contact you by phone to see how you are feeling and whether you have 
been able to think about what was discussed in the preparation session.   
 
3) Follow-up questionnaires 
Questionnaire 2:  We will send you a questionnaire 2 to fill in and return 
two weeks before you have your internal radiotherapy treatment.  If we do 
not receive this questionnaire within a week then you will be contacted by 
phone and have the opportunity to complete the questions over the phone.  
This is to make sure that we have all the information we need for this 
study. 
 
Questionnaire 3:  You will be visited by Nina Shergill, lead researcher for 
this study, on the morning following your internal radiotherapy, before you 
are discharged.  You will fill in questionnaire 3 on this morning. If, for any 
reason we are unable to meet with you that morning we will contact you 
within two days to complete the questions over the phone.   
 
4) Feedback after preparation session 
Feedback over telephone:  We will contact you by phone approximately 
two weeks following your treatment to find out what your experience was of 
the preparation session and what you found useful, and what we can 
improve.  This information will help us to think about how we could make 
this preparation session better for other patients in the future.  
 
 
 
   - 155 -
  
What are the possible disadvantages and risks of taking part? 
There are no health risks involved in taking part in this study and your 
normal treatment will take place whichever group you are in.  The 
questionnaire may make you think about your treatment and we 
recommend that you talk to your consultant oncologist or nurse about this.  
If you feel that you are overly worried about the treatment then please talk 
to the health professionals involved in your care, and they can make a 
referral to psychology services if they feel this is appropriate.   
 
What are the possible benefits of taking part? 
Your participation in this study may help future patients like yourself 
because 
a) we will understand more fully how patients cope with internal 
radiotherapy and have screening methods in place to identify patients who 
are suffering from feelings of anxiety or sadness, and who may need 
further support. 
b) we will collect information about whether a preparation session is 
beneficial to patients and in what way. This will help us to support patients 
who are going to have internal radiotherapy in order to achieve better 
patient care.  
 
What happens when the research study stops? 
Your medical care is independent of this study and your consultant will 
continue to provide the care for your current illness. 
 
What if there is a problem? 
If you are unhappy or unsure about anything that happens during the 
study, please feel free to contact the researchers at any time.  They will do 
their best to listen to and address any concerns you may have.  Their 
contact details are printed below.  If you feel unable to do this, or are not 
satisfied with the response that you receive in reaction to your concerns, 
the normal NHS complaint procedures apply. 
 
Will my taking part in the study be kept confidential? 
Yes.  All the information which is collected about you during the course of 
the research will be kept strictly confidential.  Personal information will be 
securely stored at the University of Birmingham and will not be released or 
viewed by anyone other than the researchers in this study.  The 
questionnaire data will not be linked to you as an individual, they will be 
anonymous.  If you consent to take part in the study, your GP and other 
doctors treating you will be notified of your participation in the study.  By 
signing the consent form you are agreeing for this to be done.  
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PART 2 
 
What will happen to the results of this research study? 
The researchers plan to submit the findings to a peer reviewed scientific 
journal for publication.  We will also produce a summary sheet of the main 
findings for participants of the study.  You will be given the opportunity to 
express your interest in receiving this summary in questionnaire 1 and at 
the end of the study.  Results of the study will not include your name or any 
other identifiable characteristics and you will not be identified in any of the 
reports/publications.  
 
What will happen if I don’t want to carry on with the study? 
Nothing.  The only thing we ask you to do is let the researcher know that 
you no longer wish to participate.  You don’t have to give them a reason.  
This decision will not affect your treatment in any way. 
 
Who is organising and funding the research? 
This research is being conducted as part of Nina Shergill’s Doctoral 
research and is hence not funded.   
 
Who has reviewed the study? 
The scientific study review has been undertaken by the School of 
Psychology at the University of Birmingham. 
 
If you have any questions or require any further information then 
please do not hesitate to contact me. 
 
 
 
Contact details 
 
Dr Nina Shergill,    
 
 
For concerns or complaints with regard to this study, please contact  
 
   
 
Thank you for taking the time to read this-  
please ask any questions if you need to. 
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Appendix 18: Invitation letter from consultants 
 
 
Re: Birmingham University Study 
Evaluation of a preparation session for internal radiotherapy (selectron) 
treatment 
 
The cancer centre is participating in a study researching how women cope with 
internal radiotherapy treatment (selectron) and whether they can be helped to 
cope better by a simple preparation session before treatment.  This is a joint 
research project between  and the 
University of Birmingham.  You have been invited to take part in this study 
because you are going to have internal radiotherapy treatment.  This study has 
been approved by the local research ethics committee.   
 
It is important for you to know that: 
1. Taking part in the research will not affect your care 
2. It is entirely up to you if you wish to take part 
3. You can withdraw from the study at anytime without giving a reason 
 
Over a six to eight week period you will be asked to fill in 3 questionnaires.  
Questionnaire 1 is enclosed with letter and should be filled in and sent with your 
consent form.  Questionnaire 2 will be filled in 7-10 days before you have internal 
radiotherapy and the final questionnaire will be filled in the morning after you 
have your internal radiotherapy.  The research wants to find out if providing an 
additional brief preparation session is useful and therefore you will be put into a 
group.  There are two groups in this study, Group 1 will receive usual care and 
Group 2 will have a brief preparation session.  Initially the preparation session will 
only be available for a few months in 2009.  The group you are placed in depends 
on whether the session is being offered when you receive your internal 
radiotherapy treatment.  
 
It is hoped that the study will lead to a better understanding of how women cope 
with internal radiotherapy and will help to make services better for other women 
who will have this treatment in the future.  Whatever you decide your medical and 
legal rights are not affected in any way and your future care will not be 
influenced. 
 
Enclosed with this letter are an information sheet, consent form and 
questionnaire provided by the researchers.  The information sheet describes the 
study in more detail.  It also includes the researcher’s details if you have any 
questions about the study.  If you think you might be interested in helping with 
this research please read the information and follow the instructions provided.   
 
Many thanks for taking the time to read this letter.  
 
Yours Sincerely, 
 
Consultant and Nurse  
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Appendix 19: Consent form 
 
 
                                           CONSENT FORM 
 
Title of Project: Evaluation of a preparation session for internal 
radiotherapy (selectron) treatment.  
 
Name of Researcher: Dr Nina Shergill 
 
 Please initial box
I confirm that I have read and understand the information 
sheet dated 6th February 2009 (version 2) for the above study.  
I have had the opportunity to consider the information, ask 
questions if I wish and have these answered satisfactorily. 
 
 
I understand that my taking part is voluntary and that I am 
free to withdraw at any time, without giving any reason, 
without my medical care or legal rights being affected.  
 
 
I agree to take part in the above study 
 
 
 
 
Please sign: 
 
 
Name _____________________    Signature______________   Date __________ 
 
 
------------------------------------------------------------------------------------------------------------------- 
Leave for researcher to fill in:  
 
 
Researcher _________________   Signature ________________    Date__________ 
 
 
Name of Person taking consent (if different from researcher): ____________________ 
 
 
Signature___________    Date___________ 
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Appendix 20: Baseline questionnaire 
 
University of Birmingham 
Edgbaston 
Birmingham 
B15 2TT 
 
Telephone:  
Email:  
 
School of 
psychology  
      
    
 
QUESTIONNAIRE 1 
Thank you for agreeing to help us with our research. 
• Before starting the questionnaire please make sure you have read the 
information sheet and signed the consent form 
• PLEASE RETURN THIS QUESTIONNAIRE IN THE PRE-PAID 
ENVELOPE ENCLOSED WITH YOUR CONSENT FORM 
• Please note that this questionnaire is longer than questionnaire 2 and 3  
 
 
All the information that you give us will be COMPLETELY CONFIDENTIAL 
and will not be seen by your doctor. 
Instructions for Questionnaire: 
• Please answer ALL the questions 
• There are no right or wrong answers 
• Tick the box next to the answer that you think applies to YOU the most- 
not what you think ‘most people’ would say or do 
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The following questions ask you what you think about your illness.  For the following 
questions, please circle the number that best describes what you think: 
QUESTIONS ABOUT YOUR VIEW OF YOUR ILLNESS 
How much does your illness affect your life? 
 
 
 
0 1 2 3 4 5 6 7 8 9     10 
No affect 
at all  
         Severely 
affects my life
How long do you think your illness will continue? 
 
 
0 1 2 3 4 5 6 7 8 9     10 
A very 
short time  
         forever 
How much control do you feel you have over your illness? 
 
 
0 1 2 3 4 5 6 7 8 9     10 
Absolutely 
no control 
         Extreme amount 
of control 
How much do you think your treatment can help your illness? 
 
 
0 1 2 3 4 5 6 7 8 9     10 
Not at all           Extremely 
helpful 
How much do you experience symptoms from your illness? 
 
 
0 1 2 3 4 5 6 7 8 9     10 
No symptoms at 
all  
         Many severe 
symptoms  
How concerned are you about your illness? 
 
 
0 1 2 3 4 5 6 7 8 9     10 
Not at all 
concerned 
         Very concerned 
How well do you think you understand your illness? 
 
 
0 1 2 3 4 5 6 7 8 9     10 
Don’t understand 
at all  
         Understand very 
clearly 
How much does your illness affect you emotionally? (e.g. does it make you angry, scared, upset or depressed? 
 
0 1 2 3 4 5 6 7 8 9     10 
Not at all affected 
emotionally  
         Extremely affected 
emotionally 
Please list in rank-order the three most important factors that you believed caused your illness.  The most 
important causes for me:- 
 
1. _________________________________________________________________________ 
2. _________________________________________________________________________ 
3. _________________________________________________________________________ 
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QUESTIONS ABOUT HOW YOU FEEL 
Please tick the box next to the statement which best describes your feelings during 
the past week.  Try not to think about your answers for too long  
I feel tense or ‘wound up’: 
? Most of the time  
? A lot of the time 
? From time to time, occasionally 
? Not at all  
I still enjoy the things I used to enjoy: 
? Definitely as much 
? Not quite so much 
? Only a little 
? Hardly at all  
I get a sort of frightened feeling as if  
something awful is about to happen: 
? Very definitely and quite badly  
? Yes, but not too badly 
? A little, but it doesn’t worry me 
? Not at all  
I get a sort of frightened feeling like ‘butterflies’ in 
the stomach: 
? Not at all                                               
? Occasionally  
? Quite often 
? Very often  
I can laugh and see the funny side of things: 
? As much as I always could 
? Not quite so much now 
? Definitely not so much now 
? Not at all 
 
I feel cheerful: 
? Not at all                                        
? Not often 
? Some of the time 
? Most of the time 
Worrying thoughts go through my mind: 
? A great deal of time 
? A lot of time 
? From time to time, but not too often 
? Only occasionally  
I can sit at ease and feel relaxed: 
? Definitely  
? Usually 
? Not often 
? Not at all  
I feel as if I am slowed down: 
? Nearly all the time                             
? Very often 
? Sometimes 
? Not at all   
I have lost interest in appearance: 
? Definitely  
? I don’t take as much care as I should 
? I may not take quite as much care 
? I take just as much care as ever 
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I feel restless as I have to be on the move: 
? Very much indeed 
? Quite a lot 
? Not very much 
? Not at all  
I look forward with enjoyment to things: 
? As much as I ever did 
? Rather less than I used to 
? Definitely less than I used to 
? Hardly at all  
I get sudden feelings of panic: 
? Very often indeed 
? Quite often 
? Not very often 
? Not at all  
I can enjoy a good book or radio or TV program
? Often                               
? Sometimes 
? Not often 
? Very seldom  
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 Not at all 
 
A little Moderate Quite a bit Extremely 
Active ? ? ? ? ? 
Angry ? ? ? ? ? 
Annoyed ? ? ? ? ? 
Anxious ? ? ? ? ? 
Bewildered ? ? ? ? ? 
Bitter ? ? ? ? ? 
Blue ? ? ? ? ? 
Bushed ? ? ? ? ? 
Cheerful ? ? ? ? ? 
Confused ? ? ? ? ? 
Discouraged ? ? ? ? ? 
Energetic  ? ? ? ? ? 
Exhausted ? ? ? ? ? 
Fatigued ? ? ? ? ? 
Forgetful ? ? ? ? ? 
 
Please tick a box next to the mood descriptions that describe best how you have 
been feeling for the past 48 hours.  
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 Not at all A little Moderate Quite a bit Extremely 
Full of pep ? ? ? ? ? 
Furious ? ? ? ? ? 
Grouchy ? ? ? ? ? 
Helpless ? ? ? ? ? 
Hopeless ? ? ? ? ? 
Lively ? ? ? ? ? 
Miserable  ? ? ? ? ? 
Nervous  ? ? ? ? ? 
On edge ? ? ? ? ? 
Peeved ? ? ? ? ? 
Resentful ? ? ? ? ? 
Restless ? ? ? ? ? 
Sad ? ? ? ? ? 
Tense ? ? ? ? ? 
Unable to concentrate ? ? ? ? ? 
Uncertain  ? ? ? ? ? 
Uneasy ? ? ? ? ? 
Unhappy ? ? ? ? ? 
Vigorous ? ? ? ? ? 
Weary ? ? ? ? ? 
Worn out ? ? ? ? ? 
Worthless ? ? ? ? ? 
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I usually don’t 
do this at all 
I usually do 
this a little bit 
I usually do 
this a medium 
amount 
I usually do 
this a lot 
I’ve been concentrating my efforts on 
doing something about the situation I’m 
in 
 
? ? ? ? 
I’ve been trying to come up with a 
strategy about what to do 
 
? ? ? ? 
I’ve been trying to see it in a different 
light, to make it seem more positive 
 
? ? ? ? 
I’ve been accepting the reality of the 
fact that it has happened 
 
? ? ? ? 
I’ve been making jokes about it ? ? ? ? 
I’ve been trying to find comfort in my 
religion or spiritual beliefs 
 
? ? ? ? 
I’ve been getting emotional support 
from others 
 
? ? ? ? 
I’ve been trying to get advice or help 
from other people about what to do 
 
? ? ? ? 
I’ve been turning to work or other 
activities to take my mind off things 
 
? ? ? ? 
I’ve been saying to myself ‘this isn’t real’ 
 
? ? ? ? 
I’ve been saying things to let my 
unpleasant feelings escape 
 
? ? ? ? 
 
 
 
 
QUESTIONS ABOUT HOW YOU COPE  
There are lots of ways to try to deal with stress. This questionnaire asks you to indicate what 
you generally do and feel, when you experience stressful events.  Obviously, different events 
bring out somewhat different responses, but think about what you usually do when you are 
under a lot of stress.   
• Respond to each following items by ticking the box under the category that you think 
fits you the most. 
• Please try to respond to each item separately in your mind from each other item.  
• Choose your answers thoughtfully, and make your answers as true FOR YOU as you 
can.  
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I usually don’t 
do this at all 
I usually do 
this a little bit 
I usually do 
this a medium 
amount 
I usually do 
this a lot 
I’ve been using alcohol or other drugs to 
make myself feel better 
 
? ? ? ? 
I’ve been giving up trying to deal with it 
 
? ? ? ? 
I’ve been criticising myself ? ? ? ? 
I’ve been learning to live with it ? ? ? ? 
I’ve been taking action to try to make 
the situation better 
 
? ? ? ? 
I’ve been thinking hard about what 
steps to take 
 
? ? ? ? 
I’ve been looking for something good in 
what is happening 
 
? ? ? ? 
I’ve been making fun of the situation 
 
? ? ? ? 
I’ve been praying or meditating ? ? ? ? 
I’ve been getting comfort and 
understanding from someone 
 
? ? ? ? 
I’ve been getting help and advice from 
other people  
 
? ? ? ? 
I’ve been doing something to think 
about it less, such as going to movies, 
watching TV, reading, daydreaming, 
sleeping or shopping 
 
? ? ? ? 
I’ve been refusing to believe that it has 
happened 
 
? ? ? ? 
I’ve been expressing my negative 
feelings 
 
? ? ? ? 
I’ve been using alcohol or other drugs to 
help me get through it 
 
? ? ? ? 
I’ve been giving up the attempt to cope 
 
? ? ? ? 
I’ve been blaming myself for things that 
happened 
? ? ? ? 
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INFORMATION ABOUT YOU 
First name:____________________________    Surname:___________________________ 
 
Address: ___________________________________________________________________ 
__________________________________________________________________________ 
__________________________________________________________________________ 
Postcode: __________________________________________________________________ 
Date of birth: __________________________    Age: _______________________________ 
 
 
What is your gender? 
 
?  Female ?  Male 
 
 
 
What is your marital status? 
 
?  Married 
 
?  Single 
 
?  Separated/divorce 
 
 
?  Widower 
 
?  Cohabiting  
 
What is your ethnic group? 
Please read the list below and tick one box that most describes your ethnic origin. 
   
White   
? British  ?  Irish  
Any other White background.  Please describe: 
                                                                         _____________________________________ 
 
Black or Black British 
? Caribbean ? African  
Any other black background.  Please describe: 
                                                                         ____________________________________ 
 
Asian or Asian British 
? Indian ? Bangladeshi  ? Pakistani 
Any other Asian background.  Please describe: 
                                                                           ____________________________________ 
 
Chinese or other ethnic group 
? Chinese   
Any other ethnic group.  Please describe: 
                                                                  _________________________________________ 
 
Mixed  
  
? White and Black Caribbean ? White and Black African ? White and Asian 
Any other Mixed background.  Please describe:  
                                                                          ____________________________________ 
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Have you had any full or part time further or higher education since you left school? 
? Yes ? No 
 
 
 
 
 
 
 
 
 
 
Would you like to receive a summary of the findings for this study? 
? Yes ? No 
 
 
 
 
 
 
 
How long have you had your cancer diagnosis? 
__________________________________________________________________________ 
 
Are you having or will you shortly be having any of the following treatments? 
 
? Chemotherapy ? Radiotherapy (external)  
? Other treatment 
Please explain: _______________________________________________________ 
Thank you for taking the time to fill in this questionnaire 
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Appendix 21: Consent form to receive further information about the study 
 
CONSENT TO RECEIVING FURTHER INFORMATION ABOUT THE STUDY 
 
Evaluation of a preparation session for internal radiotherapy (selectron) treatment.  
 
If you think you might wish to take part of if would like more information before deciding 
to take part please do the following:   
 
1. Fill out your name, address and telephone number below and e-mail 
address if you have one.  
2. Tear off the information about yourself, place it in the envelope and seal 
it.  Give this envelope to the health professional in the consultation with 
you now who will give it to the researchers for this study.  
3. The envelope will only be opened by a member of the research team, 
and Dr Nina Shergill will phone you in a couple of days to explain the 
study further and answer any questions you may have. 
4. Talking with the researcher will not in any way commit you to taking 
part in the study. We just want to make sure you understand the study 
fully before making a decision and/or know what is involved in taking 
part.  
 
Many thanks for taking the time to read this information. 
 
If you are interested in hearing more about the study or might wish to take part 
please complete this response slip. 
 
 
TEAR OFF 
?____________________________________________________________ 
 
Response slip: Evaluation of a preparation session for internal radiotherapy  
                          (selectron) treatment 
 
Name: ________________________________________________________________ 
 
Address: 
______________________________________________________________________ 
 
______________________________________________________________________ 
 
______________________________________________________________________ 
 
Telephone number: 
______________________________________________________________________ 
 
E-Mail address: 
______________________________________________________________________ 
 
Please pass to the professional who has spoken with you about our study.   
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Appendix 22: Power calculation 
 
Study Power 
 
The estimation of the number of patients to be included was performed using the Gpower 
programme. This found that 40 participants in total (20 per group) would be required for 
this study to achieve 80% power with a significance level of 0.05, calculated on the basis 
of an effect size of 0.70 for the primary outcome of anxiety.  There were no comparable 
studies in the literature which had used a psychosocial intervention preparing women for 
IRT.  The effect size used was based on the Spanish study by Leon-Pizarro et al (2007) 
which evaluated a relaxation only intervention on breast and gynaecological patients 
undergoing internal radiotherapy.  This study found a medium effect size (0.54) and the 
authors suggested that the heterogeneous patient group used may have reduced the power 
of the study.  As this study’s intervention goes well beyond relaxation (i.e. addressing 
concerns, cognitive and behavioural coping strategies), is conducted with a homogeneous 
group of patients, a power calculation was conducted on the basis of finding a somewhat 
larger effect size.  Thus an effect size of 0.70 was selected.   
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Appendix 23: Figure of procedure in the study 
 
Health professionals introduce study to potential participants during consultation.  Patients are provided with 
information sheet, consent form and baseline questionnaire.  Patients know from the information sheet if they are in the 
usual care (control group) or intervention group.  Patients can ‘opt-in’ to have the researcher contact them in next few 
days (not less than 24 hours) to answer their questions and give information about the study over the phone.  
Opt in – researcher will ring patients 
in 2-4 days time.  Patients are 
reminded that they can choose to 
opt out at this point. 
Opt out – no contact made by 
researcher  
If consent form not received within 7-14 days, 
reminder letter sent to potential participants  No consent
Intervention participants 
Telephone contact (informed in information sheet) 
to arrange time for preparation session  
Withdraw 
consent 
Pre-treatment questionnaire sent 2 weeks before treatment.  Telephone follow-up if questionnaire is not received 
within 7 days and participants are invited to complete questions over the phone  
Attend preparation session  Withdraw 
consent 
Booster telephone session 
Post-treatment questionnaire completed day after treatment. Those unable to do this will be 
contacted by phone (within 48 hours) and invited to complete questions over the phone. 
Withdraw 
consent 
Telephone contact to collect feedback on intervention  
Internal radiotherapy treatment 
Usual care participants 
Withdraw 
consent 
Withdraw 
consent 
 Once consent form received from patients, participation in study begins.  If baseline questionnaire is not received with 
consent form, then participants will be contacted by telephone and invited to complete the questions over the phone. 
Participation in the study is complete.  Summary of results sent if requested by participant  
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Appendix 24: Distress Thermometer  
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Appendix 25: Table of tests to assess group differences at baseline 
 
 
 
T-tests Time points assessed t-value Degrees of 
freedom 
Significance 
level 
HADS-A Baseline  0.822 17 0.42 
HADS-D Baseline  0.395 17 0.70 
POMS Baseline  0.402 17 0.70 
Mann 
Whitney 
Test 
Time points U value N1, N2 Significance
IPQ  Baseline  23.500 9, 10 0.079 
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Appendix 26: Individual scores for anxiety and depression as measured by the HADS. 
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Figure showing individual scores on the HADS anxiety sub-scale at baseline, pre-
treatment and post-treatment for the intervention group. 
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Figure of individual scores on the HADS anxiety sub-scale at baseline, pre-treatment and 
post-treatment for the control group 
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Figure of individual scores on the HADS depression sub-scale at baseline, pre-treatment 
and post-treatment for the intervention group 
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Figure showing individual scores on the HADS depression sub-scale at baseline, pre-
treatment and post-treatment for the control group 
 
 
 
 
